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The estimated global burden of STEC (Shiga toxin producing Escherichia coli) is 2,481,511 illnesses, 
269 deaths, and 26,827 DALYs with 48% of these being foodborne. This thesis provides 
information on STEC diagnostic strategy, undetected STEC in a tertiary referral hospital in Cape 
Town, and the virulence and antimicrobial resistance properties of tellurite resistant diarrheic E. 
coli isolated on CHROMagarTMSTEC (CHROMagar Microbiology, Paris, France). Deploying the 
One – Health surveillance approach to study selected diarrheic bacterial pathogens in an informal 
settlement setting, this study sheds light on the extent of bacterial foodborne pathogens in human 
and non-human sources. 
Methods 
The performance of CHROMagarTMSTEC for screening for STEC. in stool, river water, and meat 
was assessed relative to an in-house developed duplex real-time PCR assay (for detection of stx1 
and stx2) as gold standard. Stool samples presented to the stool culture bench at a tertiary referral 
hospital between September 2014 and May 2015 were screened for STEC using 
CHROMagarTMSTEC with and without enrichment in Tryptic Soy Broth. Not all specimen were 
enriched so as to evaluate the performance of the medium in either of the culture conditions. The 
enrichments were screened for stx using the duplex real-time PCR assay. Mauve colonies on 
CHROMagarTMSTEC that were confirmed to be E. coli were tested for possession of the aat, daaC, 
eaeA, ipa, and bfp using gel-based PCR and for stx1 and stx2 using the duplex real – time PCR assay. 
All the diarrheic E. coli were characterised by antibiotic susceptibility testing, serotyping and 
immunochromatography. Using quantitative tandem mass spectrometry, the virulence and 
antimicrobial resistance associated proteins of three selected drug resistant EPEC/STEC strains 
were studied. Differential expression of cell envelope proteins was further investigated using 
Transmission Electron Microscopy.  
Between September 2015 and May 2016, stool from children under 12 years, surface water from 
the Lotus River, and meat from the informal abattoirs were collected and processed using 
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standardised methods. Clinical and epidemiological data was collected using a questionnaire. 
Following enrichment in TSB, samples were tested for virulence genes (using the in-house 
developed duplex real-time PCR assay) and serotype specific marker genes rfbE and wbdl (using 
gel-based PCR). Enrichments were then screened for STEC and other diarrheic E. coli, Salmonella 
enterica (S. enterica), Shigella spp., Campylobacter spp., Aeromonas spp., Plesiomonas spp., and Vibrio 
spp. using standardised methods. The antibiograms, serotypes (for S. enterica and diarrheic E. coli), 
and virulence genes carried (by the diarrheic E. coli) were determined. The total coliform count 
per ml of Lotus River surface water was also determined. 
Multi- Locus Variable Number of Tandem-repeats Analysis (MLVA) was conducted on diarrheic 
E. coli from human and non-human sources targeting seven genomic VNTR loci. Two multiplexes
and one singleplex PCR was done using dye-labeled primers and capillary electrophoresis done 
to determine fragment sizes. The electrophoregram files were directly imported into the 
BioNumerics v7.6 software and the number of tandem repeats per locus (allelic number) 
determined. A dendrogram was then constructed using categorical coefficients and the ward 
algorithm. 
Results 
The mean melting temperature on melt-curve analysis for detection of stx1 was 58.2 ̊C and for stx2 
was 65.3 ̊C; detection of both targets could therefore occur in the same run. The limit of detection 
of the duplex real-time PCR assay was 5.3 target copies/µl of broth, 116 ±4.03 CFU per 25g of meat 
and 144 ±6.4 CFU/100ml of Lotus River surface water for both targets. For stool, the sensitivity, 
specificity, negative predictive value and positive predictive value of the CHROMagarTMSTEC 
were 33.3%, 77.4%, 95.3% and 11.3% respectively. For water, the sensitivity, specificity, negative 
predictive value and positive predictive value of the CHROMagarTMSTEC were 5.26%, 66.7%, 
62.5% and 6.25%, respectively. For meat, the sensitivity, specificity and negative predictive value 
of the CHROMagarTMSTEC were 0%, 52.94% and 66.7%, respectively. 
A total of 733 stool samples (226 were enriched while 507 were not) were processed in Groote 
Schuur Hospital. Of the 226 stool specimens screened with enrichment, real-time PCR detected 
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stx in 14 specimens (6.2%, 95% Confidence Interval=3.43%-10.18%), comprising eight stx1, five stx2 
and one with both stx1 and stx2. Of the 33 diarrheic E. coli isolates, 15% (5/33, 95% CI=6.7 – 30.1) 
were STEC, 45% (15/33, 95%CI=29.84 – 62.01) were EAggEC, 18% (6/33, 95%CI=8.6 – 34.4) were 
atypical EPEC, 15% (5/33, 95% CI=6.7 – 30.1) were typical EPEC, and 3% (1/33, 95%CI=0.54 – 15.32) 
were DAEC. Serotypes O104 (5/33, 15%) and O55 (6/33, 18%) were the dominant diarrheic E. coli 
serotypes. Fifty-five percent of the 33 diarrheic E. coli (95% CI = 40.8 – 72.7) showed resistance to 
ampicillin while all the isolates showed resistance to trimethoprim-sulphamethoxazole.  
The proteomes of three selected EPEC/STEC isolates showed an abundance of virulence and 
antimicrobial resistance proteins. The ciprofloxacin-resistant strain showed greater cell envelope 
thickness compared to the ciprofloxacin susceptible EPEC and STEC strains. 
In the Nyanga township, 66, 64, and 85 stool, water, and meat samples were tested. The rfbE and 
wbdl were detected in 2% (1/66) and 2% (1/66) of stool, 6% and 0% of meat, and 14% and 8% of 
water respectively. Of the 66 stool samples tested, the bacterial pathogens detected were: S. 
enterica (6%, 4/66), Shigella flexneri (17%, 11/66), Plesiomonas shigelloides (9%, 6/66), Aeromonas 
sorbria (3%, 2/66), Campylobacter jejuni (5%, 3/66), DAEC (12%, 8/66), EAggEC (3%, 2/66), STEC 
(2%, 1/66), EPEC (2%, 1/66), and EIEC (2%, 1/66). Of the 64 water specimens screened, real-time 
PCR detected stx (stx1 only) in 19 samples (30%, 95% Confidence Interval= 18.91%-42.42%). The 
bacterial pathogens detected were: Shigella flexneri (5%, 3/64), Plesiomonas shigelloides (17%, 11/64), 
Aeromonas sorbria (6%, 4/64), DAEC (3%, 2/64), EAggEC (2%, 1/64), STEC (2%, 1/64), and non-
choleare-Vibrio (9%, 6/64). Of the 85 meat specimens, real-time PCR detected stx in 21 samples (17 
stx1 and 4 stx2) (25%, 95% CI= 13.06%-31.39%). The bacterial pathogens detected were: Salmonella 
enterica (5%, 4/85), Plesiomonas shigelloides (1%, 1/85), Aeromonas sorbria (3%, 3/85), Campylobacter 
jejuni (7%, 6/85), DAEC (2%, 2/85), and EPEC (1%, 1/85). For all sample types, the number of 
diarrheic E. coli virulence genes detected in the TSB enrichments was higher than the actual 
number of diarrheic E. coli isolated There was no significant difference in the prevalence of 
resistance to selected antibiotics among human and environmental diarrheic E. coli isolated in 
Nyanga. Water from the Lotus River surface water possessed a high number of faecal coliforms 
(mean CFU/ml =1.11E+06 -2.74E+05) indicating faecal contamination.  
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Conclusions 
These studies demonstrate the importance of a One – Health surveillance approach for foodborne 
disease, and the need for broader adoption of similar surveillance approaches in South Africa. 
Specific gaps in this work, which should be addressed by further studies include the following: 
(1) using alternative culture media that allow growth of tellurite susceptible STEC to determine
the extent of tellurite susceptible STEC, (2) comprehensive microbiological testing and strain 
characterization on patients presenting with HUS to determine strains associated with severe 
disease, (3) a larger scale case-control study over at least 12 months needs to be carried out in 
both primary health care and the community to determine pathogens associated with diarrhoea 
in children under 12 years, (4) Larger scale studies on food from informal abattoirs and river 
surface water are needed to determine the generalizability of our findings, (4) there is need to 
screen for antimicrobial resistance genes in the human and non-human samples in addition to 
determining the antibiograms of specific foodborne pathogens isolated, so as to assess the true 
magnitude of foodborne antimicrobial resistance (5) the linkage between ciprofloxacin resistance 
in STEC/EPEC strains and cell envelope thickness (as determined by transmission electron 
micrography) should be further examined using, a larger sample size and carefully controlled 
experimental design.  
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Chapter One 
1 General Introduction and Thesis Outline 
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1.1 General Introduction 
Shiga toxin producing E. coli (STEC) is one of the emerging foodborne pathogens that can lead to 
acute renal failure associated with haemolytic-uraemic syndrome (HUS) and haemorrhagic 
colitis1 in infected patients as well as enormous economic losses in the food industry.2 Several 
outbreaks of HUS due to STEC have been reported globally, especially in the developed 
countries3-6 and only a few have been reported in Africa.7,8 In many of these outbreaks, the 
pathogen mainly reported has been the non-sorbitol fermenting STEC O157:H7. 3-6 More recently, 
the non-O157 STEC-related outbreaks have increased, and the number of non-O157 STEC 
serotypes causing severe human disease is increasing.9,10 However, in South Africa, since the 1990 
outbreak that was caused by E. coli O157: NM, no E. coli O157 related outbreak has been reported. 
At the National Institute of Communicable Disease (NICD), research carried out showed that of 
the 2378 diarrheic E. coli collected between 2006 and 2009, 14 were STEC and only one was STEC 
O157:H7. In the NICD study, the 14 STEC were a co-incidental finding because they initially had 
been presented to the NICD as enteropathogenic E. coli (EPEC) given that they also carried the 
eae gene - a virulence marker for EPEC.11 Despite the low STEC detection levels, there have been 
reports of high rates of acute renal failure associated with typical HUS for example at the Pretoria 
Academic Hospital.12,13 In February 2017, another outbreak of typical HUS (un published work in 
which the PhD candidate participated) was reported at the Red Cross War Memorial Hospital 
involving four children. In this epidemic, biltong and a few other meat products were suspected 
reservoirs of the causative STEC pathogen. The non-human (environmental) reservoirs of STEC 
in Cape Town are not known. There is no published data on the prevalence of STEC in the non-
human environment. Even though South Africa has an excellent public health system with 
functional food inspection systems at the established abattoirs, meat from the informal slaughter 
setting in the informal settlements such as Nyanga is not inspected.  
In a bid to improve storm water quality in the City of Cape Town, a private firm called Mott 
MacDonald PDNA (Cape Town, South Africa) was hired to investigate the contributing factors 
to the pollution of storm water- a significant component of the City of Cape Town aquatic 
systems. The outcomes of this investigation showed that the informal abattoirs, which are open 
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spaces in the townships are a primary source of blood, gastro-intestinal contents, salts from hide 
curing, and other post slaughter waste that gets washed into the storm water channels such as 
the Lotus River. The gastro-intestinal contents are a rich source of foodborne pathogens including 
STEC.14-16 And yet the informal abattoirs are the primary source of animal protein for people from 
the low to middle-income areas of Cape Town. 
At the Groote Schuur Hospital, a tertiary referral hospital in Cape Town, the stool is screened for 
STEC on physician request only. Screening is done only for E. coli O157:H7 basing on the non-
sorbitol fermentation property. As is the case in the developed countries and as recommended 
the Centre for Disease Control (CDC, U.S.A)17, all stool samples from patients with acute 
diarrhoea should be screened for STEC.18 Previous research on STEC at the Groote Schuur 
Hospital by Kullin et. al, focused on the presence of stx in DNA directly extracted from stool 
samples.19 This research therefore never attempted to isolate viable STEC from the stool and did 
not provide data on the serotypes, and virulence characteristics of STEC. 
CHROMagarTMSTEC is a chromogenic medium that allows tellurite resistant E. coli to form 
mauve colonies and has previously been tested for clinical and public health use in the developed 
countries. It showed excellent sensitivity for O157 and the top six non-O157 STEC serotypes. For 
this reason, it would be a good alternative to the use of sorbitol MacConkey that targets only E. 
coli O157:H7 given the increasing number of non-O157 STEC that are involved in outbreaks. This 
medium allows the formation of mauve colonies by tellurite resistant STEC. However, not all 
STEC are tellurite resistant, and so the tellurite susceptible STEC is missed on this medium.20,21 
Additionally, other pathotypes of diarrheic E. coli are tellurite resistant and form mauve colonies 
on CHROMagarTMSTEC.22 This medium has been shown to favour the growth of the stx-negative 
derivatives of the major STEC serotypes (EHEC-like).23 The shades of mauve displayed by 
tellurite resistant strains in this media also vary. From the currently published literature, no study 
in Africa has evaluated the use of this medium for isolation of STEC in clinical and public health 
settings. In this study, we report on only the tellurite resistant STEC and diarrheic E. coli (formed 
mauve on CHROMagarTMSTEC) in Cape Town. We focused on three sample types likely to be 
involved in the transmission cycle of STEC in this setting namely; stool from children less than 
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12 years attending the Nyanga Community Health Centre (NCHC), meat from the informal 
abattoirs in Nyanga, surface water from the Lotus River, and stool samples (irrespective of age 
and clinical data) from the Groote Schuur Hospital (GSH). Firstly, we validated an in-house 
developed hybridization probe-based real-time PCR assay able to simultaneously detect both stx1 
and stx2 targets, for screening stool, meat and surface water for STEC. Secondly, we used the in-
house validated real-time PCR assay as the gold standard to evaluate the performance of 
CHROMagarTMSTEC medium for screening meat from the informal abattoirs in Nyanga, surface 
water in Lotus River, and stool at the Groote Schuur Hospital. Thirdly, we characterised would 
be undetected STEC at GSH, and then used quantitative proteomics to assess the virulence and 
antimicrobial resistance proteins of three EPEC/STEC strains that formed mauve colonies on 
CHROMagarTMSTEC. This was aimed to predict the pathogenic potential and clinical relevance 
of diarrheic E. coli that formed mauve on this medium and to assess production of tellurite 
resistance proteins by these strains. Fourthly, we sought to determine the prevalence of STEC, 
diarrheic E. coli, and other foodborne pathogens in the stool of children less than 12 years 
attending the Nyanga Community Health Centre, meat from the informal abattoir settings, and 
the surface water from the Lotus River (section draining the Nyanga Township). Lastly, we used 
Multi-Locus Variable Number Tandem Repeats Analysis to determine the MLVA genotypes of 
diarrheic E. coli from human and non-human sources in Nyanga, as a means of source tracing 
and identifying the reservoirs of STEC in the Nyanga Township. The One Health approach was 
used to define the prevalence and characteristics of STEC at the human-environment interface in 
Cape Town. 
1.2 Aims of the study 
Aim 1: Enhanced surveillance of STEC and other diarrheic E. coli from human and non-human 
sources in Cape Town, South Africa. 
Objective 1.1: To validate a real-time PCR test and compare it to culture on CHROMagarTMSTEC 
for detection of Shiga-toxin-producing E. coli in stool, water from the Lotus River, and meat 
samples from the informal abattoirs. 
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Objective 1.2: To detect and characterise undiagnosed Shiga-toxin-producing E. coli and other 
diarrheic E. coli in stool processed at a tertiary referral hospital, Cape Town, South Africa. 
Objective 1.3: To compare the proteomes of three clinical diarrhoeagenic drug-resistant E. coli 
isolates grown on CHROMagarTMSTEC media. 
Aim 2: Characterise the 2015/16 epidemiology of circulating STEC and other foodborne bacterial 
pathogens isolated from stool, meat and the Lotus River surface water, Nyanga, Cape Town. 
Objective 2.1: To determine the prevalence and characteristics of STEC and other bacterial enteric 
foodborne pathogens from children with diarrhoea, meat from the informal abattoirs and Lotus 
River surface water in Nyanga Township, Cape Town, South Africa. 
Objective 2.2: To determine the Multi-Locus Variable Number of Tandem Repeats Analysis 
(MLVA) genotypes of STEC and other diarrheic E. coli from the stool, meat from the informal 
abattoirs and Lotus River surface water in Nyanga Township, Cape Town. 
1.3 Study design and population 
1.3.1 Study design 
This was a cross-sectional study conducted in Cape Town to investigate STEC in human and non-
human sources. This study was conducted at the Groote Schuur Hospital and the Nyanga 
Township. In the Nyanga Township, participants were recruited at the Nyanga Community 
Health Centre. The environmental aspect of the study was conducted in Nyanga Township and 
involved sampling meat from the informal abattoirs and surface water from the Lotus River (the 
section traversing the Nyanga Township). 
1.3.2 Study population 
1.3.2.1 Groote Schuur Hospital 
Between September 2014 and May 2015, we collected residual stool (submitted for bacterial 
pathogen culture) after routine testing from 733 consecutive stool specimens (irrespective of age 
or related clinical data) from the National Health Laboratory Services located at the Groote 
Schuur Hospital.  
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1.3.2.2 Diarrhoea patients at the Nyanga Community Health Centre 
We consecutively collected 66 stool samples from children less than twelve years of age with 
diarrhoea that attended the NCHC on Monday, Tuesday, and Wednesday of every week during 
the study period (For six months between October 2015 and April 2016).  
Inclusion criteria: Only children whose guardians consented to participation in this study and 
attended the Nyanga Community Health Centre on Monday, Tuesday, or Wednesday during the 
study period were included.  
Exclusion criteria: Children whose guardians did not consent to participation in the study were 
excluded. 
1.3.2.3 Environmental sampling 
Between October 2015 and May 2016, we used random sampling to collect Forty-nine (49) raw 
and 36 ready – to - eat meat samples from 53 randomly selected local stalls along main access 
roads in the Nyanga Township.  
Sixty-four (64) surface water samples were consecutively collected over a period of ten months 
(between 7 a.m and 12 noon) from July 2015 to April 2016 (Figure 1:1).  









Lotus River surface 
water 
733 stool samples 66 stool samples 85 meat samples 64 water samples 
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1.4 Ethics consideration 
Ethical clearance to conduct research at the Groote Schuur Hospital was obtained from the 
Human Research Ethics Committee of the Faculty of Health Sciences, University of Cape Town 
(HREC REF: 015/2014). 
To conduct research in Nyanga, ethical approval was obtained from the Research and Ethics 
Committee of the Faculty of Health Sciences, University of Cape Town, South Africa; HREC 
140/2015. Also, consent was received from the ethics committee of the City of Cape Town 
(Identification number: 10516/6547). 
1.5 Overview of the laboratory work flow 
1.5.1 Laboratory work flow for stool samples from the Groote Schuur Hospital 
Of the 733 stool specimens (based on convinience), 507 stool samples were processed by direct 
streaking onto CHROMagarTMSTEC, while 226 stool samples were enriched in Tryptic Soy Broth 
before streaking on CHROMagarTMSTEC. (Figure 1:2). Isolates confirmed as E. coli were then 
tested for possession of virulence genes by real-time and gel-based PCR. Only the E. coli isolates 
that carried virulence genes were serotyped, tested for sorbitol fermentation, tested for Shiga 
toxin production using immunochromatography, and tested for susceptibility to antibiotics using 
VITEK 2 automated system (biomerieux, USA) and broth microdilution. 
Figure 1:2 Laboratory work flow for stool samples from the Groote Schuur Hospital, Cape Town. 
32 
1.5.2 Laboratory work flow for stool, meat, and surface water samples collected in 
Nyanga. 
Stool samples were enriched in TSB for 24h before streaking on CHROMagarTMSTEC. The meat 
was pummeled in a sterile stomacher bag and 25g of tissue enriched in 225ml of TSB for 24h 
before streaking on CHROMagarTMSTEC. 100ml of water was filtered through a 0.45µm 
nitrocellulose membrane and then membrane placed in TSB with agitation before incubation for 
24h. The medium provides presumptive E. coli isolates (Mauve colonies) which were confirmed 
to be E. coli using the VITEK® 2 automated microbial identification system (biomerieux, USA, St. 
Louis, MO). E. coli isolates were then tested for possession of virulence genes using real-time PCR 
or gel-based PCR. Only those E. coli isolates that tested positive for virulence genes were then 
serotyped and tested for susceptibility to antibiotics using the VITEK® 2 automated system 
(biomerieux, USA, St. Louis, MO) and the broth microdilution method . From the TSB enrichment 
(or directly from stool or processed sample), we tested for other foodborne diarrhoea pathogens 
including Salmonella, Shigella, Plesiomonas, Aeromonas, Campylobacter, Vibrio, and Yersinia using 
selective culture media. The enrichments were also tested for serotype specific marker genes rfbE 
and wbdl (Figure 1:3). 
Figure 1:3 Summary of the laboratory work flow for meat, stool and surface water samples from Nyanga. 
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1.6 Outline of the thesis 
Chapter Two is a narrative of literature focusing mainly on STEC surveillance including 
serotypes, virulence factors, phylogenetic analyses, laboratory diagnosis, antimicrobial 
susceptibility testing, source attribution, and national surveillance strategy. Chapter Three 
involves the validation of an in-house developed real-time PCR, which is then used as a gold 
standard to assess the performance of CHROMagarTMSTEC for screening stool, surface water, and 
meat from the informal abattoirs in Nyanga. Chapter Four covers the characteristics of the 
undiagnosed STEC and other diarrheic E. coli at the Groote Schuur Hospital. Chapter Five 
involves proteomic comparison of the proteomes of three diarrheic E. coli isolated on 
CHROMagarTMSTEC. Chapter Six focuses on Nyanga. It considers the prevalence and 
characteristics of STEC (tellurite resistant strains), and other foodborne pathogens in meat, 
surface water, and stool. Chapter Seven is about the source tracing of STEC and other diarrheic 
E. coli in Nyanga. Here we determined the MLVA genotypes of diarrheic E. coli from the Lotus
River surface water, meat from the informal abattoir, and stool from children less than 12 years 
of age attending the NCHC. Chapter Eight is a general discussion of the main findings in this 
study, and the general conclusions. 
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Chapter Two 
2 One Health- an integrated approach to surveillance of 
foodborne bacterial pathogens and Foodborne antimicrobial 
resistance: A Review of the Literature  
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2.1 The Global Foodborne Disease Burden 
According to the World Health Organisation (WHO), foodborne diseases are defined as illnesses 
resulting from the ingestion of foodstuffs contaminated in the process from food production to 
consumption with microorganisms or chemicals. Often, foodborne diseases present clinically as 
gastro-intestinal symptoms like diarrhoea.1 In the Global Enteric Multi-center Study that was 
conducted in sub-Saharan Africa and Asia, most attributable cases of moderate to severe 
diarrhoea (considering all the study sites in sub-Saharan Africa and Asia) were caused by four 
pathogens namely; rotavirus, Shigella, enterotoxigenic E. coli that produces the heat stable toxin 
(ETEC-ST), and Cryptosporidium.2 Other pathogens like Aeromonas (important in Bangladesh and 
Pakistan), and Campylobacter (important in India, Bangladesh, and Pakistan) were associated with 
moderate-to-severe diarrhoea in some sites but not the others. Of the four main pathogens 
reported in the GEMS (rotavirus, Shigella, enterotoxigenic E. coli, and Cryptosporidium), rotavirus 
is mainly transmitted from human to human, Shigella is mainly transmitted via water, while both 
Cryptosporidium and ETEC-ST are mainly transmitted via food. Not all bacterial pathogens 
causing foodborne disease are transmitted solely by food; other transmission routes such as 
animals, humans, and the inanimate environment exist. Foodborne bacterial pathogens such as 
Shiga toxin producing Escherichia coli (STEC), other diarrheic E. coli, and Salmonella enterica are 
mainly transmitted via food at several points during production and processing while others like 
Listeria monocytogenes are almost 100% foodborne.3 For this reason, estimation of the global 
burden of foodborne disease is complicated. In order to have reliable estimates of the burden of 
foodborne disease, it was necessary to determine the relative contributions of food (as a 
transmission route) to the burden of foodborne disease. The most recent estimates of the burden 
of foodborne disease by the World Health Organisation (WHO) are reliant on a structured expert 
elicitation study whose main purpose was to estimate the relative contribution of food to the 
global burden of diseases transmitted via food.3 Consequently, it was established that the global 
burden of foodborne disease in 2010 caused by 31 hazards (bacterial and non-bacterial) was 33 
million disability adjusted life years (DALYs) with 40% of the burden bore by children under the 
age of five years.4  
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The impact or effect of the different pathogens can be weighted in terms of DALYs per case or 
per 100,000 population.5 Per the Foodborne Epidemiology Research Group of the WHO, 
enteropathogenic E. coli (EPEC) had the highest global DALYs per 100,000 for children under the 
age of five years as compared to other foodborne bacterial and viral pathogens (Figure 2:1). 
Listeria monocytogenes had the highest DALYs per case as compared to other foodborne bacterial 
and viral pathogens.  
Figure 2:1 Foodborne Disability-adjusted life years per 100,00 and per case attributable to the different biological and 
non-biological hazards 
LM= Listeria monocytogenes, VIB= Vibrio cholerae, SHI= Shigella, TS= Typhoidal Salmonella, ETEC= 
enterotoxigenic E. coli, CAMP= Campylobacter, NTS= non - typhoidal Salmonella, EPEC = 
enteropathogenic E. coli. The unlabeled coloured points represent non-bacterial foodborne hazards. 
This map was adopted (and modified) from the WHO FERG website.5  
2.2 Surveillance for foodborne disease 
2.2.1 The One- Health approach  
The concept of One Health is hinged on the integration of human, animal and environmental 
health in addition to scrutiny of socio-economic drivers of infectious disease.6,7 Due to pathogen 
transmission between humans, animals and the inanimate environment, it is important to focus 
surveillance and intervention across the three facets.8 The interconnectedness of individual, 
regional, global public health and planetary environments, will require a One Health approach 
to food safety. One Health has been defined as a multidisciplinary approach to attain optimal 
health for people, animals, and the inanimate environment.9 Also, social and economic drivers 
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influence transmission of infectious disease while policy and political issues become key when 
carrying out cross-institutional interventions.10,11 The concept of “One Health, One City” assumes 
a dynamic equilibrium at the human-animal-inanimate environment interface with pathogen 
transmission across the three facets without limitation of geographical, administrative or political 
boundaries; this is also referred to as “global interconnectedness”.7 One example of global 
interconnectedness is the global food chain. The global food chain refers to the complex networks 
through which food is transported from one region to another, and across nations and continents 
such that the distance from the “farm” to the “fork” is increased. For example, a meal consumed 
in South Africa, comprising of onions produced in Brazil, tomatoes grown in Zimbabwe, and 
mushrooms grown in Botswana. In effect emergence of foodborne disease in any of the countries 
involved in the food chain means that all the other countries in the food network may become 
affected. Three main factors have been shown to play a key role in the emergence of foodborne 
disease globally; (1) intensification of agricultural production12 (2) increased interaction between 
human, domestic animals, wild animals13 (3) environmental “commons” such as water.14 The 
intensification of agricultural production is such that huge numbers of animals are reared on the 
same farm with increased contact between the animals. Such a farm would be producing large 
quantities of meat and meat products for sale and with a wide consumer base. In the case of a 
foodborne disease on such a farm, it would spread widely affecting many people. 
2.3 Foodborne Antimicrobial Resistance 
2.3.1 A general overview 
On the whole, the consumption of antibiotics in the clinical setting is rising globally due to 
improved standards of living, access to health insurance and the high burden of infectious 
disease. However, in resource-limited settings as is the case in many parts of Africa, over a million 
children die annually from infectious disease due to a lack of access to antibiotics.15,16 Despite the 
limited access to antibiotics in a clinical setting, there is often resistance to first-line antibiotics 
which would be used to treat common infectious diseases. Additionally, there is a lack of effective 
public health facilities in resource-limited settings, lack of access to clean water, poor hygiene, 
and inadequate waste disposal systems encourage the spread of infectious disease usually caused 
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by drug-resistant pathogens. Consequently, resistant pathogens (in humans) are propagated 
from person to person and into the environment.17 Concomitantly, antibiotics are used for the 
treatment of animal diseases among the food animals. Given the poor veterinary infrastructure 
in many resource-limited countries, these antibiotics are misused, and antibiotic residues end up 
in the environment (surface waters) and in foods of animal origin such as milk, eggs, and meat.18 
Also, antibiotic resistant bacteria from the gut of the slaughtered food animals might get 
disseminated in the food of animal origin.19-22 Consequently, consumption of these foods of 
animal origin leads to exposure to sub-therapeutic levels of different antibiotics, and to antibiotic 
resistant bacteria with zoonotic potential.  
2.3.2 Informal abattoirs and storm water as reservoirs of antibiotic resistant 
pathogens 
2.3.2.1 Stormwater  
Stormwater is runoff that is tunnelled in streams after rainfall and is a significant component of 
the urban aquatic systems. Stormwater washes different environmental niches such as 
homesteads, hospitals, farms, and industries. It affects the water quality in the urban aquatic 
systems because it feeds into the general sewage treatment system. Sewage has to be treated for 
recycling - very contaminated sewage is not easily treated for recycling. Stormwater has been 
shown to be contaminated with bacterial pathogens (which could be drug resistant) washed from 
soil23 and with toxic compounds such as Lead and Copper.24 Visceral content, salts used in curing, 
as well as feathers and other animal waste products from informal abattoirs are also washed into 
the storm water channels.25 According to the Department of water affairs and forestry, Cape 
Town, rainwater runoff leads to the introduction of untreated waste into rivers thus affecting 
river health and posing a health risk to the communities that use these waters.26 One such risk is 
the propagation of drug-resistant organisms.27  
2.3.2.2 Informal abattoirs  
Informal abattoirs are unlicensed animal slaughter facilities whose operations are unsupervised 
by veterinary and other public health professionals. Informal abattoirs infrastructure is often poor 
and unsuitable for the purpose. Usually, such slaughter places are sited wrongly- in the 
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immediate neighbourhood of residential areas, public toilet facilities, waste disposal areas, shelter 
sites and busy access roads.28 
Informal slaughter could be drivers for antimicrobial resistance in the communities through two 
main routes; (1) the slaughter personnel who might carry drug-resistant bacteria from animals to 
the general population, (2) through the disposal of animal viscera into the storm water drains and 
thus contaminating the environment with drug-resistant bacteria.27,29 
2.3.3 The South African situation analysis, strategy, and challenges 
The Global Antibiotic Resistance Partnership–South Africa situation analysis report highlights 
the emerging threat of antimicrobial resistance.30 The Antimicrobial Resistance National Strategy 
Framework 2014-2024 aims to optimise surveillance and early detection of antimicrobial 
resistance through strengthening surveillance of local and national resistance patterns and 
antimicrobial use. Additionally, the framework seeks to prevent infection through high coverage 
vaccination programs (vaccination reduces the need for antibiotic use) and adequate infection 
control to combat antimicrobial resistance.31 This strategy, however, is faced with significant 
challenges. For example, in an informal settlement setting, with unacceptable slaughter practices, 
high diarrhoeal disease burden, and inadequate waste disposal, infection control is difficult to 
implement. In such settings, the drivers of antimicrobial resistance could include environmental 
discharge of resistant pathogens (Environmental contamination with enteric bacteria can be a 
result of inappropriate disposal of faecal waste or animal slaughter waste) into water streams.32 
Consequently, through storm water, drug-resistant enteric pathogens are disseminated in the 
inanimate environment. Wastewater and sewerage treatment methods could kill the pathogens 
but not the resistance genes which could effectively be spread through the distribution of 
chlorinated water which is often labelled as “safe” for drinking. 
Unlike South Africa, developed countries face fewer challenges in as far as environmental 
contamination with enteric bacteria. The Center for Disease Control (CDC), through the National 
Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS)- a division of the 
National Center for Emerging and Zoonotic Infectious Disease (NCEZID), antimicrobial 
resistance experts track antimicrobial resistance patterns of bacteria commonly transmitted 
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through food- bearing in mind that antibiotic resistance in other parts of the world could affect 
treatment options in the United States.33  
Broadly, the CDC recommends four essential avenues to control the spread of foodborne 
antimicrobial resistance. These include prevention of the spread of disease (thus eliminating the 
need to use antibiotics), tracking of resistance patterns and the development of new antibiotics 
and diagnostic tests primarily targeting pathogens affecting large portions of the population.33 
Diarrhoea, especially among children under five years, is one of the leading causes of mortality 
and morbidity and therefore diagnostic and prevention strategies aimed at reducing diarrhoea 
would reduce the spread of resistance (fewer antibiotics would be used to manage invasive 
diarrhoeal disease).33,34 It is, therefore, important to track antimicrobial resistance patterns of 
foodborne pathogens and then conduct surveillance of its environmental drivers to establish 
appropriate control measures.17  
2.4 Source Attribution for STEC and other foodborne bacterial pathogens 
As per the Public Health Agency of Canada, source attribution is the association of 
gastrointestinal pathogens causing disease in the human population with different animal 
reservoirs and vehicles. It is important because it helps to consider a variety of factors that play a 
role in the causation of disease and for each, to assess the number of human cases, 
hospitalisations, deaths, and the related costs.35 Even though several methods exist for 
determining the source and burden of human illness, their contributions are complementary and 
as such should be used in combination. The various methods include; microbial subtyping 
comparison, comparative exposure assessment, outbreak data analysis, case-control study, 
intervention study, and expert elicitation. Outbreaks of STEC are identified by determining the 
similarity between patients, for example, exposure to the same potential environmental reservoir, 
microbial properties among geographically related cases that happened at around the same time, 
or if the number of cases in an area is higher than the background incidence.  
At the Gastrointestinal Bacteria Reference Unit in England, the national reference laboratory for 
gastrointestinal pathogens in England, confirmed foodborne pathogens such as STEC O157:H7 
are analysed using Whole Genome Sequencing (WGS). Also, enhanced surveillance 
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questionnaires are administered to all suspect E. coli O157:H7 cases to determine similarities in 
exposure, location and time of onset of illness.36 At this unit, cases can be categorised as domestic, 
travel, household, cluster or sporadic while the groups are classified as family, known or 
wgMLST identified.36 PulseNet International is a global laboratory network dedicated to 
laboratory-based surveillance for bacterial food-borne diseases which comprises of national and 
regional laboratory networks of Africa, Asia Pacific, Canada, Europe, Latin America, the Middle 
East, and the United States. Recently, this network shared its vision to standardize the use of 
whole genome sequencing (WGS) to identify and subtype food-borne bacterial pathogens 
worldwide.37 Presently, this network relies on the use of Pulse Field Gel Electrophoresis (PFGE) 
coupled with Multi-Locus Variable Number of Tandem repeats Analysis (MLVA) to identify and 
investigate foodborne disease outbreaks. However, besides outbreak identification and 
investigation, little information about the outbreak strains can be obtained using these methods. 
Comparatively, WGS data can be used to determine relatedness between outbreak strains as well 
as information about strain characteristics such as serotype, antibiogram, and virulence 
attributes. Additionally, further in-silico analysis can be done on the WGS data retrospectively. 
Challenges to implementation of global use of WGS by the PulseNet International laboratories 
include (1) cost of sequencing, (2) bioinformatics skills need to handle WGS data, (3) Storage of 
short read sequence and contig sequence data generated, and generation of standardized 
protocols to be implemented by all the laboratories in the network. 
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2.5 Diarrheagenic Escherichia coli 
The Genus Escherichia was named after Theodor Escherich who first isolated Escherichia coli. It 
belongs to the order proteobacteria, phylum gamma proteobacteria, order enterobacteriales, and 
family enteroacteriaceae.38 Escherichia are straight gram negative rods [(1.1 – 1.5) µm * (2.0 – 6.0) 
µm] that are either non-motile or motile by means of peritrichous flagella and exist singly or in 
pairs (Figure 2:2). They metabolise by means of respiration or fermentation and rarely produce 
hydrogen sulphide. The species in this genus include Escherichia coli (commensals in the intestinal 
tract of warm-blooded animals), Escherichia hermanii (intestinal and extra-intestinal sites of warm-
blooded animals), Escherichia fergusonii (intestinal and extraintestinal sites of warm-blooded 
animals), Escherichia vulneris (intestinal and extra-intestinal sites of warm-blooded animals), and 
Escherichia blattae (commensals in the hindgut of cockroaches).38 The type species of genus 
Escherichia is Escherichia coli (E. coli). 
Figure 2:2 Transmission Electron Micrograph of E. coli showing rod-shaped cells in A and B at a magnification of 
X10,000 
This micrograph of E. coli was taken by the PhD candidate and has not yet been published. It was taken 
at the Electron Microscope Unit, Center for Imaging and Analysis, University of Cape Town. 
Some E. coli are pathogenic while others are not. The non-pathogenic strains can acquire virulence 
genes through horizontal transfer and thus become pathogenic. The pathogenic E. coli possess 
virulence factors that enable them to cause disease. The weakening of the host immune system, 
production of toxins and other virulence factors such as invasins may lead to diarrhoea and or 
extra-intestinal disease in humans and or animals.39,40  
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Pathogenic E. coli can be categorised into two groups based on the ability to invade beyond the 
intestinal tract. The pathogenic intestinal E. coli cause diarrhoea using a myriad of virulence 
factors while the extraintestinal pathogenic E. coli have possess extra virulence properties that 
enable them to invade extra-intestinal tissues and thus causing infections such as urinary tract 
infections (caused by uropathogenic E. coli-UPEC) and neonatal meningitis (neonatal meningitis 
causing E. coli-NMEC).41 The Avian Pathogenic E. coli (APEC) are also categorised as extra-
intestinal and cause generalised systemic infections in poultry, leading to the death of chicken 
embryos,42 but could also have zoonotic potential.43 A virulence marker protein for extraintestinal 
pathogenic E. coli pathotypes NMEC, UPEC, and APEC is esterase B, which is encoded by the aes 
gene.44  
The extraintestinal pathogenic E. coli have been shown to possess less antimicrobial resistance 
attributes, especially fluoroquinolone resistance, as compared to the intestinal pathogenic E. coli. 
45,46 The phenomenon of reduced virulence traits among the more antibiotic resistant intestinal 
pathogenic E. coli is referred to as the fitness cost of antimicrobial resistance. However, this 
theorem (on the fitness cost of antimicrobial resistance) has not always held true, especially with 
the pandemic spread of antibiotic resistant strains such as the ESBL-producing strain of E. coli47-49 
that carried the CTX-M-15 allele located on conjugative IncFI plasmids.50 In this case, the potential 
to spread so widely was a measure of fitness. 
The intestinal pathogenic E. coli include six main pathotypes: Shiga-toxin-producing E. coli 
(STEC), enteroaggregative E. coli (EAggEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli 
(EIEC), enteropathogenic E. coli (EPEC), and diffusely adherent E. coli (DAEC) whose marker 
genes are stx1 and stx2, aggr, LT/ST, ipa, eaeA and daaC genes respectively. All of these may cause 
diarrhoea, especially in children and the immunocompromised.51 In general, diarrheic E. coli 
could also be carried by normal children without diarrhoea. 52 The more recently described 
pathotypes of diarrheic E. coli include the cell-detaching E. coli and the cytolethal distending 
toxin–producing E. coli, which by epidemiologic associations, have been shown to cause 
diarrhoea.51 
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2.5.1 Enteropathogenic E. coli 
In developing countries, EPEC cause infantile infectious diarrhoea accompanied by fever, 
vomiting, and dehydration.39,40 In the Global Enteric Multicenter Study (GEMS), typical EPEC 
(EPEC with the bundle-forming pili gene) was significantly associated with moderate to severe 
diarrhoea among infants in Kenya.53 This pathotype forms Attachment and Effacement (A/E) 
lesions on the brush border of the small intestine. There are mainly two variants of this pathotype; 
the typical EPEC which carries the E. coli adherence factor plasmid (pEAF) and the atypical EPEC 
which does not have this plasmid.54 The typical EPEC mainly possess virulence factors encoded 
by the E. coli adherence factor plasmid and the LEE (Locus of Enterocyte Effacement) (except for 
a few that carry the cytolethal distending toxin-CDT and the enteroaggregative heat stable toxin-
EAST1). The LEE contains the eaeA gene which encodes intimin. The atypical EPEC are more 
closely related to the LEE-positive STEC in terms of serotypes, genetic characteristics, virulence 
properties, and reservoirs.54 The atypical EPEC are divided into two main categories; (1) those 
with only the LEE-encoded virulence factors, and (2) those with both the LEE and the non-LEE-
encoded virulence factors (for example the CDT and EAST1).55  
In developing countries, typical EPEC are commonly reported in the causation of infantile 
diarrhoea in children while in the developed countries atypical EPEC is a commoner cause of 
diarrhoea.55  
Adherence of these bacteria to the host’s intestinal epithelial cells is initially mediated via the 
bundle-forming pili which are a type IV protein that forms cell to cell connections leading to 
micro-colonies of EPEC along the intestinal surface.56 Adherence is followed by signal 
transduction and intimate attachment. Intimate attachment is a result of interaction between the 
translocated intimin receptor and intimin both of which are encoded by the LEE.39 The secreted 
proteins that play a role in the formation of attaching-effacing (A/E) lesions include the 
translocated intimin receptor protein (Tir)57, mitochondrion-associated protein (Map)58, serine 
protease F (EspF), serine protease Z (EspZ), serine protease G (EspG)59, serine protease H 
(EspH)60, and serine protease B (EspB).61 The formation of A/E histopathology leads to the 
effacement of the brush border microvilli at the site of attachment.62  
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2.5.2 Enteroinvasive E. coli 
Enteroinvasive E. coli (EIEC) is a facultatively intracellular pathogen that causes bacillary 
dysentery mainly by means of alteration of the secretory activity of the intestinal epithelial cells 
by producing the EAST1 (heat stable enterotoxin of enteroaggregative E. coli) toxin and other 
virulence factors encoded by the pINV plasmid. It has very similar virulence and genetic 
properties to Shigella.63,64 The chromosomally located invasion plasmid antigen H gene (ipaH) is 
responsible for the invasion of epithelial cells.64 
2.5.3 Enteroaggregative E. coli and the enteroaggregative haemorrhagic E. coli 
Enteroaggregative E. coli (EAggEC) possesses the aggr gene as the virulence marker and can be 
classified broadly into two groups namely, the atypical (without aggr) and the typical (with 
aggr).65 It causes persistent diarrhoea and traveler’s diarrhoea66 in poorly developed countries.67 
EAggEC have also previously been reported to cause community acquired urinary tract infection 
outbreaks in Denmark.68 The enteroaggregative-haemorrhagic E. coli (EAHEC) or 
enteroaggregative Shiga-toxin producing E. coli strain O104:H4 was shown to be well adapted to 
adverse environmental conditions associated with food processing by the production of a 
bacteriocin, giving it a competitive advantage over other foodborne bacteria.69 The EAHEC lacks 
the LEE and so does not attach to the intestinal cells by means of intimin. Instead, it attaches by 
means of the aggregative adherence fimbrial pili whose gene is carried on the enteroaggregative 
E. coli plasmid.70
2.5.4 Adherent-Invasive E. coli (AIEC)
An increase in the relative proportions of AIEC (pathobiont expansion) in the gut due to 
inflammation has been associated with the onset of  inflammatory bowel disease (IBD).71 IBD is a 
result of a dysregulation of gut bacteria resulting in increased permeability of the epithelial 
barrier in two conditions of the intestinal tract namely; Crohn’s disease (CD) and ulcerative colitis 
(UC).72,73  
Even though most of the AIEC that have been associated with IBD belong to phylotype B2, some 
strains belong to the other phylotypes. AIEC are distinct from other diarrheic E. coli pathotypes 
because they are difficult to identify due to the lack of a specific genetic marker. Particularly, they 
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lack the type III secretion system which is possessed by all the other pathotypes. AIEC 
Pathogenesis involves three main stages namely; (1) Interaction with the intestinal epithelial cells, 
(2) adherence, and (3) invasion. Attachment of AIEC to the intestinal epithelial cells is facilitated
by the upregulation of carcinoembryonic antigen – related cell – adhesion molecule 6 (CEACAM 
6) on the apical surface of epithelial cells in the large intestine.74  CAECAM 6 attaches to the type
1 pili on the surface of AIEC prior to cellular invasion. Invasion is by means of pinocytosis and 
vacuolization.75  Following invasion of the intestinal epithelial cells and macrophages, they 
survive and replicate leading to barrier dysfunction by affecting the intercellular junctions 
between the intestinal epithelial cells.71 
2.5.5 Diffusely Adherent E. coli 
Diffusely Adherent E. coli (DAEC) causes watery diarrhoea which is most severe in children aged 
between 18 months and 5 years.76 It causes disease by secretion of adhesins that attach to 
molecules on polarised epithelial cells leading to alteration of the epithelial cell cytoskeleton. This 
then leads to destruction or rearrangement of the microvilli which are responsible for nutrient 
absorption in the intestinal tract.76  
2.5.6 Cell Detaching E. coli  
These cause diarrhoea by way of attachment by means of the P-pili, production of alpha 
haemolysin, and the release of the Cytotoxic Necrotizing Factor.77 The cell-bound haemolysin 
(hlyA) and not the cell-free hlyA, secreted in vitro during the exponential and stationary phase 
of growth, is responsible for the cell detaching activity of cell detaching E. coli (CDEC).78 By 
epidemiologic associations, it has been linked to diarrhoea in children.77  
2.5.7 Cytolethal -distending toxin-producing E. coli  
This pathotype of E. coli has been reported to cause severe diarrhoea in children in Mexico79, 
Japan80, and Bangladesh81 and was isolated from meat in Northern Ireland.82 It causes disease by 
the production of a potent toxin called the cytolethal distending toxin (CDT). This toxin is coded 
for by three adjacent overlapping genes called the cdtA, cdtB, and cdtC. The toxin leads to arrest 
of the eukaryotic cell cycle at the G1 or G2 phase and thus leading to cell distension and eventual 
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cell death. A variant of the CDT toxin called the CDT-V has been shown to be produced by STEC 
especially the non-O157 STEC that lack the intimin coding locus of enterocyte effacement (LEE).83 
2.5.8 Shiga-toxin-producing E. coli 
Shiga toxin producing E. coli / Verocytotoxigenic E. coli (STEC/VTEC) possess stx genes and have 
previously been associated with global foodborne pandemics resulting in food trade sanctions 
and massive economic losses in the food industry.84 Enterohaemorrhagic E. coli (EHEC) are 
STEC/VTEC that have frequently been associated with severe human disease marked by bloody 
diarrhoea, hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). 
EHEC strains (for example STEC O157, O26, O103, O111, and O145) possess a bacteriophage 
carrying the stx genes which code for the Shiga toxin and a Locus of Enterocyte Effacement (LEE) 
which encodes the intimin protein used in intimate attachment to the intestinal epithelial cells. 
The locus of enterocyte effacement (LEE) is a 35.5kb pathogenicity island which carries genes that 
code for the intimin and type III secretion system proteins (EspA, EspB, and EspD), Outer 
Membrane Protein (OMP) and the translocated intimin receptor (Tir).85 However, LEE-negative 
STEC use alternative virulence factors such as a subtilase (subAB), mucinase (epeA), and an 
adhesin (saa).86 Subsequently, they invade the host epithelial cells using a process mediated by 
bacterial proteins and host cell microfilaments. LEE-negative STEC can also achieve intimate 
attachment using the aggregative adherence fimbrial pili.70 
Even though Levin coined the term enterohaemorrhagic E. coli (EHEC) to refer to a special 
category of STEC that caused severe disease such as E. coli O157,87 the nomenclature term EHEC 
is being replaced with the term verocytotoxin producing E. coli (VTEC) or Shiga-toxin producing 
E. coli (STEC) because of the emergence of outbreaks (marked by severe disease) due to strains
that don’t fit the definitive criteria of EHEC. 
The number of STEC serotypes involved in outbreaks is increasing steadily.88 Shiga-like toxins 
are encoded by genes in the genomes of functional or defective lambdoid bacteriophages termed 
stx-phages.89 The stx-phages are defined by the occurrence of the Shiga toxin operon and can 
integrate into specific sites in the host bacterial chromosome. Bacterial host cells can carry 
multiple stx phages, allowing them to produce several Shiga toxin variants, with recombination 
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of various phage sequences creating potentially novel phages.90 This is the mechanism by which 
new variants of the toxins arise. During the lytic cycle of the stx phages, the bacterial host cell is 
lysed releasing the toxin. The use of certain antibiotics (such as the DNA targeting quinolones) 
induces the SOS DNA repair response which in these bacteria is often synchronised with the 
activation of the phage lytic cycle and release of the Shiga-like toxins.91 
The most important virulence determinants for STEC are the two Shiga toxin families (stx1 and 
stx2).92 Shiga toxin 2 is 1000 times more cytotoxic to human nephrons as compared to Shiga toxin 
1 and therefore STEC isolates that carry the stx2 genes are more commonly associated with severe 
disease.93 Different variants of the stx2 genes are related to differing disease severity. The main 
stx2 variants that have been described based on sequence homology and immunological cross-
reactivity are stx2a, stx2b, stx2c, stx2d, stxe, stx2f, and stx2g.94,95 
Stools should be tested for Shiga toxin as early as possible during illness as it becomes impossible 
to detect them after one week of sickness.84 Loss of the stx phages has been reported in humans- 
initially, stx-positive STEC O26:H11/NM and sorbitol-fermenting O157:NM strains were isolated 
from patients; however, the isolates were stx-negative when isolated several days later from the 
same patient.96,97 Since stx-negative STEC fit the definition of atypical EPEC, Bielaszewska, and 
colleagues looked at these isolates recovered from the bloody stool and suggested that they were 
not atypical EPEC and so they coined the term EHEC-LST (EHEC that had lost the stx) or STEC-
LST (STEC that had lost the stx). Thus the stx status of STEC was proven to fluctuate.98 
Besides the use of the stx and eae genes as virulence markers for STEC, recent research has 
suggested the use of enterohemolysin A gene (ehxA) and ureC (one of the components of the 
urease gene operon) as additional pathogenicity markers in addition to stx2a and eae.99,100 
Possession of the ureC gene was commonly associated with co-carriage of the eae gene, one of the 
pathogenicity indicators for STEC.100 
2.5.8.1 Shiga toxin  
In 1978, Konowalchuk discovered the presence of a verocytotoxin secreted by some E. coli 
strains.101 Later, O’Brien showed that this toxin could be neutralised by antibodies against the 
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toxin produced by Shigella dysenteriae type 1. Thus this E. coli toxin was referred to as Shiga-like 
toxin.89 The rationalised nomenclature for the toxins in the Shiga toxin family was developed by 
Calderwood.102 The genes that code for the Shiga toxins are carried on Shiga toxin converting 
lambdoid phages of different types depending on the toxin subtype.89 These lambdoid phages are 
diverse and cause lysogenic or lytic infection of a diverse array of O157 and non-O157 E. coli. 
Research has proved that commensal E. coli bacteria that are susceptible to infection by the stx 
converting lambdoid phages can amplify Shiga toxin leading to more severe disease.103 All the 
AB halo-toxins (each toxin molecule has one A unit and one B unit that has five subunits) in this 
family cause disease by direct damage to the endothelial cells and thus destabilising the 
homeostatic balance of the affected cells.104-106 The Shiga toxins and the shiga-like toxins belong to 
a large group of toxins secreted by plants and bacteria that cause cellular damage by initial 
binding and then induction of cellular damage by inhibition of protein synthesis and induction 
of apoptosis. Shiga-like toxins are not only released by STEC but also by Citrobacter freundi, 
Aeromonas hydrophilia, and Enterobacter cloacae.84 These toxins affect a wide range of host cells 
including the macrophages and the proximal tubular cells of the human kidney.106 The A unit of 
the toxin is enzymatically active while the B unit has five subunits and is necessary for the 
attachment to the host cell glycolipid receptors. Strictly, these toxins attach to the Gb3 glycolipid 
receptors on the surface of cells and or Gb4 in the case of the stx2e toxins released by some strains. 
Upon attachment, they induce uptake into the Claritin pits and are endocytosed to the Golgi 
apparatus and the endoplasmic reticulum. The protease named furin then cleaves the A unit into 
two fragments, A1 and A2, by cleaving a region flanked by two arginine amino acids. The affected 
cells are induced to secrete either interleukin 1 (IL-1), interleukin 6 (IL-6) or Tumor Necrosis 
Factor (TNF). The secreted cytokines then induce an overexpression of Gb3 receptors on the 
surface of adjacent cells and thus provide attachment sites for more toxic moieties. The A1 subunit 
of the A fragment removes adenine from the 28S RNA of the 60S ribosomal subunit and thus 
prevents attachment of the aminoacyl transfer RNA and in so doing effectively inhibiting protein 
synthesis.84 The A1 fragment also induces programmed cell death (apoptosis) by inducing nuclear 
blebbing, DNA degeneration and release of cellular contents.107  
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2.5.8.2 Other known and Putative virulence factors of STEC 
Since STEC is transmitted through food, including meat and leafy vegetables,108 virulence factors 
possessed facilitate not only the ability to survive and cause disease in the human host but also 
to withstand the stresses it is subjected to during food processing and in the non-human ruminant 
host. Such could include resistance to harsh temperatures, osmotic pressures and heavy metals 
like Zinc and Copper. 109,110 
The infectious dose for STEC is 1-100 CFU which is low compared to other diarrhoea causing E. 
coli.111 This is due to the ability of STEC to survive the acidic conditions in the stomach of the host. 
Acid resistance is mediated by the rpoS gene which encodes a stationary phase sigma factor 
enabling the organism to survive at acidity levels below pH=2.5.112,113  
2.5.8.3 STEC Serotypes 
Globally, over 470 STEC serotypes have been reported. Some of these have commonly been 
associated with severe disease in humans but are not prevalent in wild and domestic ruminants, 
while others are prevalent in ruminants but also cause severe disease in humans; an example of 
such a strain is E. coli serotype O157:H7.114 The serotypes that commonly cause human disease 
have most frequently been reported in domestic and wild ruminants as opposed to the non-
ruminants.108,115  
The severity and frequency of clinical disease are the basis of the seropathotype classification 
scheme that was designed by Karmali et al. This scheme categorises STEC serotypes into five 
seropathotypes (A-E) on the basis of relative incidence, the frequency of involvement in 
outbreaks, and association with severe disease.116 In this scheme, the E. coli serotype O104:H11, 
which caused the recent spinach-contamination related outbreak in Germany, belonged to 
seropathotype C as it was rarely (until after the outbreak)117 involved in outbreaks and with a 
relatively low incidence. (Table 2.1). Seropathotype classification could be useful for predictive 
hazard identification of STEC serotypes.118 











A High Common Yes O157:H7, O157: NM 
B Moderate Uncommon Yes O26:H11, O103:H2, O111: 
NM, O121:H19, O145: NM 
C Low Rare Yes O91:H21, O104:H21, 
O113:H21; others 
D Low Rare No Multiple 
E Non-human 
only 
NA No Multiple 
This table is an extract from Karmali et al.,2003. NA-Not applicable. 
2.5.8.4 Phylogenetic analyses of STEC 
Phylogenetic analysis serves to determine the evolutionary origins and relations of STEC. 
Phylogenetic grouping is using three PCRs targeting the chuA, TSPE4.C2 DNA fragment, and the 
yjaA. The presence or absence of the three fragments determines the group of a pathogenic E. coli 
strain. This analysis is important because it can help predict the potential health risk of an isolate 
from the environment.119 For example, STEC belonging to phylogenetic group A are less likely to 
cause human disease.120 
Of the four main E. coli phylogenetic groups (A, B1, B2 and D), STEC has been shown to belong 
to phylogenetic groups A, B1, and D.121  Extra-intestinal E. coli belongs mainly to phylogenetic 
groups B2 and D while most commensal and other diarrheagenic E. coli belong to phylogenetic 
groups A and B1.120 
2.5.8.5 Laboratory diagnosis of STEC 
Laboratory practice guidelines call for routine investigations for STEC in all diarrhoeal stool 
samples in European countries.122 According to the Centre for Disease Control (CDC), all acute 
community-acquired diarrhoea cases should be screened for STEC in a timely and accurate 
manner since early treatment helps to avoid severe clinical outcome such as renal failure.123 
Commonly, culture for STEC is done on media selective for E. coli O157: H7 and Shiga toxin 
proteins detected from stool by immunochromatography methods following overnight 
enrichment. Currently, in South Africa, at the Groote Schuur Hospital, screening is done for only 
sorbitol-negative E. coli O157:H7 (after 24 hr incubation at 37°C) on sorbitol MacConkey agar at 
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the explicit request of a physician whose basis to request for a laboratory test for E. coli O157:H7 
is usually presence of blood in stool or clinical presentation of HUS.124 
Selective testing of bloody stools, targeting only sorbitol-negative (O157) E. coli, may lead to 
underestimation of the incidence of STEC disease in South Africa, and hinder the laboratory 
detection of STEC outbreak strains. Foodborne disease outbreaks, for example, those caused by 
STEC, in South Africa are a common occurrence but are rarely reported.125 Recently, (February 
2017), there has been an outbreak of STEC at the Red Cross War Memorial Hospital, Cape Town 
leading to HUS in four children (laboratory testing done by this PhD candidate, not yet 
published). In this suspected outbreak, which was caused by eaeA and hlyA positive STEC O26, 
routine screening for E. coli O157:H7 and further screening for the other sorbitol-fermenting E. 
coli strains was required to identify the causative bacteria. However, most NHLS (state) 
laboratories in South Africa focus only on detection of the non-sorbitol fermenting E. coli 
O157:H7. This is not limited to only South Africa but is common in many developing countries, 
where there is difficulty detecting non-O157 STEC as reported by Brooks et al.126 
2.5.8.5.1 Chromogenic media for isolation of STEC 
Several chromogenic media have been developed to screen for the presence of STEC. Some have 
been specifically designed to detect specific serotypes of STEC (CHROMagarTMSTEC O104 for 
isolation of E. coli O104: H4) while others broadly identify several STEC serotypes for example, 
CHROMagarTMSTEC.127 
2.5.8.5.1.1 CHROMagarTMSTEC 
Only tellurite resistant STEC are able to grow on this medium. Tellurite resistance is a result of 
possession of the tellurite resistance gene complex Ter-ZABCDEF.128 Only TerB, TerC, TerD and 
TerE genes are necessary for tellurite resistance.129 Pathogenic STEC have been shown to be 
widely diverse regarding their tellurite resistance properties, with some being  resistant and 
others being susceptible. However, the possession of tellurite resistance genes has been shown to 
be associated with an increased resilience to oxidative stress and survival inside the macrophage 
for tellurite resistant strains compared to the susceptible ones.130,131 
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2.5.8.5.1.1.1 Performance on stool 
A recent study has shown that CHROMagarTMSTEC has a high negative predictive value and has 
the potential to detect the non-sorbitol fermenting E. coli (STEC O157:H7 and O157:NM), as well 
as the conventional sorbitol fermenting strains producing Shiga toxin.132 Of the top six non-O157 
E. coli O-serogroups (seropathotype B) known to cause severe illnesses in humans,
CHROMagarTMSTEC efficiently detects O26, O111, O121, and O145 but its performance has been 
shown to be weaker in as far as detection of ter D negative O103 (only growing if a higher 
inoculum is streaked).133  Using archived isolates and human stool samples, this medium was 
shown to be sensitive for detection of most common STEC serotypes as well as the detection of 
other diarrheagenic E. coli in Finland. The adequately detected serotypes included: O2: [H29], O5, 
O26, O104, O111, O121, O130, O145, O157: [H7], and OX182.  However, the medium showed 
inadequate detection for tellurite susceptible sorbitol-fermenting O157: NM and a common 
clinical serotype O103:H2.132  Gouali and Wylie evaluated the same agar for use on stool and 
found that it had high sensitivity, specificity, and negative predictive value.134,135  The main 
limitation, therefore, with the use of CHROMagarTMSTEC for detection of STEC in stool , is its 
failure to detect tellurite susceptible STEC (Figure 2:3). 
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Figure 2:3 Event tree on use of CHROMagarTMSTEC to screen for STEC in stool, meat, and water 
2.5.8.5.1.1.2 Performance on food samples 
Per the manufacturer of this medium (CHROMagar, Paris, France), the common serotypes of 
STEC form mauve coloured colonies, while the other enterobacteriaceae form blue colonies or are 
inhibited. Tzschoppe et al, 2012 evaluated the performance of CHROMagarTMSTEC on vegetables 
and reported low detection rates for STEC O103:H2 but efficient detection of STEC serotypes O26, 
O103, O111, O118, O121, O145, and O157.136 A comparative study, which compared the 
performance of different chromogenic media for isolation of STEC in food, reported that of six 
chromogenic media compared (including CHROMagarTMSTEC, Rapid E. coli O157:H7, Tryptone 
Bile X-glucuronide agar, Rainbow® Agar O157, Modified MacConkey Agar, and 
chromIDTMEHEC), only CHROMagarTMSTEC and Rapid E. coli O157:H7 were selective enough to 
inhibit the growth of non-STEC strains totally.137 
2.5.8.5.1.2 Other chromogenic media used for isolation of STEC 
2.5.8.5.1.2.1 Performance on stool 
The STEC strain O157: H7 is commonly associated with severe disease and is identified in the 
clinical laboratory because it does not ferment sorbitol and shows marked resistance to tellurite 
CHROMagarSTEC use on Water, Stool, or Meat
Detection
O26, O45, O157:H7, O111, O121, Other tellurite resistant STEC





and cefixime.138 The media used for this purpose are sorbitol MacConkey (to test for sorbitol 
fermentation) and Cefixime-Tellurite Sorbitol MacConkey (to test for sorbitol fermentation as 
well as resistance to cefixime and tellurite).139 Other selective and non-selective media have been 
used to screen for both O157 and non-O157 STEC with varying sensitivity and specificity for the 
different serotypes. Highly STEC selective media such as R&F E. coli O157: H7 agar, Rainbow 
agar and modified Rainbow agar, actually inhibit the growth of the non-STEC organisms but also 
hinder the growth of the non-tellurite resistant strains which grow weakly except on addition of 
washed blood cells.140 Less selective media, such as the STEC Heart Infusion Broth agar with 
Mitomycin C (SHIBAM), although lacking in the inhibitory components possessed by the 
selective agars, rely on the characteristic hemolytic pattern shown by STEC and enable growth of 
STEC that would otherwise be inhibited.141  
In summary, only CHROMagarTMSTEC and Rapid E. coli O157:H7 are selective enough for 
inhibition of non-target strains totally in both clinical and non-clinical samples – an attribute of 
the concentration of inhibitory chemicals present in them (Table 2.2). 
However, Rapid E. coli O157:H7 does not favor the growth of non-O157 STEC. Less selective 
media such as SHIBAM facilitate the growth of tellurite sensitive STEC but are less specific in a 
sense that they permit growth of other microflora in stool or food sample. Therefore, a paired use 
of a more selective and less selective medium may be a better option for isolation of O157 and or 
non- O157 STEC.142 
Table 2.2 A comparison of the performance of different chromogenic media for STEC detection 
Media Level of selectivity O157 STEC Non-O157 STEC 
CHROMagarTMSTEC High + + 
SHIBAM Low + + 
Rapid E. coli O157:H7 High + - 
CT-Sorbitol MacConkey High + - 
R&F E. coli O157:H7 High + - 
Rainbow® Agar O157 Low + - 
chromIDTMEHEC Low + - 
Tryptone Bile X-glucuronide agar Low + + 
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2.5.8.5.2 Microbiological testing of foods 
2.5.8.5.2.1 Testing meat for STEC  
 To aid identification of food safety risks and prevent microbial hazards associated with the 
animal slaughter process, the Hazard Analysis Critical Control Points System (HACCP) is 
increasingly becoming necessary for all meat slaughterhouses to ensure safety and quality of 
meat. All operations during slaughter must be evaluated to ensure that the final product complies 
with stringent food safety objectives (maximum level of microbiological contamination 
acceptable for human consumption).143 In Canada for example, all meat must have zero levels of 
STEC or risk being recalled.144 However, successful implementation of an HACCP system lies 
hugely on the successful identification of the critical control points.145 Based on these, 
microbiological testing of meat is done following both the local and international standards  with 
priority given to pathogens of public health importance. International standards on food testing 
include; Bacteriologic Analytical Methods (BAM of US FDA), International Commission for the 
Microbiological Specification of Foods (ICMSF), American Public Health Association (APHA), 
and Health Protection Agency (HPA of UK). In South Africa, the International Standards 
Organisation (ISO) methodology was adopted by the South African Bureau of Standards and 
referred to as South African National Standards (SANS) methodology or the methodology 
prescribed by the Codex Alimentarius. These methods are prescribed by law in the regulations 
of the Foodstuffs, Cosmetics & Disinfectant Act (Act 54 of 1972) and are generally applied for 
non-automated analytical procedures. Generally, for all these methods, coliform counts per 25g 
of meat are an indicator of how contaminated the meat is with microbes from the gastro-intestinal 
tract of the slaughtered animal. Research has shown that while swabbing with gauze, a tenfold 
increase in the surface area swabbed doubles the number of samples from which coliforms were 
recovered.146  
2.5.8.5.2.1.1 Enrichment for STEC in foods 
The International Organization for Standardization (ISO) recommends that following enrichment 
of a food sample in suitable broth medium, isolation of STEC from all PCR (for stx) positive broths 
should be attempted. Enrichment for STEC in processed foods is necessary because various 
processing methods frequently damage the cells. The use of modified tryptic soy broth 
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supplemented with novobiocin (10mg/liter) is highly selective, but could lead to false negative 
results.147 Despite the fact that various enrichment media and conditions have been compared, 
there is no standardized method for the enrichment of O157 and non-O157 STEC.148 No single 
STEC enrichment protocol has conclusively been recommended for STEC enrichment.148 
Enrichment broths are often supplemented with selectively inhibitory chemicals such as 
antibiotics. But it is now recommended to use non-selective enrichment such as Buffered Peptone 
Water (BPW) because of the potential damage to the already stressed cells by the inhibitor 
chemicals.147  Tryptone Soya Broth (TSB) and E. coli broth (EC) are the commonly used enrichment 
broth for O157 and non-O157 STEC, but the Food Safety Inspection Services of the U.S. has 
recently recommended the modified Tryptone Soya Broth (mTSB) to favor combined enrichment 
for both Salmonella enterica and STEC.149 Incubation for O157 and non-O157 STEC is usually done 
at 35-37°C for 16-24h, but if the food or food product has a lot of background competing bacteria, 
sometimes incubation is done at 42°C.127 The elevated incubation temperature help to suppress 
the antagonistic activity of the background microflora even though such an approach may 
interfere with growth of injured STEC cells. 
2.5.8.5.3 Molecular assays 
Varyingly rapid, sensitive and accurate PCR-based assays have been used to target the primary 
virulence and marker genes carried by STEC. The most notable virulence genes for STEC are stx1 
and stx2 which may rarely be carried by other organisms such as Citrobacter freundi. 150 Other 
virulence genes include eae, bfp and hlyA.85 Hybrid strains of STEC carry additional virulence 
genes such as the est, elt, ipa, aat and daaC.151,152 The presence of these, in addition to the stx genes, 
has been associated with increased likelihood of HUS.153,154 Serotype-specific genes for E. coli O 
and H antigens are often included to aid detection of serotypes commonly associated with severe 
clinical disease. Such genes include rfbE and wbdl for STEC serotypes O157 and O111 
respectively.155,156 Sero-groups O26 and O113 are detected by PCR amplification of the serotype-
specific genes wzx and wzy respectively.126 However, WGS eliminates the need for additional 
detection of serotype-specific genes.157  
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Subtyping of stx is necessary for risk profiling of STEC strains because some subtypes have 
frequently been linked to clinical disease, while others have rarely associated with clinical 
disease. The World Health Organization (WHO) Collaborating Center for Reference and Research 
on E. coli and Klebsiella uses conventional PCR amplification to detect the three stx1 and seven stx2 
subtypes.158 Other approaches have relied on the use of electrospray ionization mass spectrometry 
to identify and differentiate the STEC strains.159 Since there are different amino-acid subtypes for 
stx1 and stx2, the proteomic fingerprint of each of these can be used to quickly delineate the 
different subtypes even though there is a high level of similarity between stx2a, stx2c, and stx2d at 
nucleotide sequence level.160 In this approach, the more abundant B subunit of the AB5 toxin 
(Shiga toxin is an AB5 toxin composed of the A and B subunits) and the A2 fragment of the A 
subunit are identified.89 Thus, mass spectrometry, in addition to being rapid and cost efficient, 
would remedy the challenge of subtyping closely related subtypes such as stx2a, stx2c, and stx2d.161 
More recently, Whole Genome Sequencing (WGS) technologies have been used for public health 
surveillance of STEC and have shown to be comparable to the PCR-based methods in terms of 
sensitivity and specificity.161-164  
2.5.8.5.4 Antibody-based methods 
Murine monoclonal and polyclonal antibodies against Shiga-toxin have been developed.165 These 
antibodies can be used to differentiate between stx1 and stx2 because these two types of toxins are 
antigenically different.39 They have been employed in different Enzyme-Linked Immunosorbent 
Assay (ELISA) kits to detect and differentiate Shiga-toxin. ELISA assay kits that have been 
developed to detect the different subtypes of Shiga-toxin include: ProSpecT Shiga toxin E. coli 
(STEC) Microplate Assay (Remel Inc., Lenexa, KS), ImmunoCard STAT! EHEC (Meridian 
Bioscience, Cincinnati, OH) , Ridascreen (r-Biopharm AG, Darmstadt, Germany), Premier EHEC 
test (Meridian Bioscience), Verotoxin Enzyme Immunoassay (r-Biopharm AG), Shiga Toxin Chek 
(TECHLAB, Inc., Blacksburg, VA), and VTEC-PRLA (Denka Seiken, Japan).166 These kits are 
however limited in the scope of Shiga-toxin subtypes that they are able to detect.167 
Shiga toxin can also be identified by use of Vero-cell lines or HeLa cell lines, which are rich in 
globotriaosylceramides (Gb3 and Gb4). In these cell lines, the toxins cause cell death due to 
61 
protein synthesis inhibition. The fluorescent d2EGFP protein has been developed to assess effects 
of the Shiga toxin on these cell lines.168  
The other antibody based option is immunomagnetic separation. During immunomagnetic 
separation, affinity purified monoclonal and polyclonal antibodies against O and H antigens of 
O157 and non-O157 STEC (especially the top six non-O157 STEC serotypes) are coated on the 
immuno-magnetic-separation beads to assist target specific serotypes on culture.169 The beads are 
placed in the sample before it is cultured and are expected to bind to the O and H antigens (on 
the bacteria of interest) in the sample that matches the antibody bound to the bead surface. The 
super paramagnetic beads (bacteria-bead complexes) are then placed on a suitable medium and 
incubated to grow the bacteria attached to them. Immunomagnetic beads have particularly been 
used to detect O26 and O111 in ground beef. 117  
2.5.8.6 Antimicrobial resistance in STEC 
There is a steady increase in antimicrobial resistance to commonly used antimicrobials globally. 
The WHO, through its global action plan, has recently urged governments to implement policies 
that control the misuse of antibiotics in both human and non-human users. E. coli is one of the 
bacteria associated with several non-human sources and has the potential to cause severe human 
disease. For this reason, the antimicrobials used to treat STEC (if indicated) infections are 
categorized as critically important antibiotics (CIA) by the WHO.170  
As described above, the use of DNA-targeting antibiotics like fluoroquinolones to treat STEC 
infection triggers the SOS DNA repair response and the expression of Shiga toxin genes.91 
Antimicrobials that rupture the bacterial cell wall also lead to the release of Shiga toxins and thus 
accelerate development of HUS.171 STEC infections are sometimes treated with antimicrobials to 
reduce the risk of progression to HUS and yet there have already been reports of multidrug 
resistance.172-174 The antibiotic resistance profile of STEC can be influenced by the use of antibiotics 
in ruminants since they are the main reservoirs of STEC.175,176 Recent reports have shown multiple 
drug resistance in both O157 and the non-O157 STEC with the most common antimicrobial 
resistance profile being sulfisoxazole-streptomycin-tetracycline.177  
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2.5.8.7 Epidemiology of STEC 
The WHO Foodborne Disease Epidemiology Reference Group (FERG) estimated the global 
impact of foodborne disease to be more than six hundred million cases, 420,000 deaths, and 33 
million Disability-Adjusted Life Years (DALYs) in 2010.178 The estimated global burden of STEC 
was: 2,481,511 illnesses (95%Confidence Interval= 1,594,572 – 5,376,503), 269 deaths (95%CI=111 - 
814), and 26,827 DALYs (95% CI=12,089 – 72,204). Of all the STEC infections, the proportion that 
was foodborne was 0.48 (95%CI=0.33 – 0.60).179 However, this estimate which considered data 
from only 21 countries- may not accurately represent the true global burden given that there was 
no data from many WHO sub-regions and countries. 
2.5.8.7.1 Geographical differences in STEC disease 
Previous research has attempted to explain the differences in the STEC disease burden per region 
and particularly, to explain the low prevalence (or few reports) of STEC disease in Africa. For 
instance, compared to the Europe and America, fewer outbreaks of bloody diarrhoea due to STEC 
have been reported in sub-Saharan countries.180-182  
It has been postulated that the different domestic ruminant feeding diets (grain-based vs. non-
grain based diets) are responsible for these differences.183 However, an alternative explanation is 
the differences in laboratory diagnostics between Africa, and more developed countries. 
However, even in developed countries, there are differences in the serotypes of STEC causing 
disease. Many studies, mainly in Europe and the United States, have reported the occurrence of 
E. coli O157:H7 in several outbreaks.184 There are however geographical differences in the non-
O157 STEC serotypes reported in Europe, Asia, and the United States. Even though serotype O26 
is common in many countries in Europe, Asia, and the United States, it was not reported in France 
and Sweden. Detection depends on a high index of suspicion for these serotypes in the countries 
where they were frequently detected and on the availability of suitable laboratory methods to 
detect them.185 
2.5.8.7.2 Transmission modes of STEC in the human and non-human environment 
On explicit request by the Codex Committee on Food Hygiene (CCFH), the joint FAO (Food and 
Agricultural Organisation)/WHO (World Health Organisation) Core Expert Group Meeting on 
63 
STEC was held in Geneva, Switzerland in July 2016 to discuss three aspects of STEC namely; (1) 
global burden of STEC (2) hazard identification and characterisation of STEC (3) current 
monitoring and assurance programs for STEC. During this meeting, it was noted that while there 
was considerable knowledge of specific STEC serotypes such as STEC O157:H7, there was limited 
knowledge on foodborne STEC caused by the other STEC serotypes. The experts believed that 
the linkage between the illness causing strain and the STEC in foods was often influenced by the 
region’s environment and food handling context. It was also recommended that the food 
categorization scheme by the United States’ Interagency Food Safety Analytics Collaboration 
(IFSAC) be used to categorise foods with slight modifications to suit the different countries or 
regions. In this scheme, foods are broadly categorised into three groups namely: (1) aquatic 
animal foods, (2) land animal foods, and (3) plant foods. The aquatic foods are divided into three 
commodities namely; fish, crustaceans, and molluscs. The land animal foods are divided into six 
commodities namely: dairy, eggs, beef, game, pork, and poultry. The plant foods are divided into 
six commodities namely: grains, oils, fruit-nuts, fungi, leafy, root, sprout, and vine-stalk 
vegetables.186 
Over a ten-year period, between 1998 and 2008, the percentage of annual foodborne illness in the 
USA caused by STEC was attributable to eight commodities of food subtypes namely: dairy, beef, 
game, pork, poultry, grains, fruit-nuts, leafy, and sprout186 (Table 2.3).  
Table 2.3 Percentage annual foodborne illness due to O157 and non-O157 STEC in the USA (1998-2008) 186 
Proportion of foodborne STEC associated with food 
subtypes annually 
Food subtypes O157 STEC Non-O157 STEC 
Dairy 6.7%-9.8% - 
Beef 33% - 41.3% 29.7% 
Game 0.5% - 0.8% - 
Pork 0.7% - 4% - 
Poultry 0.8% - 2.5% - 
Grains 0.1% - 10.4% - 
Fruit-nuts 18% - 22.5% 62.2% 
Leafy 19.3% - 31.5% 8.1% 
Sprout 1.1% - 1.7% 
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This means that in the USA, over the ten-year period, non-O157 STEC was mainly transmitted 
from fruit-nuts, while the O157 STEC was mainly transmitted from beef.  
Besides the USA picture, globaly, various other transmission vehicles are involved in the 
transmission of STEC to humans and are of different levels of importance for both non-O157 
STEC and O157 STEC (see Table 2.4). Non-O157 STEC are five times more likely to be present in 
the environment than the E. coli O157.187 Due to their ubiquitous distribution, the non-O157 STEC 
have frequently been reported as contaminants of agricultural produce. Increased cross-border 
trade in agricultural produce, therefore, provides additional risk to the importation of STEC 
outbreak strains as exemplified by the recent O104 STEC outbreak which originated in Germany 
and affected 16 countries causing 4,000 cases of disease, including 908 cases of HUS.117 Indeed, 
most of the recent foodborne STEC pandemics could easily be traced among the trade partner 
countries.117 There is probably limited trade linkage (in food products) between Africa and the 
countries where STEC disease is commonly reported (America and Europe).  
Table 2.4 Comparison of the relative importance of transmission vehicles associated with outbreaks of O157 and non-
O157 STEC. 
Vehicle E. coli O157:H7 E. coli Non-O157:H7
Animal Contact 6.2% 9.7% 
Water 10% 25.6% 
Person to person 28.8% 6.8% 
Dairy 10% 12.5% 
Meat 11.2% 24.6% 
Produce 6.2% 9.2% 
Other food 8.8% 5.8% 
Unknown 18.8% 5.8% 
This table has been adopted from Charles Kasper,  Doyle, et al., 2009188. 
Globally, most of the described STEC infections are associated with vehicles relating to beef and 
livestock related products.188 Food products of ruminant origin such as meat and milk are 
contaminated with STEC during harvesting, handling and processing.138 During the animal 
slaughter process, bacteria from the heavily contaminated hide and the gastrointestinal tract may 
be spread on the carcas to the extent that even the post-slaughter washing may not eliminate 
them. The level of carcas contamination with STEC varies depending on conditions such as the 
65 
physiological state of the animal at slaughter, animal handling prior to slaughter, and 
management.189 For instance, animals that shed more than 104 CFU of STEC per gramme of faeces 
prior to slaughter are considered heavy shedders and are more likely to be linked to carcas 
contamination. Research by Gyles et al. estimated high levels of carriage of STEC in healthy cattle 
using the occurrence of the stx genes in the stool.190 However, this would probably not be an 
accurate estimate of the health risk posed because stx genes can be carried by non-pathogenic 
organisms or no organism at all (as freely occurring bacteriophages in the gut/faeces). Since the 
infectious dose of STEC is low, it is prudent to track the shedding levels of ruminants prior to 
slaughter. 191,192 
2.5.8.7.2.1 The African picture 
The non-human environment that has been studied in Africa includes animal faeces, water, 




Table 2.5 Reported environmental reservoirs of STEC in Africa. 
Environmental reservoir Genes detected STEC serotypes 
identified 
References 
Beef, pork, water, human, animals. rfbE O157 and fliCH7, hlyA 
and eaeA. 
O157 195
Raw meat and beef intestines at 
local markets. 
stx1 and stx2. No isolation 196
Zebu Cattle, fish, and water None O157: H7, and O157: 
NM 
197
Shellfish and coastal environments stx1 mainly, stx2 O157 193
Meat and dairy products, human stx1, stx2, ehxA and eaeA. O157 194,198
Beef, pork, chicken, deer, boar, 
bison, and retail rabbit meats. 
Springbok 
stx1 O45 199,200
Water and cattle stx1 and stx2 201,202 
Cattle  stx1 and stx2 STEC 180
Calves, camels, humans, STEC 203
Beef and beef value-added 
products 
stx1 and eaeA. Non-O157 STEC. 
O111,055, O26, O128 
204
67 
Raw milk cheese stx1, stx2 O22: H8, O26: H11, 
O86: H21, O103: H2, 
O113: H21 and O146: 
H21 
205
Home cooked food samples O157 206
Meat and faeces of food animals stx1, stx2, and eaeA O157, O26, O91, 
O103, O111, O128, 
O145 
207
Hides and faeces O157: H7 208
Meat and dairy products stx1, stx2, eaeA 194
2.5.8.7.3 STEC infections in South Africa 
Research as early as 1978 by Seedat et al., suggested bacterial infections as the predominant cause 
of acute renal failure (ARF) in South Africa.209,210 HUS was reported as the most common cause of 
ARF in children between 1986 and 2002 in South Africa.211 Of note, hemolytic uremic syndrome, 
which is overwhelmingly caused by STEC, is the leading contributor to ARF in paediatric patients 
at the Pretoria Academic Hospital.211,212 
Since the first report of severe STEC infection in South Africa in 1990, which was seven years after 
the release of the first report on HUS and haemorrhagic colitis-associated E. coli by Karmali et al., 
there have been scattered reports of both O157 and non-O157 STEC albeit with the earlier research 
efforts mainly based on serology and only in cases that were hospital-based.213 Later, in 1993, the 
second STEC report of a waterborne outbreak was noted in  Swaziland and South Africa. This 
outbreak which killed over 2000 people was found to originate in Swaziland on a sugar plantation 
which was contaminated by STEC via contaminated water flowing from an area with sick cattle.214 
Since then, with the initiation of the National Institute of Communicable Diseases (NICD) in 2004, 
Tau et al and Ateba et al reported the occurrence of STEC O104 (no stx genes were detected, but 
the strains were human diarrhoea associated) and STEC O157  in archived hospital isolates and 
the non-human environment respectively.195,215 Investigators at the NICD screened 2378 suspect 
diarrheic E. coli isolated from stool of patients with diarrhoea received from collaborating clinical 
microbiology laboratories across the country between 2006 and 2009 for stx genes.  Results 
showed that only 14 of them were STEC. Of these 14 STEC, only one was E. coli O157:H7.216 
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In 2011, at the Mafikeng provincial hospital, up to 56.5% (11/19) of stool samples from HIV-
infected patients with diarrhoea in the North West province, tested positive for the presence of 
STEC O157:H7.195 Immunocompromised individuals are particularly at risk of poor clinical 
outcome from HUS as up to 9% of immunocompromised adults and children die within four 
years after developing HUS.51  
Recent environmental survey data describe a relatively high prevalence of E. coli O157: H7 
identified by PCR from meat (27.7 – 67.7%), water (2.3 – 25.5%), and vegetable (21.7%) samples 
from the Eastern Cape and North West provinces of South Africa.217 A separate study on piglet 
oedema by Mohlatlole et al. 2013, reports the occurrence of stx genes in diarrhoeagenic E. coli in 
piglets, though the serotypes were not determined.218  
Most recently, in February 2017, there has been an outbreak of STEC O26 (associated with HUS) 
at the Red Cross War Memorial Hospital in Cape Town affecting four children (unpublished 
data).  
In most of the instances where STEC was reported in a patient, there was no success in terms of, 
or effort made in as far as identification of the non-human sources of the outbreak strain.   
2.5.8.8 Regional surveillance and monitoring strategies for STEC 
Regional surveillance strategies differ, depending on the presence or absence of an outbreak in a 
country. In the absence of an outbreak, efforts may be focused on food safety (particularly for 
foods for export) or public health and may differ from country to country. 
Regions should have a STEC surveillance strategy because of the public health impact as well as 
the economic impact of STEC infection.  
Surveillance of stx related disease should, in addition to a hospital laboratory-based identification 
of cases, include attempts to identify the non-human sources of the infection through the 
administration of food history surveys in addition to testing of the food samples themselves.219 
Such a strategy should consider the possibility of more than one STEC strain causing disease and 
also the fact that an implicated food source could have travelled more than the geography of the 
patient.115,220 The National STEC surveillance strategy by the Centers for Disease Control (CDC) 
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emphasises the passive model where laboratory-confirmed STEC (from food and water samples) 
and stx positive broths are sent to central public health laboratories where they are further 
characterised. However, this is in addition to a unified nationwide clinical diagnostic strategy for 
STEC where all stool samples presented for bacterial culture are tested for STEC and for presence 
of the Shiga toxin using a non-culture based method.221 
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3 Development of a real-time PCR test and comparison to 
culture on CHROMagarTMSTEC for detection of Shiga-toxin-
producing E. coli in Stool, Water, and Food samples. 
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3.1 Summary 
Introduction: Shiga toxin producing Escherichia coli (STEC) is an emerging pathogen with the 
potential for severe clinical manifestations including Haemolytic Uremic Syndrome, and is 
associated with economic losses in the food industry. CHROMagarTMSTEC is a selective and 
differential screening medium for STEC whose performance is serotype dependent. Molecular 
detection of STEC is increasingly used in diagnostic laboratories. Even though previous studies 
have compared the performance of CHROMagarTMSTEC to real-time PCR in Europe, no studies 
have been done to assess its performance in Africa. 
Objectives: This project was undertaken to optimise a real-time PCR-based assay for 
simultaneous detection of stx1 and stx2. We aimed to achieve the following objectives: 
i. To optimise and determine the limit of detection of the in - house developed real-time PCR
assay.
ii. Assessment of the performance of CHROMagarTMSTEC in comparison to the in – house
developed real-time PCR assay for detection of stx in stool, water and meat.
iii. To determine the prevalence of stx in the stool at a tertiary academic hospital laboratory in
Cape Town, surface water from the Lotus River, and meat from the informal slaughter
setting in Nyanga, Cape Town, South Africa.
iv. To characterise the E. coli strains that formed mauve colonies on CHROMagarTMSTEC.
Methods: Between September 2014 and May 2015, residual stool (submitted for bacterial 
pathogen culture) after routine testing were collected from 226 consecutive stool specimens 
(irrespective of age or related clinical data) from the National Health Laboratory Services located 
at the Groote Schuur Hospital in Cape Town, a tertiary care academic teaching laboratory 
affiliated with the University of Cape Town. This tertiary academic hospital serves the greater 
Cape Town area. 
Between September 2015 and May 2016, forty-nine (49) raw and 36 ready – to - eat meat samples 
were collected from 53 randomly selected local stalls along main access roads in the Nyanga 
Township. Sixty-four (64) water samples were collected over a period of ten months (between 7 
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a.m and 12 noon) from July 2015 to March 2016 by using the depth integrated grab sampling
method with samples being collected at a depth of approximately 30cm below the surface of the 
river. A multiplex real-time PCR for detection and differentiation of stx1 and stx2 was optimised, 
and performance characterised using stool spiked with plasmids containing cloned stx genes. We 
enriched for STEC in Tryptic Soy Broth (TSB). Real-time PCR was used to screen TSB, and mauve 
isolates on CHROMagarTMSTEC for stx, while agarose gel detection PCR was used to detect other 
diarrheic E. coli (DEC) virulence genes possessed by the isolates. The ImmunoCard STAT! 
EHEC® rapid test was used to test the isolates for Shiga toxin production. 
Results: The real-time PCR limit of detection was 5.3 target copies/µl of broth. The mean melting 
temperature on melt-curve analysis for detection of stx1 was 58.2 ̊C and for stx2 was 65.3 ̊C; 
detection of both targets could therefore occur in the same run. Of 226 stool specimens screened, 
real-time PCR detected stx in 14 specimens (6.2%, 95% Confidence Interval=3.43%-10.18%), 
comprising eight stx1, five stx2 and one with both stx1 and stx2. Using the in-house real-time PCR 
as reference, for clinical specimens, the sensitivity, specificity, negative predictive value and 
positive predictive value of the CHROMagarTMSTEC were 33.3%, 77.4%, 95.3% and 11.3% 
respectively.  
The limit of detection of the in-house developed assay for stx targets in meat and water was 116 
±4.03 CFU per 25g of meat and 144 ±6.4 CFU/100ml of Lotus River surface water for both targets. 
Of the 64 water specimens screened, real-time PCR detected stx genes in 19 samples (29.7%, 95% 
Confidence Interval= 18.91%-42.42%), while the sensitivity, specificity, negative predictive value 
and positive predictive value of the CHROMagarTMSTEC were 5.26%, 66.7%, 62.5% and 6.25%, 
respectively. Of the 85 meat specimens, real-time PCR detected stx genes in 18 samples (21.2%, 
95% Confidence Interval= 13.06%-31.39%), while the specificity and negative predictive value of 
the CHROMagarTMSTEC were 52.94% and 66.7%, respectively.  
Conclusions: CHROMagarTMSTEC cannot be relied on solely to screen stool for STEC in this 
setting. To improve patient management, and to ensure the safety of food and water for public 
use, a robust nucleic acid amplification-based assay is needed in limited resource settings. 
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3.2  Background 
Globally, food and water-borne outbreaks of both O157 and non-O157 STEC (Shiga-toxin-
producing Escherichia coli) have been successfully detected due to the availability of good baseline 
data and efficient active laboratory-based surveillance systems.1-4 Early detection of outbreaks is 
important to minimise morbidity, mortality, and associated economic losses5. There is a lack of 
good baseline data on STEC in Africa, which can be attributed to a lack of laboratory resources 
and the surveillance strategy employed. STEC has been reported in outbreaks of bloody diarrhoea 
in sub-Saharan countries.6-8 However, these have been difficult to manage due to laboratory 
weakness.9,10 Furthermore, typical Haemolytic Uremic Syndrome (tHUS), which is 
overwhelmingly caused by STEC, was reported as the leading contributor to acute renal failure 
(ARF) in paediatric patients at a South African academic hospital.11  
Laboratory methods to isolate STEC involve the use of sorbitol MacConkey containing cefixime 
and tellurite to culture the non-sorbitol fermenting O157: H7 STEC12, coupled with the use of 
immunochromatographic methods to detect Shiga toxin in stool.13 However, non-O157 STEC 
have recently emerged as causes of serious STEC disease.14 For this reason, several chromogenic 
media like CHROMagarTMSTEC have been developed to target both O157 and non-O157 STEC in 
clinical and environmental samples.15 Even though several studies have evaluated the 
performance of CHROMagarTMSTEC by comparison to molecular and antigen detection methods 
in developed countries16,17, no study has so far evaluated its performance in Africa. This may be 
important, given that there are geographical differences in characteristics of STEC prevalent per 
region. Detection of the prevalent STEC serotypes in an area is dependent on the index of 
suspicion for the different STEC serotypes and on the availability of suitable laboratory methods 
to detect them.14  
In many South African (and African) laboratories, stool specimens are not routinely tested for 
STEC, although physicians may request testing specific for E. coli serotype O157:H7 if clinically 
suspected. In the National Health Laboratory System (NHLS, South Africa) laboratories, testing 
is often based on the non-sorbitol fermenting property of some STEC, using sorbitol MacConkey, 
and only on request by a physician. This practice is likely to underestimate the real magnitude of 
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STEC since not all serotype O157 strains are non-sorbitol fermenting (O157: NM), and > 470 non-
O157 serotypes have been associated with clinical disease.18  
Laboratory capacity for molecular detection is increasingly available in African countries, and 
may in some cases be simpler than culture-based detection. Therefore, we validated the use of a 
duplex hybridization probe-based real-time PCR assay and compared findings to those obtained 
using a chromogenic screening culture medium. We used the PCR assay to assess the prevalence 
of STEC in specimens submitted to the National Health Laboratory Services at Groote Schuur 
Hospital, a tertiary academic hospital laboratory in Cape Town, South Africa. We further 
characterised the E. coli isolates that formed mauve colonies on CHROMagarTMSTEC from the 
same specimens by serotyping, detection of Shiga toxin production, as well as detection of the 
fimbrial adhesion gene (daaC) for diffusely adherent E. coli (DAEC), the anti-aggregation protein 
transporter gene for Enteroaggregative E. coli (EAggEC) (aat), heat-stable (ST) and heat-labile (LT) 
enterotoxin genes of enterotoxigenic E. coli (ETEC), the intimin coding gene eae for 
enteropathogenic E. coli (EPEC), and the bundle forming pili gene (bfp) for typical EPEC. 
3.2.1 Aims and objectives 
i. To optimise and determine the limit of detection of the in - house developed real-time
PCR assay. 
ii. Assessment of the performance of CHROMagarTMSTEC in comparison to the in – house
developed real-time PCR assay for detection of stx in stool, water and meat. 
iii. To determine the prevalence of stx in the stool at a tertiary academic hospital laboratory
in Cape Town, surface water from the Lotus River, and meat from the informal slaughter setting 
in Nyanga, Cape Town, South Africa.  
iv. To characterise the E. coli strains that formed mauve colonies on CHROMagarTMSTEC.
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3.3 Methods 
3.3.1 Target plasmid preparation. 
The real-time PCR previously described by Grys et al. 19 was used to amplify stx1 and stx2 gene 
targets from STEC O157:H7 NCTC control strain (C4193-1) with both stx1 (subtype 1a) and stx2 
(subtype 2a). PCR amplicon size was confirmed visually by agarose gel detection (~208bp for stx1 
and ~204bp for stx2) before confirmation by sequencing using the Big Dye® Terminator v3.1 Cycle 
Sequencing Kit. We used primers 1a and 2a for unidirectional Sanger sequencing of the amplicons 
(Table 3.1). 
Table 3.1 Primers and probes used for real-time PCR 
Primers/probes 5́ Sequence 3 ́ Reference 
stx1a-primer CAAGAGCGATGTTACGGT 19
stx1b-primer AATTCTTCCTACACGAACAGA 19
stx1f-probe CTGGGGAAGGTTGAGTAGCG Fluorescein 19
stx1r-probe CAL Fluor 610 CCTGCCTGACTATCATGGACA 3' phosphor 19
stx2a-primer GGGACCACATCGGTGT 19
stx2b-primer CGGGCACTGATATATGTGTAA 19
stx2f-probe CTGTGGATATACGAGGGCTTGATGTC Fluorescein 19
stx2r-probe CAL Fluor 610 ATCAGGCGCGTTTTGACCATCT 3' phosphor 19
Resultant sequences were then trimmed and submitted for BLAST analysis against the NCBI 
database and confirming stx1 or stx2 target sequences in comparison to O157:H7 EDL933 (NCBI 
Reference: NC_002655.2)20. Purified amplicons (Mini Elute Gel extraction kit, Qiagen, Madrid 
Spain) were cloned using CloneJet PCR cloning kit (Thermofisher Scientific, Austin Texas, USA) 
into a pJet 1.2 / blunt vector using the sticky end cloning protocol and transfected into the JM109 
competent cells by calcium chloride transformation. Plasmids containing stx1 and stx2 were 
separately extracted using a Genopure plasmid Maxi kit (Roche Life Sciences, Industriestrasse, 
Switzerland) and quantified by spectrophotometry. To verify successful preparation purified 
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plasmids were subjected to PCR amplification using primers 1a and 1b for stx1 and 2a and 2b for 
stx2 with amplicon size visually confirmed by agarose gel detection and subsequent sequence 
analysis. Plasmid quantification was performed spectrophotometrically employing the BioDrop-
µlite (Isogen Life Science, B.V, Veldzigt, Netherlands). The A260 was used to calculate the plasmid 
concentration expressed as the number of molecules/µl. Three measurements were made and the 
average determined. Briefly, the plasmid concentration was calculated as the product of the A260, 
the dilution factor, and the concentration with one A260 being the equivalent of 50µg/ml and 1 pico 
mole being equivalent to 660pico grammes. 
3.3.2 PCR Assay Validation 
To assess the potential for PCR cross-reactivity and assess the analytical specificity of the 
hybridization probe-based real-time PCR described by Grys et al19 the primer and probe 
sequences were subjected to BLAST analysis on the NCBI database. The PCR reaction was 
optimized for use on the LightCycler®480 Instrument II (Roche Life Sciences, Industriestrasse, 
Switzerland) employing the LightCycler® 480 Probes Master mastermix (Industriestrasse, 
Switzerland) with modification to the thermal cycling conditions for amplification consisting of 
denaturation at 95 ̊C for 10 minutes followed by 45 cycles of 95 ̊C for 5s, 56 ̊C for 5s, and 72 ̊C for 
15s.  A positive amplification signal was defined as an increase in fluorescence signal that crossed 
the threshold before 35 cycles. Amplicon identity was determined using the melt-curve analysis  
program of 95 ̊C for 30s, 40 ̊C for 60s, and 85 ̊C 5s with continuous fluorescence acquisition. The 
Multi-color HybProbe detection format was used for analysis, combining the Red 610, Red 640 
and FAM filter pairs (LightCycler®480 Instrument II Manual, Roche Life Sciences). The resulting 
amplicon was visualized using agarose gel electrophoresis and subjected to DNA sequencing and 
BLAST alignment to reference stx1a and stx2a sequences (NC_002655.2).  
Stool: To mimic the sample matrix for sensitivity determination, TSB was inoculated with a pea-
size amount of stool (from a single donor shown to be stx-negative by PCR). To this inoculated 
broth, 1 ml of plasmid stock (5.3*106 copies/µl or 5.3*109 copies/ml) containing both stx1 and stx2 
was added and serially diluted eight times in 9 ml of TSB, to the lowest dilution of 1:108 (53 
plasmid copies/ml).  
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Meat samples: Firstly, we prepared a 0.5 McFarland concentration of C4193-1 O157: H7 (using 
1% PBS). Twenty-five grammes of meat were rinsed by pummelling in 225ml of TSB (TSB; Oxoid, 
Basingstoke, UK). Tenfold serial dilutions of the bacterial suspension were made in the TSB meat 
rinsate to a final dilution of 100 CFU/ml. From the third dilution to the highest dilution (105 to 
100), 1ml of TSB with C4193-1 O157: H7 bacteria was spread out on a 2% Blood agar plates using 
a plastic spreader and incubated for 24hrs at 35 ̊C. For each dilution, the culture was carried out 
on five 2% Blood agar plates, and the mean of the counts from the five plates represented the 
number of colony forming units at a dilution.   
Water samples: A 0.5 McFarland concentration of C4193-1 O157: H7 (using 1% PBS) was 
prepared. Ten millilitres of the 0.5 McFarland solution was resuspended in 90ml of Lotus River 
surface water. Then, this solution (100ml) was filtered through a 0.45µM membrane filter on a 
calibrated filtration unit attached to a vacuum pump. This membrane was placed in 100ml of 
sterile TSB (Oxoid, Basingstoke, UK) and agitated with vortexing for at least 15 minutes to release 
bacteria from the membrane into the TSB (Oxoid, Basingstoke, UK) to a final concentration 
equivalent of 107CFU/ml. Seven tenfold serial dilutions of the TSB-bacterial suspension were 
made in the TSB rinsate to a final dilution of 100 CFU/ml (this procedure was used to mimic the 
routine water testing process). From the third dilution to the highest dilution (105 to 100), 1ml of 
TSB (Oxoid, Basingstoke, UK) with C4193-1 O157: H7 bacteria was spread out on a 2% Blood agar 
plates using a plastic spreader and incubated for 24hrs at 35 ̊C. For each dilution, the culture was 
carried out on five 2% Blood agar plates, and the mean of the counts from the five plates 
represented of the number of colony forming units at a particular dilution.   
Nucleic acid extraction was performed on 200µl TSB broth (without enrichment/incubation for 
TSB rinsates of meat, Lotus River surface water and stool) employing the MagNApure LC 
instrument (Roche Diagnostics, Industriestrasse, Switzerland) to yield 100µl of extract.  
Initially, real-time PCR was performed in triplicate using a template from each of the 8 dilutions 
to estimate a limit of detection (LOD). Subsequently, real-time PCR was performed in eight 
replicates on the dilution (replicated only the real – time PCR and not the extractions) with the 
93 
estimated LOD, as well as one dilution above and one dilution below the estimate. The LOD was 
defined as the lowest plasmid concentration spiked into TSB, before nucleic acid extraction, 
yielding a positive signal, as described above in all eight replicates. Nucleic acid extractions from 
STEC subtypes 1d (Reference strain MH1813, GenBank accession No. AY170851), 2b (Reference 
strain EH250, GenBank accession No. AF043627), 2c (Reference strain 031, GenBank Accession 
No. L11079), 2d (Reference strain C165-02, GenBank accession No. DQ059012), 2e (Reference 
strain S1191, GenBank accession No. M21534), 2f (Reference strain T4/97, GenBank accession No. 
AJ010730) and 2g (Reference strain 7V, GenBank accession No. AY286000) were also subjected to 
PCR amplification to assess impact of strain variation on detection. The reproducibility of melting 
temperature assessment for stx1 and stx2 differentiation was determined by testing 24 replicates 
of TSB (Oxoid, Basingstoke, UK) spiked with stx1 and stx2 plasmids.  To further assess the 
reproducibility of melting temperature, the three stx1 subtypes and seven stx2 subtypes were 
tested similarly. 
3.3.3 Clinical specimen testing 
Between September 2014 and May 2015, we collected residual stool (submitted for bacterial 
pathogen culture) after routine testing from 226 consecutive stool specimens (irrespective of age 
or related clinical data) from the National Health Laboratory Services located at the Groote 
Schuur Hospital in Cape Town, a tertiary care academic teaching laboratory affiliated with the 
University of Cape Town. This tertiary academic hospital serves the greater Cape Town area. 
A pea sized stool sample was inoculated in 90ml of TSB and vortexed before incubation at 37°C 
for 18h. Two hundred microliters of broth were subsequently extracted employing the MagNA 
Pure LC Total Nucleic Acid isolation kit (Roche Diagnostics, Industriestrasse, Switzerland) using 
the total variable elution volume protocol and following the manufacturer’s manual (version 14) 
to yield 100µl of nucleic acid extract.  
In addition, CHROMagarTMSTEC (CHROMagar Microbiology, Paris, France) was inoculated with 
a loop full of overnight incubated broth and incubated at 37 ̊C for 18h. Bright mauve colonies 
were sub-cultured onto MacConkey agar with crystal violet, sorbitol MacConkey agar, and 2% 
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Blood agar (Green point Media, NHLS, Albertynshof). E. coli was presumptively identified as 
lactose-positive, oxidase-negative, spot indole-positive, and pyrrolidonyl arylamidase (PYR)-
negative with confirmatory identification using VITEK® 2 automated system (bioMerieux, USA). 
3.3.4 Environmental sample testing 
We collected 64 surface water samples over a period of ten months (between 7 a.m and 12 noon) 
from July 2015 to March 2016 by using the depth integrated grab sampling method. These were 
collected 30cm below the Lotus River surface. Between October 2015 and May 2016, we collected 
Forty-nine (49) raw and 36 ready – to - eat meat samples from 53 randomly selected local stalls 
along main access roads in the Nyanga Township. 
Meat: Twenty-five grammes of meat tissue was thoroughly pummeled using a sterile mortar and 
pestle, and inoculated into 225ml of Tryptic Soy Broth (TSB; Oxoid, Basingstoke, UK) and 
incubated at 35°C for 24 hours as previously described but with slight modifications21.  
Water: One hundred millilitres of surface water was filtered through a 0.45µM nitrocellulose 
membrane (Pall Corporation, Port Washington, USA) on a filter funnel mannifold (Pall 
Corporation, Port Washington, USA). The post – filtration membrane was placed in 90ml of 
Tryptic Soy Broth (Oxoid, Basingstoke, UK) using sterile forceps, vortexed and then incubated at 
35 ̊C for 18-24h. This was in accordance with the International Standards Organisation guidelines 
on microbiology of water (ISO 9308-3: 1998)22. Two hundred microliters (200µl) of broth was then 
loaded into the sample cartridge and processed using the MagNA Pure LC (Roche) instrument 
using the total variable elution volume protocol and following the manufacturer’s manual 
(version14) to yield 100µl of nucleic acid extract.  
CHROMagarTMSTEC (CHROMagar Microbiology, Paris, France) was inoculated with a loopful 
of overnight incubated broth and incubated at 37 ̊C for 18h. Bright mauve colonies were processed 
as described in 3.3.3.  
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3.3.5 Isolate characterization. 
Isolates yielding mauve colonies on CHROMagarTMSTEC and presumptively identified as E. coli 
were subjected to stx characterization employing the real-time PCR assay described here as well 
as a conventional PCR performed as previously described by Paton and Paton (1998).23 The 
presence of virulence genes including the fimbrial adhesion gene for diffusely adherent E. coli 
(daaC), the anti-aggregation protein transporter gene for Enteroaggregative E. coli (aat), heat-
stable (ST) and heat-labile (LT) enterotoxin genes of enterotoxigenic E. coli (ETEC), the invasive 
plasmid antigen gene for enteroinvasive E. coli (ipa) and the intimin coding gene (eaeA) for EPEC 
were determined using standard gel-based PCR as previously described23 using primers as 
shown below (Table 3.2). 
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Table 3.2: Primers used for detection of diarrheic E. coli virulence genes 
Reaction Target genes Primers used Primer sequence Product size 
A eaeA eae-F TCAATGCAGTTCCGTTATCAGTT 482bp 
eae-R GTAAAGTCCGTTACCCCAACCTG 
Bfp bfp-F GGAAGTCAAATTCATGGGGGTAT 298bp 
bfp-R GGAATCAGACGCAGACTGGTAGT 
stx1 stx1-F CAGTTAATGTGGTGGCGAAGG 348bp 
stx1-R CACCAGACAATGTAACCGCTG 
stx2 stx2-F ATCCTATTCCCGGGAGTTTACG 584bp 
stx2-R GCGTCATCGTATACACAGGAGC 
B Est ST-F ATTTTTCTTTCTGTATTGTCTT 190bp 
ST-R CACCCGGTACAAGCAGGATT 
Elt LT-F GGCGACAGATTATACCGTGC 440bp 
LT-R CGGTCTCTATATTCCCTGTT 
C Ipa ipaH-F CTCGGCACGTTTTAATAGTCTGG 933bp 
ipaH-R GTGGAGAGCTGAAGTTTCTCTGC 
Aat pCVD432-F CTGGCGAAAGACTGTATCAT 630bp 
pCVD432-R CAATGTATAGAAATCCGCTGTT 
daaC daaC-F CAGGTCATCCGGTCAGTCGG 212bp 
daaC-R CAATGCCACGTACAACCGGC 
Screening of E. coli colonies for Shiga toxin production: The Immunocard STAT! ® EHEC was 
used to detect Shiga toxin 1 and Shiga toxin 2 by the isolates employing immunochromatography 
with toxin-directed monoclonal antibodies labelled with red-coloured gold particles (Meridian 
Biosciences, Inc., USA).  
Serotyping: All mauve isolates found to carry virulence genes were serotyped at the Centre for 
Enteric Diseases, National Institute of Communicable Disease (NICD), Johannesburg employing 
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(Statens Serum Institut, Copenhagen, Denmark) antisera and the detection of somatic O- antigens 
as previously described.24,25 H-antigen serotyping was not undertaken. 
3.3.6 Data Analysis 
All data were entered into an Excel database (Microsoft Corporation, USA). Two-by-two tables 
were created. The performance of CHROMagarTMSTEC was compared with that of the in-house 
qPCR (reference standard) in order to determine its sensitivity, specificity, negative and positive 
predictive values for the different sample matrices. 
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3.4 Results 
3.4.1 Real-time PCR validation 
The BLAST analysis of the primers and probe sequence specificity yielded no significant 
homology to non-stx targets (data not shown). Real-time PCR amplicons generated were 
confirmed as 208bp and 204bp for stx1 and stx2, respectively (Figure 3:1). 
Figure 3:1 PCR amplicons of stx1 and stx2 
Lanes 1,2 and 3 show stx1 amplicon bands. Lane 4 shows the negative control. Lanes 5,6, 
and 7 show the stx2 amplicon bands. 
 Sequencing and BLAST analysis confirmed the identity of both stx1 and stx2 amplicons. The 
serially diluted plasmid-stool-TSB was successfully amplified in 8/8 replicates in the fifth dilution. 
The sixth and seventh dilutions yielded amplification signal in 8/8 and 3/8 replicates respectively, 
yielding a LOD of 5.3 target copies / µl of broth. All other stx subtypes investigated (stx1a, stx1b, 
stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g) were successfully amplified by this assay (data 
not shown). Stx1 and stx2 were successfully distinguished by a melting temperature of 58.2 ̊C 
(SD=0.033) and 65.3 ̊C (SD=0.037), respectively (Figure 3:2).  
1 2 3 4 5 6 7
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Figure 3:2: Performance of the optimised real-time PCR 
A- Amplification curves on amplification of serially diluted template DNA (eight dilutions from
107 to 100), B-Melting curves for the duplex real – time PCR (stx1a peak at 58.2 ̊C and stx2a peak
at 65.3 ̊C) on the serially diluted DNA (eight dilutions from 107 to 100), C-Melting curves for stx2 
on serially diluted stx2 plasmids (eight dilutions from 107 to 100), D-Melting curves for stx1d on
serially diluted genomic DNA (eight dilutions from 107 to 100).
The Tm for subtypes stx2 subtypes 2a, 2b, 2c, 2d, 2e, 2f and 2g were the same at 65.3̊C (SD=0.037, 
0.041, 0.035, 0.039, 0.034, 0.033 and 0.032 respectively) while that of 1d was 45.7 ̊C (SD=0.042). The 
efficiency of the assay was 1.99 as calculated from the amplification curves generated using the 
Light Cycler® 480 software. The duplex assay detected both targets in the same run, and these 
could be differentiated by the melt curve with two distinct peaks at 58.2 ̊C for stx1 and 65.3 ̊C for 
stx2 (Figure 3:3).  
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Figure 3:3: Amplification curves and Melting Peaks for the in-house optimised real-time PCR assay. 
A- Amplification curves for the duplex real – time PCR targeting both stx1 and stx2 simultaneously on
serially diluted DNA extracts from TSB rinsates of meat.
B- Melting peaks for the duplex real-time PCR assay targeting both stx1 and stx2 simultaneously on
serially diluted DNA extracts from TSB rinsates of meat.
Determination of the LOD of the assay for stx1 and stx2 in water and meat 
The mean count of colony forming units growing on 2% Blood agar for increasing dilutions for 
TSB rinsate of 25g of meat were 116 ±4.03, 29 ±2.61 and 2 ±1.9 for the sixth, seventh and eighth 
dilutions, respectively (the extrapolated original CFU/ml values were 102, 101, and 100 for the 
sixth, seventh and eighth dilutions respectively). The mean count of colony forming units on 2% 
Blood agar for increasing dilutions for Lotus River water in TSB were 212 ±6, 32 ±5 and 5 ±0.8 (The 
extrapolated original CFU/ml were 102, 101, and 100 for the sixth, seventh and eighth dilutions 
respectively) (Table 3.3). We observed amplification curves for DNA template from the serial 
dilutions in TSB up to the sixth dilutions for template from 25g of meat and Lotus River surface 
water. The mean crossing points were 18.87, 21.7, 23.5, 27.6, 31.02 and 34.02 for the first, second, 
third, fourth, fifth and sixth dilutions, respectively, for template from TSB rinsate of 25g of meat. 
The mean crossing points were 19.53, 22.53, 25.43, 28.20, 31.21 and 34.23 for the first, second, third, 
fourth, fifth and sixth dilutions, respectively, for template from TSB dilutions of Lotus River 
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surface water (Table 3.3). The limit of detection of the in-house developed assay for stx targets in 
meat and water was 116 ±4.03 CFU per 25g of meat and 144 ±6.4 CFU/100ml of Lotus River surface 
water for both targets.  
Table 3.3 Mean cell counts/ml of TSB rinsate (river water and meat samples) with crossing points, and melting 
temperatures for stx1 and stx2 targets resulting from a duplex qPCR run in triplicate on broth DNA extracts from 
TSB dilutions. 
TSB rinsate of 25g of meat following 
pummelling 
















107 ND 55.12 61.90 107 ND 55.23 62.80 
107 18.87 ND 54.97 61.91 107 19.53 ND 55 60.81 
107 ND 55.12 61.90 107 ND 55.3 62.78 
106 ND 54.46 61.76 106 ND 54.6 61.66 
106 21.7 ND 55.28 61.96 106 22.53 ND 56 61.96 
106 ND 54.88 61.84 106 ND 56.4 61.54 
105 ND 55.48 62.20 105 ND 55.3 62.0 
105 23.5 ND 54.92 61.93 105 25.43 ND 54.8 62.83 
105 ND 54.73 61.94 105 ND 55.4 62.44 
104 ND 55.11 61.99 104 ND 55.87 62.14 
104 27.6 ND 55.37 62.38 104 28.20 ND 55.95 62.10 
104 ND 53.67 61.72 104 ND 54.5 61.52 
103 TNTC 53.73 61.89 103 TNTC 53.73 62.8 
103 31.02 TNTC 56.25 62.26 103 31.2 TNTC 55.8 62.0 
103 TNTC 55.71 62.26 103 TNTC 55.71 62.07 
102 53.79 61.88 102 54.3 62.5 
102 34.20 116 
±4.03 
55.35 62.24 102 34.23 144 
±4.0 
55.2 62.6 
102 55.44 62.40 102 55.65 62.44 
101 56.61 62.55 101 56.78 62.64 
101 29 
±2.61 
62.39 101 32 
±2.4 
62.45 
101 56.54 62.64 101 56.89 62.48 
100 - - 100 - - 
100 2 ±1.9 - - 100 2 ±1.3 - - 
100 - - 100 - - 




Mean Tm 55.6 
±1.72 
62.2 ±0.53 
SD: standard deviation, ND: not detectable, TNTC: too numerous to count, Tm: melting temperature. 
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The mean melting temperatures (Tm) for stx1 (Tm1) and stx2 (Tm2) detection in TSB rinsate of 25g 
of meat over 24 DNA replicates using the duplex qPCR were 55.10 ̊C±0.82 and 62.09 ̊C ±0.27, 
respectively. The mean melting temperatures for stx1 (Tm1) and stx2 (Tm2) detection in TSB 
dilutions of Lotus River surface water over 24 DNA replicates using the duplex qPCR were 55.10 
̊C ±0.82 and 62.09 ̊C ±0.27, respectively. 
3.4.1 Clinical and Environmental specimen testing 
Clinical specimen testing: Of the 226 specimens screened, real-time PCR detected Shiga toxin 
genes in 14 samples (6.2%), comprising eight stx1, five stx2 and one specimen containing both stx1 
and stx2. CHROMagarTMSTEC yielded mauve colonies from 23.45% (53/226) of the stool broth 
cultures. 
Environmental specimen testing: Of the sixty-four water sample broths, 19 (29.7%, 95% 
Confidence Interval= 18.9%-42.4%) tested positive for the stx1 using the in-house developed 
qPCR. None of the samples tested positive for stx2. Eighteen of the 86 meat sample broths (21.2%, 
95% Confidence Interval= 13.1%-31.4%) from the informal slaughter setting tested positive stx 
genes with the qPCR, 15 had the stx1 genes; one sample had both the stx1 and stx2 genes while 
four samples possessed the stx2 genes.  
3.4.2 The performance of CHROMagarTMSTEC for clinical and Environmental 
specimen testing 
Clinical specimen: Of the 53 mauve isolates, 48 were negative for stx genes using the real-time 
PCR assay.  Of the 14 broths that were positive on real – time PCR, nine did not yield any mauve 
colonies on CHROMagarTMSTEC culture (diagnostic odds=1.898). 
Lotus River surface water: Of the 64 water samples screened, 16 yielded mauve colonies on 
CHROMagarTMSTEC following overnight incubation (one mauve colony was selected from each 
sample). Of the 19 Lotus River surface water enrichment broths that tested positive for stx1 using 
the in-house optimised real-time PCR, only five formed mauve colonies on CHROMagarTMSTEC. 
Of these five, one isolate tested positive for stx1. The other 11 mauve colonies (to form a total of 
16 mauve colonies from all the 64 water samples) were isolated from stx negative broths. 
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Meat samples: Of the 85 meat samples processed, 32 formed mauve colonies on 
CHROMagarTMSTEC. All the 18 meat sample broths that tested positive for stx genes using the 
in-house developed real-time PCR formed mauve colonies on CHROMagarTMSTEC. 
3.4.3 Isolate characteristics for isolates from clinical and environmental testing  
Two hundred twenty-six stool isolates, 85 meat samples and 64 water samples were screened. 
Fifty-three, 32, and 16 mauve isolates were detected in stool, meat, and water respectively. Of 
these, five, zero, and one tested positive for stx using the real – time PCR (Figure 3:4). 
Figure 3:4: Summary of results showing growth properties on CHROMagarTMSTEC and the detection of stx genes 
from the mauve isolates. 
Clinical testing: Forty-four (83%) of the 53 mauve colonies fermented lactose on MacConkey agar 
with crystal violet. Eleven (25%) of the 44 lactose fermenters were non-sorbitol-fermenting. Real-
time PCR on the 44 E. coli confirmed the presence of stx genes in five (11%) while 39 were negative 
for the stx gene.  
Real-time PCR was not done on the nine non-lactose fermenting isolates as these were found not 
to be E. coli on biochemical testing. Four of the five stx positive E. coli colonies were from 
corresponding real-time PCR positive broths. Of the 39 stx-negative E. coli, only four (12.5%) 
carried eae genes, while four possessed aat genes. Of the four eae positive isolates, two also had 

























genes and were classified as atypical EPEC. The four enteroaggregative stx-negative isolates all 
belonged to E. coli serotype O104. All the typical EPEC belonged to serotype O55 while one of the 
two atypical EPEC belonged to serotype O101. The atypical EPEC serotype O101 was from stx2 
positive broth. The other atypical EPEC isolate was untypeable. None of the 53 E. coli isolates that 
were screened by immunochromatography was positive for Shiga toxins. The sensitivity, 
specificity, negative predictive value and positive predictive value of the CHROMagarTMSTEC 
were 35.71%, 77.4%, 95.3% and 11.3% respectively (Table 3.4). The diagnostic accuracy of the test 
for stool screening was 74.78%. 
qPCR assay 
CHROMagarTMSTEC + _ Total 
+ 5 48 53 
_ 9 164 173 
Total 14 212 226 
Table 3.4 Two-by-two table showing the performance of CHROMagarTMSTEC in comparison to the qPCR on clinical 
stool specimens. 
Sensitivity =5/14*100=35.71%  (95% Confidence Interval=16.34 - 61.24) 
Specificity=164/212*100=77.4% (95% Confidence Interval=71.27 – 82.48) 
Positive Predictive Value= 5/53*100=9.4% (95% Confidence Interval=4.097 – 20.25) 
Negative Predictive Value =164/173*100=95% (95% Confidence Interval=90.41 – 97.24) 
Isolates from water: From the 64 water samples, mauve colonies were detected in 16 water 
samples (16 mauve colonies). All the 16 mauve colonies were lactose fermenters, and we 
confirmed them to be E. coli. However, of these, only four carried virulence genes. Two of these 
isolates carried daaC genes while one had the eae gene and one carried the ipa gene. One mauve 
isolate tested positive for Shiga toxin 1 on immunochromatography. The sensitivity, specificity, 
negative predictive value and positive predictive value of the CHROMagarTMSTEC were 5.3%, 
66.7%, 62.5% and 6.3%, respectively (Table 3.5). The diagnostic accuracy of this media was 
48.44%. 
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Table 3.5 Two-by-two table showing the performance of CHROMagarTMSTEC in comparison to the qPCR to detect 
STEC in Lotus River water samples. 
qPCR assay 
CHROMagarTMSTEC + _ Total 
+ 1 15 16 
_ 18 30 48 
Total 19 45 64 
Sensitivity= 1/19*100= 5.3% (95% Confidence Interval= 0.9352 – 24.64) 
Specificity= 30/45*100= 66.7% (95% Confidence Interval= 52.07 – 78.64) 
Negative predictive value= 30/48*100= 62.5% (95% Confidence Interval=48.36 – 74.78) 
Positive predictive value= 1/16*100= 6.3% (95% Confidence Interval= 1.112 – 28.33) 
Isolates from the informal slaughter: Of the 85 meat samples, only 32 formed mauve colonies on 
CHROMagarTMSTEC. The 32 mauve colonies were confirmed to be E. coli using the VITEK®2 
automated system. Only three of the 32 mauve colonies on CHROMagarTMSTEC carried virulence 
genes. Of these three, two possessed the daaC genes while only one carried the eae gene. None of 
the mauve colonies had stx genes. To detect stx genes from 25g of meat samples, the sensitivity, 
specificity, positive predictive value and negative predictive value of the CHROMagarTMSTEC 
were 0%, 52.9%, 0%, and 66.7%, respectively (Table 3.6). The diagnostic accuracy of this media 
was 41.86% for screening meat. 
Table 3.6 Two-by-two table showing the performance of CHROMagarTMSTEC in comparison to the qPCR on meat 
samples. 
Sensitivity=0.0% (95% Confidence Interval=0.0 – 17.59) 
Specificity= 36/68*100= 52.9% (95% Confidence Interval=0.0 – 17.59) 
Positive Predictive Value=0.0% (95% Confidence Interval=41.24 – 64.33) 
Negative Predictive Value= 36/54*100= 66.7% (95% Confidence Interval=53.36 – 77.76) 
In-house developed assay 
CHROMagarTMSTEC + _ Total 
+ 0 32 32 
_ 18 36 54 
Total 18 68 86 
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3.5 Discussion 
Validation and determination of the limit of detection of the in - house developed real-time PCR 
assay.  
We validated the use of and modified a previously described duplex real-time PCR assay to detect 
and differentiate stx1 (melting temperature=58.2 ̊C ) and stx2 (melting temperature=65.3 ̊C) from 
overnight broth enrichment cultures with a LOD of 5.3 target copies/ul broth, and compared 
findings to those of culture-based CHROMagarTMSTEC. The limit of detection of the in-house 
developed assay for stx targets in meat and water were 116 ±4.03 CFU per 25g of meat and 144 
±6.4 CFU/100ml of Lotus River surface water for both targets. The in-house developed 
hybridisation probe based assay is more sensitive than CHROMagarTMSTEC (sensitivity and 
specificity of 35.7% and 77.4, 5.3% and 66.7%, 0% and 52.9% for screening stool, Lotus River 
surface water and meat from the informal slaughter setting respectively).This is in agreement 
with previously published findings.26 
The performance of CHROMagarTMSTEC in comparison to the in – house developed real-time 
PCR assay for detection of stx genes in stool, water and meat.  
Compared to the validated duplex real-time PCR, CHROMagarTMSTEC showed a sensitivity, 
specificity, negative predictive value and positive predictive value of 35.7%, 77.4%, 9.4% and 95% 
respectively for detection of STEC in stool following TSB enrichment. Specifically, of the 53 
mauve isolates, 48 were negative for stx genes on the real-time PCR while nine of the 14 PCR 
positive broths did not yield any mauve colonies when cultured on CHROMagarTMSTEC.  
For screening of environmental samples, it showed sensitivity and specificity of 5.3% and 66.7%, 
0% and 52.9% for screening Lotus River surface water and meat from the informal slaughter 
setting respectively. 
Notably, this chromogenic media performed best at screening of stool (diagnostic 
accuracy=77.4%) and performed worst at screening of meat samples (diagnostic 
accuracy=41.86%). It showed a diagnostic accuracy of 48.4% for screening surface water for STEC. 
The differences in performance among the sample types could be due to the differences in the 
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prevalences of STEC and or tellurite resistant STEC among the different sample types. This is in 
agreement with previously published research.27 
Comparison of CHROMagarTMSTEC performance in this setting to its performance in other 
contexts: This media contains chromogenic conjugates of a substrate-linked with a chromophore 
such that when the substrate is cleaved with an enzyme, insoluble chromophores are released 
giving a distinctive colour to the colonies. These media also contain selective inhibitors such as 
potassium tellurite (at a concentration of 2.5mg/L).28,29 The exact chemistry of how 
CHROMagarTMSTEC works is proprietary information to the manufacturer.  
For a chromogenic media to be considered for routine screening purposes, it must have high 
specificity so as not to waste resources on false positives.  
CHROMagarTMSTEC has previously been used to screen for STEC from human and non-human 
sources. In this study, CHROMagarTMSTEC has sensitivity and specificity lower than has been 
reported in Europe, especially for clinical samples. Similar studies to evaluate these media were 
done in Canada, Finland, and Germany. In all these studies, higher sensitivities were shown for 
STEC serotypes O26, O111, O121, O145, O118, and O157 .17,30,31 The specificity of 77.4% noted in 
this study was low compared to values reported in these studies that reported specificities 
between 95.8% and 98.9%.  
For example, in comparison to a sensitivity of 89.1% and specificity of 83.7% as reported by Gouali 
et al.16 Another related study performed in Canada showed a sensitivity and specificity of 85.7% 
and 95.8% respectively.29  
Possible reasons for the poor performance of CHROMagarTMSTEC in this setting. 
STEC numbers are sharply reduced in stool after one week of illness, and the Shiga toxin genes 
might be lost by the bacteria.32 Therefore, it may be argued that due to delays in reporting of 
diarrhoea cases to a tertiary hospital, some of the mauve colonies may have lost stx genes or that 
there were no longer viable STEC in the stool. For example, one of the atypical EPEC belonged to 
serotype O101 which is one of the top five STEC serotypes globally.  
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These findings could be explained by the differences in the approaches used. For example, in this 
study, we did not strictly use stool from patients with bloody diarrhoea and or HUS as was the 
case in some of the studies conducted in Europe.16 Instead, we screened all stools that were 
presented on the stool bench within the study period.  
Some of the qPCR positive broths could have carried tellurite susceptible STEC strains and so 
were missed on CHROMagarTMSTEC culture. This is inferred from the fact that nine of the 14 
PCR positive broths did not yield any mauve colonies.  
Also, a negative stx PCR on a colony might indicate that the isolate carries a variant that may not 
be detectable using the available set of primers.33 Whole Genome Sequencing would help to 
characterise further the tellurite susceptible E. coli that formed mauve in this study.  
There is a question of how mauve a colony should be to be considered as suspect STEC. The high 
false positivity rate may be attributable to the various shades of mauve shown by colonies 
growing on this media. According to Claire Jenkins of the Public Health Laboratory in England 
(personal communication), the use of this media in their Laboratory was halted because of the 
different shades of mauve formed by E. coli on this media. The different shades could be 
attributable to the various levels of production of tellurium resistance proteins. 
This media was designed for the screening of food, faeces and environmental samples for STEC. 
It was particularly meant to target the top six STEC serotypes globally including STEC serotypes 
O45, O157, O111, O121, O103 and O45. The detection of these serotypes is based on the 
production of tellurite resistance proteins, which varies among STEC from human and non -
human sources, that enables them to grow on tellurite containing media such as 
CHROMagarTMSTEC.27 However, not all STEC serotypes are able to produce tellurite resistance 
proteins. For this reason, not all STEC serotypes will form mauve colonies on this media or even 
grow on this media. There is need to determine the dominant STEC serotypes in this setting and 
then determine their ability to secrete tellurium resistance proteins.  
When judging the performance of CHROMagarTMSTEC, it is important to remember that it was 
designed as a screening media to help to detect STEC in many samples. The findings of 
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CHROMagarTMSTEC screening would have to be confirmed using more sensitive and specific test 
such as real – time PCR.  
The prevalence of stx in the clinical and environmental samples. 
The prevalence of stx in stool samples was 6.2%. This is slightly lower than the 9% of STEC/EPEC 
reported in the same setting, but in the previous study, only the eaeA gene (as a proxy for 
EHEC/EPEC colonisation) was screened for in the stool DNA extracts.34 Interestingly, an earlier 
study conducted at the Centre for Enteric Disease, National Institute of Communicable Disease 
(NICD), using STEC collected in the period 2006 – 2009, showed that of the 2378 DEC isolates 
screened, only 14 were EHEC (0.6%).35 Only one of the 14 STEC belonged to serotype O157. 
According to STEC data collected over three years at the NICD, most of the isolates presented 
were from sporadic cases and not outbreak cases. Low levels of outbreak detection may be linked 
to the NHLS clinical microbiology diagnostic protocol according to which, DECs are not routinely 
screened for. The same protocol advises screening for only STEC O157:H7 and yet of the 14 STEC 
isolates collected over the three-year period, 2006 – 2009, only one was E. coli O157. Clearly,in the 
NICD study, non-O157 STEC serotypes O111 and O26 were dominant and may be dominant in 
the general population. And yet the NHLS diagnostic strategy prioritises E. coli O157, and this 
may partly explain low levels of STEC detection. The low levels of STEC infection in Africa have 
previously been attributed to the type of diet that is used to feed ruminants36,37,and thus low levels 
of carcas contamination at slaughter and subsequent low levels of human infection. But this 
finding may not be relevant in the South African context because the cattle experiments only 
focused on E. coli O157 which is not dominant in South Africa.35 So, diagnostic strategy, and the 
non- dominance of O157 in South Africa may play a role in the low STEC detection rates 
especially given the high number of typical HUS cases reported among children.11 
Of the sixty-four water sample broths, 19 (29.7%, 95% Confidence Interval= 18.91%-42.42%) tested 
positive for the stx1 using the in-house developed qPCR. This is higher than the 15% detected in 
the Berg River system (2015) in South Africa.38 An earlier study that tested South Africa water 
sources (Eastern Cape) intended for direct and indirect consumption showed that they had no E. 
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coli O157:H7; but this study never tested for the non-O157 STEC.39 A similar study conducted in 
the Eastern Cape showed a 25.5% prevalence of E. coli O157:H7 in the surface water.40 
Eighteen of the 86 meat sample broths (21.2%, 95% Confidence Interval= 13.06%-31.39%) from the 
informal slaughter setting possessed stx genes on testing with the in-house developed qPCR. 
Previous reports conducted in South Africa, but mainly in the Eastern Cape, have reported a 
prevalence of 1.4%, 88.42%, 2.8%, and 35% for STEC in swine faecal samples (2016)41, cattle faeces 
(2015)42, meat/meat products (2009)43, and raw meat (2008)40 respectively. However, most of these 
have only targeted E. coli O157:H7 and did not attempt to isolate the non-O157 STEC.  
Previous research done in some African countries, which targeted E. coli O157 resulted in no 
isolation of this pathogen. This was the case in Uganda44, Burkina Faso45, and the Central Africa 
Republic46. E. coli O157 was however successfully isolated from shellfish and meat in separate 
studies conducted in Morocco47 (prevalence of 1.9% in meat samples) and Tunisia (prevalence of 
1.2% in meat)48 respectively. Another study conducted in Egypt49 showed the presence of both 
O157 and non-O157 STEC in Egypt (prevalence of 13.8% in beef). In Namibia50, another Southern 
Africa country, E. coli O157 was detected in meats of different livestock (prevalence of 1% – 20%). 
Characteristics of the E. coli strains that formed mauve colonies on CHROMagarTMSTEC. 
Among the 53 isolates that formed mauve colonies on CHROMagarTMSTEC, five were STEC (two 
serotype O26 and non-typeable), four were EAggEC (serotype O104), two were atypical EPEC 
(serotype O101 and non-typeable) while two were typical EPEC (serotype O55). This means that 
even though CHROMagarTMSTEC is intended for STEC culture, we detected other E. coli 
pathotypes are presenting as mauve colonies on this media. There is the possibility of hybrid 
strains losing stx genes. Notably, bacteriophages carrying the stx genes are very quickly lost both 
in vivo and in vitro51; and not all stx primers can detect all the stx gene variants.33 Notably, 
serotypes O26 and O104 are among the top six STEC serotypes globally.52,53 The high carriage rate 
of eae genes among isolates from TSB enrichment with stx genes could indicate increased 
pathogenic potential since possession of the genes by STEC has been associated with more severe 
disease54. None of the 53 E. coli isolates that were screened by immunochromatography was 
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positive for Shiga toxins. Firstly, not all of these tested positive for stx using the primers we 
utilised in this study. Secondly, even if they possessed the genes, not all the isolates may be 
expressing these genes as sometimes it may require exposure to antibiotics such as polymyxin B 
to induce the isolates to secrete toxin in-vitro. There is no evidence to suggest that these isolates 
were secreting toxin at the point they were isolated from the patients. We did not collect 
accompanying clinical data. 
Limitations of this study 
The evaluation of CHROMagarTMSTEC was carried out over a short period and on a limited 
number of samples. Some of the stx variants may have been missed due to a mismatch with the 
primers available. 
3.6 Conclusions 
CHROMagarTMSTEC can only be used as a supplementary to molecular tests such as PCR or 
detection of the toxin using enzyme immunoassays or immunochromatography. The integrated 
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Chapter Four 
4 Undiagnosed Shiga-toxin-producing E. coli and other 
diarrheic E. coli in stool processed at a tertiary referral 
hospital, Cape Town, South Africa.  
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4.1 Summary 
Introduction: In the previous chapter, the performance of CHROMagarTMSTEC was assessed in 
comparison to an in - house validated real-time PCR assay. In this chapter, it was purposed to: 
i. Determine the prevalence and pathotypes of tellurite resistant diarrheic E. coli isolated on
CHROMagarTMSTEC from stool samples submitted to the National Health Laboratory
Sciences, Groote Schuur Hospital.
ii. To characterize the tellurite resistant STEC and other diarrheic E. coli isolated from stool
by determining their serotypes, antibiotic susceptibility patterns, and sorbitol
fermentation ability.
This would inform diagnostic policy and provide baseline information to physicians on the 
prevalence of tellurite-resistant STEC and other diarrheic E. coli in stool samples submitted to the 
National Health Laboratory Services at Groote Schuur Hospital.  
Methods: We tested all the stool samples presented to the stool culture bench at the National 
Health Laboratory Sciences, Groote Schuur Hospital between September 2014 and May 2015. We 
used CHROMagarTMSTEC with and without enrichment to isolate tellurite resistant E. coli strains, 
instead of the routinely used National Health Laboratory Services (NHLS) protocol involving the 
use Sorbitol MacConkey. Confirmed E. coli were tested for possession of the aat, daaC, eaeA, ipa, 
bfp, stx1 and stx2 using gel-based PCR and real – time PCR. All the E. coli strains that possessed 
virulence genes were then serotyped, tested for the ability to ferment sorbitol by culture on 
sorbitol MacConkey, and tested for Shiga toxin production by immunochromatography.  
Results: The prevalence of tellurite resistant diarrheic E. coli in stool at the Groote Schuur Hospital 
was 5% (33/733, 95% Confidence Interval=3.2 – 6.2). Of the tellurite resistant diarrheic E. coli 
isolated, 15% (5/33, 95% CI=6.7 – 30.1) were STEC, 45% (15/33, 95%CI=29.84 – 62.01) were 
EAggEC, 18% (6/33, 95%CI=8.6 – 34.4) were atypical EPEC, 15% (5/33, 95% CI=6.7 – 30.1) were 
typical EPEC, and 3% (1/33, 95%CI=0.54 – 15.32) were DAEC.  
Of the 33 diarrheic E. coli isolated, 45% (15/33, 95%CI=29.84 – 62.01) were non - sorbitol 
fermenting. The five STEC strains isolated belonged to serotype O186 and O101. Serotypes O104 
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(5/33, 15%) and 055 (6/33, 18%) were the dominant diarrheic E. coli serotypes in this setting. Of 
the 33 tellurite resistant diarrheic E. coli strains, 55% (95% Confidence Interval= 40.8 – 72.7) 
showed resistance to ampicillin.  
Conclusions: Culture on CHROMagarTMSTEC coupled with enrichment enabled detection of 
STEC plus other pathotypes that would have been missed by commonly used methods (sorbitol 
MacConkey). Further studies are needed to determine the proportion of STEC and other diarrheic 




STEC are important causes of diarrhoea, haemorrhagic colitis, bloody diarrhoea, and haemolytic 
uremic syndrome (HUS).1 HUS is characterised by acute renal failure, haemolytic anaemia, and 
neurological complications in about 10% of the cases especially the young and the elderly. The 
top STEC serotypes that are most commonly associated with severe disease globally include O26, 
O45, O103, O111, O121, O145 and O157.2,3 According to a study conducted by the National 
Institute of Communicable Disease (NICD), over a three-year period from 2006 to 2009, the 
dominant STEC serotypes were the non – sorbitol fermenting STEC serotypes O26 and O111.4 In 
the NICD study, only one of the 14 STEC isolated belonged to serotype O157:H7.4 This means 
that STEC O157:H7 may not be the dominant non – sorbitol fermenting STEC in this setting.  
STEC isolates that carry the stx2 genes have been commonly associated with severe disease; and 
include the following variants; stx2a, stx2b, stx2c, stx2d, stx2e, stx2f and stx2g with stx2a, stx2c and stx2d 
more frequently associated with severe clinical outcome.5,6 In another related study that used 
Whole Genome Sequencing (WGS), strains that harboured stx2a were most commonly found to 
have multiple alleles (more than one copy of stx2a in the same genome) of the same subtype.7 
Genes stx2d and stx2c have often been associated with post infection HUS with stx2c being activated 
by the presence of intestinal mucus and urease.8 As a result of interchange of genes among 
traditional diarrheic E.coli, new virulence genes have led to the creation of new STEC strains. For 
example, the hybrid EAHEC (enteroaggregative Haemolytic E. coli) outbreak strain O104: H11 in 
Germany that carried both aat and stx genes harboured a combination of virulence traits derived 
from two different ancestors; one enteroaggregative (EAggEC) and the other STEC. This hybrid 
carried the  AAF genes for the Enteroaggregative E. coli (EAggEC) and the stx phage which is 
characteristic of STEC O157: H7 but it lacked the Locus of enterocyte effacement which contains 
the eae gene that STEC O157:H7 commonly carries.9 Another emerging E. coli pathotype, EAHEC 
O104: H4, is endemic in Central Africa and has spread to Europe but its prevalence in South 
Africa is not known.10  
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Failed laboratory detection of STEC 
Criteria for specimen selection for STEC testing may hinder STEC diagnosis. For example, many 
infections are missed due to testing only children, only those presenting with bloody diarrhoea 
(blood and or white blood cells in the stool) or only testing specimen submitted in the summer 
months.11 This approach is questionable because STEC has been isolated from patients with non-
bloody diarrhoea and some stools of STEC-infected patients do not contain white blood cells.12,13  
As regards the selection of patients based on age, despite the fact that most of the cases have been 
reported in children, a significant proportion has been reported in cases older than 12 years.13 
Additionally, studies have reported the occurrence of infections throughout the year and not only 
during the summer months.12  
Furthermore, bacteriophages carrying the stx genes are very quickly lost both in vivo, and in-
vitro 14; and not all stx primers can detect all the stx gene variants.15 For these reasons, stools 
should be tested as early as possible in the course of illness, as it becomes less likely to detect 
them in stool after one week of the disease.16  
Testing algorithms in well-resourced countries recommend an initial screening by use of selective 
media for E. coli O157: H7 as well use of immunoassays on overnight broth for Shiga toxin for all 
stool specimen submitted to the diagnostic laboratory.11,17 The use of sorbitol MacConkey to 
screen for O157:H7, as is the case in many laboratories within the NHLS South Africa, has 
limitations due to the inability to detect emerging sorbitol-fermenting non-O157 STEC and the 
sorbitol-fermenting O157 strains. Indeed, new chromogenic media, for example, 
CHROMagarTMSTEC have been developed to detect both O157 and the non-O157 STEC with 
some targeting specific STEC serotypes.18 CHROMagarTMSTEC is a screening media which selects 
for tellurite resistant E. coli strains.18 Per the manufacturer, the common STEC serotypes form 
mauve colonies, other Enterobacteriaceae form blue or colourless colonies, while gram-positive 
bacteria are completely inhibited.19 In order to isolate the tellurite resistant diarrheic E. coli, the 
mauve colonies are picked. Also, earlier research has shown that this media allows growth of 
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other diarrheic E. coli pathotypes other than STEC.20 The chemistry behind the formation of the 
mauve coloured colonies is proprietary information.  
Routine STEC screening at the National Health Laboratory Services, Groote Schuur Hospital 
Groote Schuur is a referral (for primary or secondary health facilities) tertiary academic hospital 
that was opened in 1938 and provides tertiary and quaternary care for patients of the Western 
Cape and beyond.21 In NHLS laboratories at Groote Schuur, stool specimens are not routinely 
screened for entero-haemorrhagic E. coli. Physicians are advised to contact the laboratory within 
7 days if there is a clinical suspicion of EHEC infection or haemolytic-uraemic syndrome.22 On 
specific request from a physician, screening is done using MacConkey –sorbitol and suspicious 
colonies forwarded to NICD for further identification and typing. Other diarrheic E. coli are not 
routinely screened for in the Groote Schuur laboratory (this practice is variable at different 
laboratories), unlike the other bacterial causes of infectious diarrhoea such as Salmonella and 
Shigella. The problem with this approach is that there are over 450 non-O157 STEC serotypes that 
have been associated with clinical disease globally23 some of which are also non-sorbitol 
fermenting, for example, O26 and O104. Based on research done at the NICD considering STEC 
isolates collected between 2006 and 2009, the dominant STEC serotypes in S. Africa belonged to 
serotypes O26 and O111. 
4.2.1 Aims and objectives 
Given the many avenues through which we might fail to detect STEC and other diarrheic E. coli 
in the laboratory in this setting, we employed a multi-pronged approach to the diagnosis of STEC 
using culture (on CHROMagarTMSTEC), PCR (real-time and gel-based) and Shiga toxin detection 
by immunochromatography. CHROMagarTMSTEC was used instead of sorbitol MacConkey for 
primary isolation of STEC with and without enrichment in Tryptic Soy Broth (TSB). Since 
CHROMagarTMSTEC selects for only the tellurite resistant E. coli, and yet not all STEC are tellurite 
resistant, we don’t report on the tellurite susceptible STEC in this study. Since the current STEC 
diagnostic strategy is based on non-sorbitol fermentation, we also sought to determine the 
prevalence of tellurite resistant non-sorbitol fermenting diarrheic E. coli in this setting. Even 
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though diarrhoea is not commonly treated using antibiotics, antibiotic profiles of diarrheic E. coli 
can be utilised for sentinel surveillance for antimicrobial resistance. This is because E. coli easily 
acquire and transfer antimicrobial resistance genes to transient pathogens in the gastro-intestinal 
tract. Even though diarrheic E. coli infections are usually self-limiting, persistent and invasive 
infections, especially in the immunocompromised persons, may necessitate the use of antibiotics. 
Aim 1: Determine the prevalence and pathotypes of tellurite resistant diarrheic E. coli identified 
from CHROMagarTMSTEC culture of stool submitted to the NHLS, Groote Schuur Hospital, Cape 
Town. 
Aim 2: Characterise the tellurite resistant STEC and other diarrheic E. coli isolated from stool by 
determining their serotypes, antibiotic susceptibility patterns, and sorbitol fermentation ability. 
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4.3 Methods 
4.3.1 Sample collection and processing 
In tandem with the routine stool processing in the clinical microbiology laboratory, Groote 
Schuur Hospital, we tested the residual stool sample. All stool samples from diarrhoea patients 
that were submitted to the NHLS for testing between September 2014 and May 2015 were 
included in this study irrespective of age. Some of the stool specimens (collected between 
September 2014 and November 2014) were directly streaked onto CHROMagarTMSTEC while 
others (collected between December 2014 and May 2015) were enriched in TSB (TSB; Oxoid, 
Basingstoke, U.K) before streaking on CHROMagarTMSTEC and were not directly plated. 
Direct Streaking: Stool specimens received between September and November 2014 were directly 
streaked (A sterile loop was used to pick and streak a small piece of the stool sample) onto 
CHROMagarTMSTEC (CHROMagar, Paris) and incubated for 24h at 37oC. Mauve colonies were 
identified by visualisation under white light and considered suspect STEC. A maximum of five 
mauve colonies (depending on the number of mauve colonies formed) were selected from each 
of the culture plates which showed growth of a mauve colony. The mauve colonies were then 
streaked onto MacConkey agar with crystal violet (NHLS, Green point media) and sorbitol 
MacConkey (NHLS, Green point media) and incubated at 37°C for 18h. 
Enrichment before streaking: From December 2014 to May 2015, stool samples that were 
presented to the stool culture bench at the clinical microbiology laboratory were processed.  After 
the routine stool testing the residual sample was used in this study. .A pea-sized amount of stool 
was inoculated in 10ml of TSB and incubated for 24h at 37 ̊C. A loopful of broth was then streaked 
on CHROMagarTMSTEC and incubated at 37 ̊C for 24h. Following incubation, plates were viewed 
under a light source and observed for mauve colonies. A single mauve colony was picked from 
53 culture plates which showed mauve growth (Figure 4:1). The mauve colonies were then 
streaked onto MacConkey agar with crystal violet (NHLS, Green point media) and sorbitol 
MacConkey (NHLS, Green point media) and incubated at 37°C for 18h. 
124 
Figure 4:1 Summary of stool processing workflow indicating the samples directly streaked onto 
CHROMagarTMSTEC, and those streaked after enrichment in TSB. 
4.3.2 Isolate Characterization 
This was done as described in 3.3.5. Briefly, the isolates identified as E. coli were subjected to stx 
characterization employing the in-house developed real-time PCR assay as well as a conventional 
PCR performed as previously described by Paton and Paton (1998).24 The presence of virulence 
genes including the fimbrial adhesion gene for diffusely adherent E. coli (daaC), the anti-
aggregation protein transporter gene for enteroaggregative E. coli (aat), heat-stable (ST) and heat-
labile (LT) enterotoxin genes of enterotoxigenic E. coli (ETEC), the invasive plasmid antigen gene 
for enteroinvasive E. coli (ipa) and the intimin coding gene (eae) for EPEC were determined using 
standard gel-based PCR as previously described.24 
The Immunocard STAT! ® EHEC was used to detect Shiga-toxin 1 and Shiga-toxin 2 by the isolates 
employing immunochromatography with toxin-directed monoclonal antibodies labelled with 
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red-coloured gold particles (Meridian Biosciences, Inc., USA). We did not screen the broth for 
Shiga-toxin because the broth was not a suitable sample type for the Immunocard STAT! ® EHEC 
kit. We had already tested the broth for stx using the in-house validated real-time PCR. Serology 
using antisera (Statens Serum Institut, Copenhagen, Denmark) was done to detect E. coli somatic 
O- antigens.25,26 H-antigen serotyping was not undertaken.
4.3.3 Antimicrobial Susceptibility Testing of the diarrheic E. coli using VITEK® 
automated system and broth microdilution. 
Isolates were tested for susceptibility to 19 antibiotics following the Clinical Laboratory Standards 
Institute guidelines (CLSI, 2015). Since VITEK® automated system offers a limited MIC range, we 
further re-tested these isolates using the broth microdilution based GNX2F sensititre MIC plate 
(Thermo-scientific, USA) to confirm the MICs observed using VITEK®2 automated system. MIC 
values from broth microdilution were used as the final reference for classification as resistant, 
intermediate or susceptible. E. coli ATCC 25922 was used as the control strain. The antibiotics 
included in the VITEK®2 automated system panel were: ampicillin (AMP), amoxicillin – 
clavulanic acid (AMC), piperacillin – tazobactam (TZP), cefuroxime (CXM), cefuroxime Axetil 
(CXA), cefoxitin (FOX), cefotaxime (CTX), ceftazidime, (CAZ), cefepime (FEP), ertapenem (ETP), 
imipenem (IMP), meropenem (MEM), amikacin (AMK), gentamicin (CIN), ciprofloxacin (CIP), 
tigecycline (TIG), nitrofurantoin (NIT), colistin (COL), and trimethoprim – sulfamethoxazole 
(SXT). 
The antibiotics included in the broth microdilution panel on the GNX2F sensititre plate were: 
amikacin, aztreonam, cefepime, cefotaxime, ceftazidime, ciprofloxacin, colistin, doripenem, 
doxycycline, ertapenem, gentamicin, imipenem, levofloxacin, meropenem, minocycline, 
piperacillin – tazobactam, polymixin B, ticarcillin – clavulanic acid, tigecycline, tobramycin, and 
trimethoprim – sulfamethoxazole. 
MIC data was entered in WHONET 5.6 software. Resistance to third generation cephalosporins 
and or carbapenems was confirmed using the ESB1F sensititre MIC plates (Thermo-scientific, 
USA).  
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4.3.4 Data analysis 
Data on cultural characteristics, serotypes, and pathotypes was entered into Microsoft Office 
Excel 2016 (Microsoft Corporation, USA) software, coded and later exported to STATA version 
12 for analysis. Further analysis was done using the R-statistical package.27 Antimicrobial 
resistance data in the form of Minimum Inhibitory Concentrations (MICs) was entered into World 
Health Organization (WHO) antimicrobial resistance data management software called 
WHONET 5.628,29 and analysed as per the Clinical Laboratory Standards Institute (CLSI), 2016, 
USA guidelines and breakpoints for testing of E. coli.  
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4.4 Results 
4.4.1 Isolate characteristics  
Isolates from direct and indirect streaking: 
Of the 733 specimens, 507 were directly inoculated on CHROMagarTMSTEC while 226 were first 
enriched in TSB before inoculation on CHROMagarTMSTEC. Of 733 specimens screened on 
tellurite-containing CHROMagarTMSTEC, 257 (35%) yielded mauve colonies. Of the 257 mauve 
colonies derived from direct and indirect streaking, 192 (75%) were lactose fermenting colonies 
on MacConkey agar with crystal violet. All the 192 lactose fermenters were confirmed to be E. coli 
using the VITEK® 2 automated system (bioMerieux, USA). Of these, 29% (56/192) were sorbitol 
fermenting. 
Mauve colonies were obtained from 40% (204/507) of the directly inoculated specimens, and 24% 
(53/226) of stool samples that were enriched first in tryptic soy broth (p=0.001). Of the 204 mauve 
colonies obtained from direct culture, 12 were diarrheic E. coli while 21 of the 53 mauve colonies 
obtained following enrichment in TSB were diarrheic E. coli. Tellurite resistant diarrheic E. coli 
were therefore obtained from 5% (33/733) of the stool specimens.  
4.4.1.1 Pathotypes and prevalence of tellurite resistant diarrheic E. coli 
Real-time PCR on the 192 E. coli for stx yielded five positives. Of these five STEC isolates, three 
also carried the eae gene while two did not. Only one of the five STEC  isolates carried both the 
stx1 and stx2 genes while four carried only the stx1 gene. All the five STEC were obtained after 
enrichment in TSB. Of the 187 stx-negative E. coli, 11 (6%) carried eae genes, 15 (8%) carried aat, 
and only one (1%) possessed the daaC gene. Of the 11 eae positive isolates, five also had the bfp 
genes and were typical EPEC. The other six eae positive isolates did not possess the bfp genes and 
were classified as atypical EPEC. A total of 33 tellurite resistant diarrheic E. coli were therefore 
obtained. 
Of the 33 tellurite resistant diarrheic E. coli , 64% (21/33) were obtained following enrichment in 
TSB while 36% (12/33) were obtained without enrichment (p=0.004). Of all the 33 diarrheic E.coli 
strains isolated on CHROMagarTMSTEC, 15% (5/33) were STEC; 45% ( 15/33) were EAggEC, 18% 
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(6/33) were atypical EPEC, 15.2% (5/33) were typical EPEC, and 3% ( 1/33) were DAEC. No 
Enteroinvasive E. coli (E. coli) were detected among the DEC pathotypes (Figure 4:2).  
Figure 4:2 Bar graph showing the number of each of the diarrheic E. coli pathotypes isolated on 
CHROMagarTMSTEC from stool. 
Shiga toxin production: Of the 33 diarrheic E. coli strains, two isolates that also tested positive for 
stx, tested positive for Shiga-toxin production on immunochromatography (the three STEC that 
tested positive for stx genes by PCR were negative for Shiga-toxin production on 
immunochromatography) with the formation of a band indicating the detection of Shiga toxin 1. 
All isolates showed the presence of the control band which was a marker for the validity of the 
test (Figure 4:3). 
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Figure 4:3 Images for the ImmunoCardSTAT® test panels showing the Shiga-toxin1 bands for the isolates that 
tested positive for Shiga-toxin 1 by immunochromatography 
Isolates NY29, 710, 73, and 232.1 were positive for Shiga toxin 1 production. The upper red band in 
the test well is the positive control which should show in all valid tests. The positive control test (2nd 
from the left) showed both the Shiga toxin 1 and Shiga toxin 2 bands. 
4.4.1.2 Serotypes 
Of the five STEC serotypes, two belonged to serotype O186, while one belonged to serotype O101. 
The other two STEC were non-typeable (NT). 
Of the six atypical EPEC isolates, two belonged to serotype O26, one of each belonged to serotypes 
O25, O182, O111, and one was not typeable. All the five typical EPEC belonged to serotype O55. 
Of the 15 EAggEC, five belonged to serotype O104; four belonged to serotype O175, while one of 
each belonged to serotypes O3, O8, O9, O16, O25, and O33.  
Considering all the 33 diarrheic E. coli isolated on CHROMagarTMSTEC, there were altogether 16 
different serotypes. These included: O3, O104, O16, O25, O9, O8, O175, O101, O111, 055, 026, 0182, 
O186, O9, O33 and NT (Non - Typeable). Serotypes O104 (5/33, 15%) and O55 (6/33, 18%) were 
dominant serotypes among the tellurite resistant diarrheic E. coli isolated on CHROMagarTMSTEC 
(Figure 4:4). All the E. coli isolates that belonged to serotypes O104, and O55 were EAggEC and 
EPEC respectively. 
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Figure 4:4 Bar graph showing the serotype distribution of diarrheic E. coli serotypes isolated from the stool with and 
without enrichment on CHROMagarTMSTEC. 
‘NT’ means non-typeable, the isolate could not be serotyped using the available antisera as used at the 
Centre for Enteric Disease, National Institute of Communicable Disease, Johannesburg. 
4.4.2 Sorbitol fermentation property of diarrheic E. coli 
Of the 33 tellurite - resistant diarrheic E. coli isolated on CHROMagarTMSTEC, 45% (15/33) were 
non – sorbitol fermenting. Of the 15, seven were EPEC while seven were EAggEC (Table 4.1). Of 
the five STEC isolates, only one was non-sorbitol fermenting. 
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Pathotype Immunoassay TSB 
enrichment 
Sorbitol 
271 - O55 eae, bfp Typical EPEC - - - 
722.2 - O55 eae, bfp Typical EPEC - + - 
722.1 - O55 eae ,bfp Typical EPEC - + - 
279 - O55 eae, bfp Typical EPEC - - - 
344 - O55 eae, bfp Typical EPEC - + - 
345.1 - O55 eae, bfp Typical EPEC - + + 
291 - O182 eae Atypical EPEC - - + 
286 - O111 eae Atypical EPEC - + + 
600 + NT eae Atypical EPEC - + + 
15.1 + O26 eae Atypical EPEC - - - 
284 - O25 eae Atypical EPEC - - + 
15.2 + O26 eae Atypical EPEC - - - 
63.2 - O1 daaC DAEC - - + 
689 - O175 aat EAggEC - + - 
326 - O16 aat EAggEC - + - 
229.2 - O104 aat EAggEC - - - 
229.1 - O104 aat EAggEC - - - 
473 - O33 aat EAggEC - + + 
371.1 + O25 aat EAggEC - + - 
336 - O175 aat EAggEC - + + 
229 - O104 aat EAggEC - - - 
733 - O104 aat EAggEC - + - 
502 - O9 aat EAggEC - + + 
688 - O3 aat EAggEC - + + 
480 - O8 aat EAggEC - + + 
250 - O175 aat EAggEC - - + 
207 - O104 aat EAggEC - - + 
696 - O175 aat EAggEC - + + 
29.4 - O186 stx1, eae STEC - + + 
29.5 - O186 eae, stx1 STEC - + + 
602 - O101 eae, stx1, stx2 STEC - + - 
232.1* - NT stx1 STEC Shiga toxin 1 + + 
73* - NT stx1 STEC Shiga toxin 1 + + 
 EAggEC-enteroaggregative E. coli, STEC-Shiga-toxin producing E. coli, EPEC-enteropathogenic E. coli, 
DAEC-diffusely adherent E. coli, NT-non typeable. 
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4.4.3 Antibiotic Susceptibility of STEC and other DECs from stool in GSH 
There was a 100% agreement between the MIC data we obtained from using the VITEK® 2 
automated system and the broth microdilution method. 
Overall, of the thirty-three diarrheic E. coli we isolated from stool in GSH with and without 
enrichment, 55% (18/33) were resistant to ampicillin (AMP), 3% (1/33) to tazobactam – piperacillin 
(TZP), 6% (2/33) to cefuroxime (CXM), 3% (1/33) to cefoxitin (FOX), 21% (7/33) to nitrofurantoin 
(NIT), 9% (3/33) to cefuroxime-axetil (CXA), 3% (1/33) to tigecycline (TGC) and 3% (1/33) to 
ciprofloxacin (CIP) All the isolates in this study were resistant to trimethoprim – 
sulphamethoxazole (SXT) while none was resistant to a third-generation cephalosporin (Figure 
4:5). The cluster of five atypical EPEC that belonged to serotype O55 had distinct antimicrobial 
resistance patterns despite being of the same serotype. The cluster of five serotype O104 EAggEC 
strains were noted within a collection period of 38 days, and had similar antimicrobial 
susceptibility patterns (Resistance to only SXT). 
Figure 4:5 Bar graph showing the  percentage of resistant isolates to the different antibiotics. 
Only three isolates were Multidrug-resistant, one of which (EAggEC, serotype O25) was resistant 
to six antibiotics while the atypical (serotype O182) and typical EPEC (serotype O55) were 
resistant to three and four antibiotics respectively. The commonest resistance profile involved 
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resistance to only ampicillin (Table 4.2). All the STEC were susceptible to all the antibiotics 
included in this study except SXT. 
Table 4.2 Resistance profiles of Diarrheic E. coli obtained with and without Tryptic Soy Broth (TSB) enrichment. 
Isolate ID Serotype Resistance Profile Pathotype 
336 O175 AMP EAggEC 
279 O55 AMP Typical EPEC 
480 O8 AMP EAggEC 
696 O175 AMP EAggEC 
688 O3 AMP EAggEC 
326 O16 AMP EAggEC 
271 O55 AMP AMC CXA Typical EPEC 
291 0182 AMP CXM CXA FOX atypical EPEC 
371.1 O25 AMP AMC TZP CXM CXA FOX EAggEC 
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4.5 Discussion 
The main findings of this study were; (1) Five STEC, twelve EPEC, one DAEC, and fifteen EPEC 
strains were missed using the routine laboratory diagnostic strategy at the GSH, (2) All the 
diarrheic E. coli isolated in this study were resistant to trimethoprim-sulphamethoxazole while 
55% (18/33) were resistant to ampicillin. 
Prevalence of tellurite resistant diarrheic E. coli in stool 
The inhibitory action of potassium tellurite on coliforms was first reported by Fleming in 1940.30 
Tellurite-containing media have been routinely used to screen for STEC31, but not the other 
pathotypes. This is because the commonly reported STEC serotypes have a similar characteristic 
of being tellurite resistant. However, Hirvonen et al., 2012 reported the formation of mauve 
colonies by other tellurite resistant diarrheic E. coli on this medium.20 Of the 733 stool samples 
processed in this study, 33 (5%) were tellurite-resistant diarrheic E. coli. However, tellurite media 
have limited ability to select for STEC. In a study conducted on STEC from human, animals and 
food in Austria, the prevalence of tellurite resistance amongst STEC was 26% - therefore 74% of 
the STEC would not be detected by the tellurite-containing medium.32 Tellurite resistance is 
associated with high virulence and antimicrobial resistance among diarrheic E. coli.32 
Recovery of E. coli from tellurite-containing solid media may select for strains carrying tellurite 
resistance determinants on plasmids (IncHI1,IncHI2, IncP) that are known to harbour multiple 
antibiotic resistance determinants.33,34 Commercial selective media such as CHROMagarTMSTEC 
and Sorbitol MacConkey with cefixime and potassium - tellurite use this property to select STEC 
O157:H7 and other pathogenic STEC. This is the first study documenting the prevalence of 
tellurite resistant STEC in South Africa. There was a relatively low prevalence of tellurite-resistant 
diarrheic E. coli in stool samples submitted to NHLS, Groote Schuur Hospital. We were unable to 
determine the prevalence of non-tellurite-resistant STEC in this study.  
Missed laboratory detection and characteristics of STEC 
Five STEC were detected in this study. All the five were detected after enrichment in TSB, and 
none was obtained by directly streaking on CHROMagarTMSTEC. Overall, the number of 
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diarrheic E. coli obtained after enrichment in TSB was significantly higher than the number 
obtained without (p=0.004). This may suggest that enrichment in TSB may be a better method of 
recovering STEC (and other pathotypes) from a stool sample. The STEC diagnostic strategy 
employed by the NHLS clinical laboratory at the Groote Schuur Hospital targets only the O157 
STEC. It is based on the non-sorbitol fermenting attribute of STEC O157:H7. However, not all the 
E. coli O157 are non-sorbitol fermenting. Therefore, this strategy would miss the non-O157 STEC
and sorbitol-fermenting O157: NM (non-motile) (O157 STEC with no H-antigen). This would 
have public health implications in S. Africa because the 1990 STEC outbreak was caused by STEC 
O157 :NM.35 Therefore, the five non- O157 STEC that we report in this study would have been 
missed. The low rate of STEC isolation could be due to a number of reasons: (1) loss of stx genes, 
since patients with diarrhoea may have had the condition for more than a week by the time they 
are referred from a primary or secondary health care centre to Groote Schuur hospital. (2) Criteria 
for specimen selection for STEC testing may hinder STEC diagnosis. For example, many 
infections are missed due to testing only children, only those presenting with bloody diarrhoea 
(blood and or white blood cells in the stool) or only testing specimen submitted in the summer 
months.11 (3) Not all stx primers can detect all the stx gene variants.15 (4) Low prevalence of STEC 
in stool samples processed especially if the stool specimens are not from patients presenting with 
bloody diarrhoea, or HUS. There are higher chances of recovering STEC from the stool of patients 
with bloody diarrhoea or HUS as opposed to those without.36 In South Africa, like in many 
African countries, there may be a lower prevalence of STEC as compared to America and Europe. 
This has been thought to be related to the type of diet given to ruminants in America and Europe 
that favour the proliferation of STEC in cattle. This STEC later gets disseminated to the human 
population via the fecal-oral route.37 
It is important to detect STEC in stool because the use of antibiotics such as the quinolones leads 
to bacterial lysis thus increasing the chances of HUS in affected patients.38 Four of the five STEC 
detected in this study carried the stx1 genes. Possession of stx2 genes has been associated with the 
more severe form of illness.5,6 Also, we detected eae in three of the five STEC, while two did not 
possess the eae gene. The eae gene which is located in the locus for enterocyte effacement (LEE) 
codes for the intimin protein which is necessary for the formation of attaching-effacing (A/E) 
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lesions in the intestinal tract.39 STEC that carries eae (LEE-positive STEC) has been shown to cause 
more severe disease as compared to STEC without any attachment protein (LEE-negative STEC). 
In the two STEC where we did not detect the eae gene, it could be due to the two strains carrying 
a different variant of eae other than eaeA that was targeted in this study. 
Serotypes of STEC 
Per the manufacturer of CHROMagarTMSTEC, the commonly encountered STEC serotypes 
should form mauve coloured colonies on this medium. However, the serotypes categorised as 
“common” (O157, O26, O45, O145, O111, O121, and O103) were categorised as such, based on 
studies conducted in developed countries. This is partly because there have been fewer reports 
of STEC in Africa as opposed to America and Europe. In this study, STEC belonged to serotypes 
O101 and O186. These serotypes were not detected in an earlier study conducted at the NICD 
(2006 to 2009) which screened 2378 diarrheic E. coli isolates. The 14 STEC identified in that study 
belonged to serotypes O4, O5, O21, O26, O84, O111, and O157.4  
Other related studies reported STEC serotypes O8 and O9 in pigs in South Africa40; while O104 
was reported in humans albeit without the stx genes.10 So, the serotypes of STEC reported in this 
study are rarely reported in South Africa. 
We did not detect any E. coli O157:H7,possibly because some of the non-sorbitol fermenters were 
E. coli O157: H7 but without the stx genes; we only serotyped virulence gene positive non-sorbitol
fermenting strains. The Centre for Disease Control (CDC) of the USA recommends that E. coli 
O157: H7 always be considered of public health importance even when the stx genes are not 
detected.11 This is because the presence of this serotype could indicate a previously undetected 
STEC O157:H7 infection.11  High sensitivity for the STEC serotype O157 has been previously 
reported for CHROMagarTMSTEC.18  
Antimicrobial resistance of STEC 
The STEC detected in this study were only resistant to SXT. This finding is similar to a 2011 study 
that was conducted in Kenya that reported a high level of resistance to SXT among STEC.41 
Contrary to other studies, for example in Mexico42, the STEC in this study were susceptible to 
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ampicillin. The susceptibility of STEC to antibiotics is important because antibiotics are often used 
to decolonize long-term STEC carriers, and to treat invasive STEC disease43. However, the use of 
cell lysing antibiotics such as quinolones to treat invasive STEC infection has been linked with 
progression to HUS.38 
Cultural characteristics of tellurite resistant STEC on sorbitol MacConkey 
Sorbitol – negative STEC O157:H7 have been associated with more cases of HUS worldwide than 
other STEC serotypes.44-48 However, STEC O157:H7 is not the only sorbitol – negative STEC or 
STEC that has been associated with HUS.49 Others include O111, O145, O45, O26, and O104. Of 
the five STEC reported in this study, only one was non-sorbitol fermenting and belonged to 
serotype O101. Since failure to ferment sorbitol is the criteria used to screen for O157 STEC at the 
Groote Schuur Hospital, all the five STEC detected in this study would have been missed. This is 
because even the non-sorbitol fermenting non-O157 STEC would have tested negative for the 
O157 surface antigen by latex agglutination. 
Shiga-toxin production by STEC 
Using immunochromatography, we confirmed Shiga-toxin production by two strains which both 
carried the stx1 genes and produced Shiga toxin 1. The other three stx gene-positive isolates tested 
negative for Shiga-toxin production. Despite possessing the stx genes, they were not expressed 
in the three strains. The production of Shiga toxin 2 by STEC has been associated with more severe 
illness5,6 since Shiga-toxin 2 is 1000 times more potent than Shiga-toxin 1.6 
Missed laboratory detection and characteristics of EAggEC, EPEC, and DAEC. 
At the Groote Schuur Hospital, stool from diarrhoea patients is not routinely screened for 
diarrheic E. coli. The current protocol stipulates the use of sorbitol MacConkey to screen for only 
the non-sorbitol fermenting O157 STEC. The other pathotypes including EAggEC, EPEC and 
DAEC that were isolated in this study on CHROMagarTMSTEC would have been missed if sorbitol 
MacConkey had been used instead. CHROMagarTMSTEC favoured the growth of the other 
tellurite resistant diarrheic E. coli pathotypes. This medium does not favour the growth of the 
tellurite susceptible diarrheic E. coli, and so those are not reported in this study. Of all the 33 
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diarrheic E.coli strains isolated on CHROMagarTMSTEC, 45% ( 15/33) were EAggEC, 18% (6/33) 
were atypical EPEC, 15% (5/33) were typical EPEC, and 3 % ( 1/33) were DAEC. No enteroinvasive 
E. coli (E. coli) were detected. This finding is in agreement with an earlier study which showed
that EAggEC were most likely to be cultured from stool since they cause a more persistent form 
of diarrhoea.10 
Serotypes of EAggEC, EPEC, and DAEC 
CHROMagarTMSTEC favours the growth of tellurite resistant E. coli (forming mauve colonies) 
irrespective of whether they carry the stx genes or not. Of the 16 diarrheic E. coli serotypes that 
were isolated using CHROMagarTMSTEC in this study, only serotypes O111, O104 and O26 were 
previously reported to be detectable on this medium by studies conducted in Europe.18,20 In this 
study, we report the detection of the other tellurite resistant serotypes including O16, O175, O182, 
O186, O25, O3, O33, O175, O8, O9, O55, and O101 on CHROMagarTMSTEC. The dominant tellurite 
resistant diarrheic E. coli serotypes we identified in this study were O104 (15%), and O55 (18%). 
The cluster of six serotype O55 EPEC had clearly distinct antimicrobial resistance patterns and so 
was not an outbreak cluster. Since the cluster of five serotype O104 EAggEC strains were noted 
within a collection period of 38 days, and had the same antimicrobial susceptibility pattern, they 
are possibly an outbreak cluster of EAggEC. Further molecular epidemiology testing would be 
needed to confirm this.  
Considering the recent German outbreak caused by an enteroaggregative- haemorrhagic E. coli 
strain, it is worth further investigating the epidemiology of enteroaggregative O104 at primary 
health care settings, especially among children. In the wake of the German outbreak, Tau et. 
al,2011 screened all E. coli O104 that had been associated with human diarrhoea and were 
received at the NICD between 2004 and 2011, for stx genes.50 These isolates lacked the stx genes. 
Of the seven E. coli O104 isolates in that study, five were EAggEC, while two were EPEC. None 
of the E. coli isolates was STEC. 
Antimicrobial resistance of EAggEC, EPEC, and DAEC 
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It’s recommended that E. coli be tested for susceptibility to ampicillin, nalidixic acid, 
ciprofloxacin, tetracycline, chloramphenicol, gentamicin, ceftriaxone, and trimethoprim – 
sulfamethoxazole since these antimicrobials are clinically relevant for the management of 
community and hospital acquired E. coli infections. 
EAggEC, EPEC, and DAEC in this study showed resistance to SXT (100%, 28/28) and Ampicillin 
(64%, 18/28). These findings are similar to reports from Kenya which showed a high prevalence 
of resistance to SXT among intestinal E. coli.51 In the Kenya study, daily prophylactic use of SXT 
led to corresponding resistance to SXT by the enteric E. coli.  
Of the 15 EAggEC isolates in this study, five were resistant to ampicillin while one was resistant 
to six antibiotics including ampicillin. There are increasing reports of resistance to multiple 
antibiotics among EAggEC.52 Altogether, three strains were multidrug resistant with one 
(EAggEC serotype O25) being resistant to six antibiotics, while the atypical EPEC strain (serotype 
O182) was resistant to four antibiotics, and the typical EPEC strain (serotype O55) resistant to 
three antibiotics. Even though they are few, measures need to be put in place to avoid 
dissemination of such strains in the clinical setting.  
Cultural characteristics of tellurite resistant EAggEC, EPEC, and DAEC on sorbitol MacConkey 
Of the 33 diarrheic E. coli isolated on CHROMagarTMSTEC, 15 (45%) were non-sorbitol 
fermenting. Of the 15 non-sorbitol fermenting diarrheic E. coli isolated in this study, seven were 
EPEC (out of 12 EPEC in total), while seven (out of 15 EAggEC in total) were EAggEC. Only one 
of the non-sorbitol fermenting diarrheic E. coli was STEC. A similar study conducted in Tanzania 
reported a 14% prevalence of non-sorbitol fermenting E. coli in 1049 human stool and non-human 
samples.53 This is higher than the 2% (15/733) prevalence of non-sorbitol fermenting E. coli 
reported in this study. The high number of non-sorbitol fermenting EAggEC can be explained by 
the fact that serotype O104 is one of the prevalent non-sorbitol fermenting serotypes.18 
Limitations of this study 
CHROMagarTMSTEC only permits the growth of tellurite resistant STEC and not the tellurite 
susceptible strains.  
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This study did not have a long sampling timeframe, and not all children that presented with 
diarrhoea may have had stool specimens taken. Only diarrheic E. coli that possessed virulence 
genes were characterised; therefore, we might have missed strains that lost the virulence genes. 
4.6 Conclusions 
We suggest that a new screening approach is required to detect STEC in this setting. The use of 
sorbitol MacConkey at the NHLS laboratory, Groote Schuur hospital to screen for possible STEC 
would lead to failed detection of the non-O157 STEC and of sorbitol-fermenting O157 STEC. None 
of the non-sorbitol fermenting E. coli strains reported in this study belonged to serotype O157:H7. 
The use of CHROMagarTMSTEC coupled with an enrichment step enables detection of both O157 
and non-O157 STEC in addition to allowing the detection of the other diarrheic E. coli pathotypes. 
In this study, we could detect EAggEC, EPEC, and DAEC. Further work is required to determine 
what proportion of STEC (and other pathotypes) are tellurite susceptible and would be missed 
with this strategy.  
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5 Proteomic comparison of three clinical diarrhoeagenic drug-




Introduction: Shiga-toxin-producing Escherichia coli (STEC) and Enteropathogenic Escherichia coli 
(EPEC) are key diarrhoea-causing foodborne pathogens.  
Objective: To investigate the use of high-throughput mass spectrometry-based proteomics and 
transmission electron microscopy of isolates grown on CHROMagarTMSTEC solid media culture, 
to compare the proteomes and morphotypes of three clinical EPEC/STEC strains isolated from 
patients with diarrhoea. 
Methods: Here, we used mass spectrometry-based proteomics to characterise the virulence and 
antimicrobial resistance protein profiles of three clinical pathogenic E. coli isolates (two EPEC [one 
of which was resistant to ciprofloxacin] and one STEC) cultured on CHROMagarTMSTEC solid 
media after minimal laboratory passage.  
Results: We identified a total of 4767 unique peptides from 1630 proteins groups across all three 
clinical E. coli strains. Use of a label-free proteomic approach also allowed the identification of 
virulence and drug resistance proteins unique to each of the clinical isolates. The B subunit of 
Shiga toxin, ToxB, was uniquely detected in the STEC strain only and additionally several other 
virulence factors including SheA, OmpF, OmpC and OmpX were significantly more abundant in 
the STEC strain. The ciprofloxacin resistant EPEC isolate possessed reduced levels of key 
virulence proteins compared to the ciprofloxacin susceptible EPEC and STEC strains.  
Conclusions: Data presented here indicates that propagation of clinical isolates on a relevant solid 
medium followed by mass spectrometry analysis represents a convenient means to assess in a 
quantitative manner virulence factors and drug resistance determinants that might other wise be 
lost through extensive in vitro passage in enteropathogenic bacteria.  
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5.2 Background 
Infections by pathogenic intestinal Escherichia coli constitute a major cause of worldwide 
morbidity and mortality. Diarrheagenic E. coli outbreaks are frequent in developing countries, 
resulting in several thousand deaths per year1 and enormous economic losses due to trade 
sanctions.2 Additionally, there is increasing concern regarding the occurrence of diarrhoeagenic 
E. coli outbreaks in developed countries.3-5 A recent example is the 2011 international outbreak of
a Shiga-toxin-producing E. coli (STEC) strain (STEC O104: H4) which originated in Germany and 
led to a total of 3816 cases including more than fifty deaths.6  
Different types of virulence factors have been described in STEC and Enteropathogenic E. coli 
(EPEC) which have been classified mainly into adhesion group, toxin group, and the type III 
secretion group. These virulence factors are encoded by over 75 genes, including genes carried 
on the Locus of Enterocyte Effacement (LEE) and other Pathogenicity Islands.7 Importantly, STEC 
and EPEC share particular virulence factors such as the LEE pathogenicity island.8 Intimate 
attachment due to intimin encoded by the LEE genes and the production of Shiga toxin leads to 
heavy colonisation by STEC with levels reaching 90% of all aerobic faecal flora in the intestinal 
tract.9,10 However, the emergence of human infections caused by LEE-negative STEC strains 
indicates the presence of other pathogenicity islands or plasmids that carry additional virulence 
factors.11  
Recently, the co-occurrence of antibiotic resistance and virulence of pathogenic bacteria including 
E. coli has been a matter of great concern worldwide12, particularly in developing countries.1 The
link between bacterial antibiotic resistance and virulence remains controversial.13 For example, 
previous reports have suggested reduced virulence among multi-drug resistant E. coli isolates 
relative to sensitive strains.14 However, other authors have emphasised the fact that acquisition 
of antimicrobial resistance does not necessarily compromise microbial fitness.15 Consistent with 
this notion, recent epidemiological data indicate that antibiotic resistance and virulence factor 
carriage are linked in E. coli populations in some community settings.16 A related study showed 
that the expression of virulence factors led to the formation of an antibiotic-tolerant 
subpopulation17 and that antibiotic treatment indeed may select for virulence.18 In addition to 
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drug resistance, treatment failure on the use of antibiotics in a clinical setting could be due to 
tolerance and or persistence to antibiotics.19  
Mass spectrometry-based proteomics has been successfully employed to explore aspects of both 
bacterial virulence and antimicrobial resistance.20-22 Mass spectrometry data has led to the better 
understanding of EPEC and STEC pathogenesis and identification of markers for laboratory 
diagnoses of these pathogens.23 Recently, Pettersen et al.24, employed label-free quantitative 
proteomics to characterise five extraintestinal pathogenic E. coli strains purified from clinical 
blood cultures associated with sepsis and urinary tract infections. Importantly, the report 
included a further comparison of the E. coli strains cultivated in blood culture on two different 
solid media, revealing differential responses in strains grown in the different culture 
environments.24 Here, the use of high-throughput mass spectrometry-based proteomics and 
transmission electron microscopy of isolates grown on CHROMagarTMSTEC solid media culture 
was investigated. Consequently, the proteomes and morphotypes of three clinical EPEC/STEC 
strains isolated from patients with diarrhoea were compared. 
5.2.1 Aims and objectives 
To investigate the use of high-throughput mass spectrometry-based proteomics and transmission 
electron microscopy of isolates grown on CHROMagarTMSTEC solid media culture, to compare 




5.3.1 E. coli isolation, identification, and antimicrobial susceptibility testing 
Stool samples were collected between June 2014 and March 2015 from patients presenting with 
diarrhoea at Red Cross War Memorial Children’s Hospital. Specimens were analysed at the 
clinical microbiology laboratory at Groote Schuur Hospital and the University of Cape Town, 
medical microbiology laboratory. Stool samples were inoculated onto CHROMagarTMSTEC plates 
(CHROMagar, Paris, France). Discrete, strongly mauve colonies were picked and streaked out on 
LB (Luria-Bertani) agar and MacConkey agar with crystal violet (Green point Media, NHLS, 
Albertynshof) and incubated for 18h. E. coli was identified as lactose-positive, oxidase-negative, 
spot indole-positive, and pyrrolidonyl arylamidase (PYR)-negative. Identification was confirmed 
using the VITEK® 2 automated systems (bioMérieux, USA).  
The minimum inhibitory concentration (MIC) was determined with broth microdilution using 
the Trek sensititre GNX2F plates (Thermo Fischer Scientific, USA). The MIC values were 
interpreted following the Clinical Laboratory Standards Institute guidelines for antibiotic 
susceptibility testing using the WHONET software version 5.6.25 
5.3.2 Polymerase chain reaction detection of stx1, stx2, and eaeA 
We selected three suspect STEC isolates (from three different stool specimen) that formed mauve 
colonies on CHROMagarTMSTEC. To determine the presence of the eaeA and stx genes, discrete 
colonies were streaked onto 2% blood agar and incubated for 18h at 35 ̊C before nucleic acid 
extraction.26 An endpoint PCR was done to detect eaeA on a 2720 Thermal Cycler detection 
platform (Applied Biosystems, Foster City, CA).  
The following primers were used 
Table 5.1). 
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Table 5.1 Primers used for conventional PCR to detect the eaeA gene 
Target gene PCR primer Primer sequence PCR product 
eaeA eaeA-F TCAATGCAGTTCCGTTATCAGTT 482bp 
eaeA-R GTAAAGTCCGTTACCCCAACCTG 
To detect stx1 and stx2, a real-time PCR reaction was set up on a LightCycler480 II (Roche 
Molecular Systems, Pleasanton, CA) instrument with stx1 and stx2 primers at a concentration of 
0.45µM, probes (Inqaba Biotec Laboratory, South Africa) as previously described27 The following 
primers and probes were used (Table 5.2). 
Table 5.2: Primers and probes used in the Real-Time PCR assay to detect stx1 and stx2 targets. 
Primers/probes  5́ Sequence 3́ 
stx1a-primer CAAGAGCGATGTTACGGT 
stx1b-primer AATTCTTCCTACACGAACAGA 
stx1f-probe CTGGGGAAGGTTGAGTAGCG Fluorescein 
stx1r-probe CAL Fluor 610 CCTGCCTGACTATCATGGACA 3' phosphor 
stx2a-primer GGGACCACATCGGTGT 
stx2b-primer CGGGCACTGATATATGTGTAA 
stx2f-probe CTGTGGATATACGAGGGCTTGATGTC Fluorescein 
stx2r-probe CAL Fluor 610 ATCAGGCGCGTTTTGACCATCT 3' phosphor 
5.3.3 Electron Microscopy 
Sample preparation and initial fixation: Three sweeps of bacteria from CHROMagarTMSTEC 
were fixed in a 2.5% solution of glutaraldehyde in phosphate buffer (pH 7) with vortexing. The 
suspension was then pelleted by centrifugation at 4000 rpm for five minutes and then 
resuspended in buffered, 2.5% glutaraldehyde. The fixed bacteria were then washed twice with 
sterile 1x phosphate buffered saline (PBS) with the supernatant discarded after centrifugation at 
4000 rpm after each wash. After the second wash, the pellet was re-suspended in an equal amount 
of 4% agarose (30µl) and allowed to solidify. 
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High-Pressure Freezing: The glutaraldehyde fixed, agarose-embedded samples were thinly sliced 
(0.2mm) and loaded onto 6mm diameter freezing hats. Hexadecene was used as a filler, and the 
samples were high-pressure frozen using the Leica HPM100. 
Freeze Substitution: The cryo-fixed specimens were immersed in a dry, pre-cooled (-85oC) 
cocktail of 2% osmium tetroxide (OsO4) in anhydrous acetone in a Leica AFS Automatic Freeze-
Substitution unit. After 60h, the temperature was set to rise by 10 ̊C every hour to –60 ̊C. The 
samples were left for 8h at this temperature. The temperature was gradually raised to room 
temperature, and the osmium tetroxide solution was replaced with acetone. The samples were 
washed with absolute acetone and prepared for embedding in Spurrs resin. The samples were 
infiltrated with increasing concentration of resin over a period of 3 days, and once in 100% resin. 
They were then positioned in molds and allowed to polymerize at 60 ̊C. 
Ultramicrotomy and transmission electron microscopy: Approximately 100-120nm sections were 
cut using a Leica EM UC7 and collected on copper grids. The samples were stained with uranyl 
acetate and lead citrate and viewed using an FEI Tecnai F20 transmission electron microscope 
operating at 200kV. Images were collected using a 4Kx4K Gatan CCD camera. We considered five 
sections of view at low magnification and five sections of view at 19,000X magnification. From 
these five sections, we observed each of the sections in detail at 100,000X magnifications. From 
each of these sections, we examined all the cells in the field of view. 
5.3.4 Protein extraction 
Single colonies of isolates (16.5, 29.4 and 424.2) described above were selected from 
CHROMagarTMSTEC plates and directly streaked onto a new Luria-Bertani agar plate and 
incubated for 48h at 37oC. After incubation, a single loop of cells was scrapped from the solid 
media, suspended in 1% PBS (Sigma-Aldrich, St Louis, USA) and cells were broken using an 
ultrasonic cell disruptor (Virsonic; 6 x 30s on ice with a 3.2mm microprobe operated at 20% output 
power). Chloroform in methanol (1:1; v:v) was added, and the mixture was vortexed for 1 minute 
and centrifuged at 4000 rpm for 30 min. The upper phase was carefully removed, and 100% 
methanol was added. The whole cell lysate proteins were then pelleted by centrifugation at 4000 
152 
rpm. Air dry protein pellets were suspended in denaturation buffer (6M urea, 2M Thiourea, 
10mM Tris buffer, pH 8.0). Protein was quantified using a modified Bradford assay.28 For in-
solution trypsin digest, 200 μg total protein was reduced with 1 mM 1,4-dithiothreitol (DTT) for 
1 hour with agitation and alkylated with 5.5 mM 3-iodoacetamine (IAA) for one hour in the dark. 
Proteins were diluted with four-fold ammonium bicarbonate (ABC) (20 mM) before adding 
sequencing grade trypsin (NEB, New England Biolabs, UK, Ltd) supplemented with 20 mM 
CaCl2 (1:50; w/w) and digested overnight at 37 ̊C with agitation at 30rpm. Proteolysis was 
quenched by addition of trifluoroacetic acid (TFA) (Sigma-Aldrich). Before LC-MS/MS, peptides 
were dried and suspended in 0.1% formic acid (FA) and 2% acetonitrile (ACN) and cleaned up 
using stage tips.  
5.3.5 Mass spectrometry analysis 
Data-dependent acquisition of tandem mass spectrometry was performed on Orbitrap Q-
Exactive mass spectrometer (Thermo Scientific) in a data-dependent manner, coupled to the 
Dionex Ultimate 3500 RS nano UHPLC (Thermo Scientific). Six hundred nanogram of peptide 
was loaded in technical triplicate onto an in-house packed pre-column (100 μm ID × 40 mm) 
packed with 5µm Luna C18 (Phenomenex 04A-4398) connected to an in-house packed analytical 
column (75 μm × 400 mm) packed with C18 3.5μm Aeris Peptide (Phenomenex 04A-4507) for 
liquid chromatography separation. The flow rate was set to 400nl/min with the gradient of 8% to 
40% ACN for 118 minutes using Dionex curve 7, then increasing to 80% in 5 minutes. To wash 
the column, ACN was maintained at 80% for 10 minutes followed by a column equilibration at 
2% ACN for 10 minutes. A “top ten” method with 30 s dynamic exclusion was used to acquire 
mass spectra, with automatic switching between MS and MS/MS scans. 
5.3.6 Data processing 
A total of nine MS raw data files were processed together in the MaxQuant (version 1. 5.0.30). 
Andromeda search engine integrated into the MaxQuant Suite29 performed the spectra search 
against the E. coli O157: H7 proteome downloaded from Uniprot (10 December 2015). The search 
criteria were set as follows: tryptic digest with two missed cleavages; fixed modification 
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carbamidomethylation (C); variable modification of Acetyl (protein-N-term) and Oxidation (M). 
The raw mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium via the PRIDE partner repository with the dataset identifier PXD005546. 
5.3.7 Data analysis 
We further analysed the Maxquant output data with the Perseus module. RAW files were 
analysed using the MaxQuant suite together with Perseus to determine significantly regulated 
proteins. Unique proteins (present in at least two strains, two or more replicates based on 
intensity values, two ≥ peptides per protein) in each isolate were excluded and analysed 
separately. Mean values of technical replicates were calculated, log transformed, and used in 
further analyses. Principal component analysis (PCA) was done by Perseus. One-way analysis of 
variance (ANOVA) with permutation-based FDR correction for multiple hypothesis testing (p-
value cut-off 0.01) was used to compare protein LFQ intensities of all three strains in this study. 
Comparative analysis between strains was performed using a paired Student’s t-test with p-
values of 0.01. P-values were used to identify significantly up/down-regulated proteins and 
pathways. The identified proteins were functionally categorised based on universal Gene 




5.4.1 Characterization of the clinical E. coli isolates 
5.4.1.1 Virulence profiles 
Three suspected STEC strains which formed bright mauve colonies on CHROMagarTMSTEC were 
selected. The strains were numbered 29.4, 16.5, and 424.2, respectively. Virulence gene profiling 
using an endpoint PCR assay and a real-time PCR assay revealed that only strain 29.4 possessed 
both the stx1 and eaeA genes while strains 424.2 and 16.5 possessed the eaeA gene only (Figure 5:1 
and Figure 5:2).  
Figure 5:1: Gel image for PCR to detect eaeA. 
Lane 1= 1kb Ladder, Lane 2= STEC strain ; Lane 3= ciprofloxacin resistant EPEC, Lane 4= 
ciprofloxacin susceptible EPEC; Lane 5= Negative control. 
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Figure 5:2 Showing the amplification curves for the stx positive mauve isolates on using the qPCR assay 
1-positive control (E. coli O157:H7 strain C4193-1), 2-STEC strain, 3-ciprofloxacin susceptible EPEC
strain, 4-ciprofloxacin resistant EPEC strain, 5-negative control.
None of the isolates carried stx2. Additionally, hemolysis assays established that strain 29.4 was 
non-haemolytic on 2% sheep blood agar, while both 16.5 and 424.2 were β-haemolytic. 
5.4.1.2 Drug resistance profiles 
All three strains were resistant to potassium tellurite and thus formed mauve colonies on the 
CHROMagarTMSTEC substrate. To characterise their drug resistance profiles further, the isolates 
were tested against a total of 19 antibiotics (Table 5.3). 
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Table 5.3: Minimum Inhibitory Concentrations (µg/µl) to selected antibiotics of three E. coli clinical isolates. 
Isolate/Antimicrobial STEC ciprofloxacin susceptible EPEC ciprofloxacin resistant EPEC 
Cotrimoxazole R R R 
320 320 320 
Ampicillin S S R 
2 4 32 
Cefuroxime S S S 
4 4 4 
Amoxicillin-clavulanic 
acid 
S S S 
2 4 4 
Ciprofloxacin S S R 
0.25 0.25 4 
Piperacillin/Tazobactam S S S 
4 4 4 
Cefotaxime S S S 
1 1 1 
Ceftazidime S S S 
1 1 1 
Cefepime S S S 
1 4 1 
Ertapenem S S S 
0.5 0.5 0.5 
Imipenem S S S 
0.25 0.25 0.25 
Meropenem S S S 
0.25 0.25 0.25 
Amikacin S S S 
2 2 2 
Gentamicin S S S 
1 1 1 
Tigecycline S S S 
0.5 0.5 0.5 
Nitrofurantoin S S R 
32 16 256 
Colistin S S S 
0.5 0.5 0.5 
Polymyxin B S S S 
0.25 0.25 1 
R=resistant, S=susceptible 
Strain 16.5 was resistant to a wide spectrum of antibiotics, including trimethoprim-
sulfamethoxazole, ciprofloxacin, ampicillin, and nitrofurantoin. Strain 29.4 and 424.2 were both 
resistant to trimethoprim-sulfamethoxazole. Even though all the strains were susceptible to 
cefepime, strain 424.2 showed a higher MIC (4 µg/µl) compared to strain 29.4 (1 µg/µl) and strain 
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16.5 (1 µg/µl). Based on these results, and for convenience in the text, strain 29.4 is hereafter 
referred to as the “STEC strain”, and strain 16.5 as “ciprofloxacin resistant EPEC strain” while 
strain 424.2 is referred to as the “ciprofloxacin susceptible EPEC strain”. 
5.4.1.3 Electron Micrographs of the three Isolates 
Proteomic data showed different levels of key cell envelope proteins including OmpC, OmpF and 
OmpA. Since low levels of OmpC coupled with higher levels of OmpF have been shown to 
influence bacterial response to antibiotic exposure30, we conducted electron microscopy on the 
three isolates to examine the difference in their cell envelope thickness and see if it correlates with 
the observed differences in the cell envelop proteins we detected. The three strains exhibited 
distinct cell envelope features on the electron micrographs (Figure 5:3).  
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Figure 5:3: Transmission Electron Microscopy images of strains ciprofloxacin resistant EPEC (A and B), 
ciprofloxacin susceptible EPEC (C and D) and STEC (E and F). 
The red arrows show the entire margin for the ciprofloxacin-resistant isolate as well as disrupted 
margins for the ciprofloxacin susceptible strains. 
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The STEC and ciprofloxacin susceptible EPEC isolates showed uniform (all cells examined) 
disruption of the cell envelope at 19,000X and 100,000X magnification. The ciprofloxacin resistant 
EPEC showed an intact cell envelope. The ciprofloxacin-resistant strain also showed significantly 
greater cell envelope thickness (mean cell envelope thickness of 64 nm (±1.4) while the STEC 
strain had a mean cell envelope thickness of 39.4 (±3.1) nm and the ciprofloxacin susceptible EPEC 
had a mean cell envelope thickness of 45.16 (±2.2) nm (Figure 5:4).  
Figure 5:4 Mean cell thickness of the Ciprofloxacin-resistant EPEC and the Ciprofloxacin susceptible strains. 
The ciprofloxacin susceptible EPEC showed sections of invagination of the cell envelope, which 
were not present in other strains. The outer membrane proteins OmpF and OmpC were 
significantly lower in the ciprofloxacin-resistant isolates, as compared to the ciprofloxacin 
susceptible isolates. Our preliminary observations establish a link between cell envelope 
thickness and higher levels of OmpF coupled with lower levels of OmpC. This, however, requires 
future research.  
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5.4.2 Global proteomic analysis 
LC-MS/MS analyses generated nine raw spectra (one for each triplicate- three for the STEC isolate, 
three for the ciprofloxacin-resistant EPEC, and three for the ciprofloxacin susceptible EPEC) and 
were analyzed in the MaxQuant environment which matched the spectral files to approximately 
19197 peptides.  
A good peptide read was noted for the STEC isolate triplicates. The relative abundance of 
peptides eluting from the column during the run showed a good gradient for both the MS and 
MS2 spectra (Figure 5:5).  
Figure 5:5 Mass spectral files (MS) showing relative abundance of peptides and peptide ions over time for one of the 
STEC isolate triplicates. 
The top panel shows the MS spectra while the second panel shows the MS2 spectra 
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A good peptide read was noted for the ciprofloxacin resistant EPEC isolate triplicate. The relative 
abundance of peptides eluting from the column during the run showed a good gradient for both 
the MS and MS2 spectra (Figure 5:6).  
Figure 5:6 Mass spectral files (MS) showing relative abundance of peptides and peptide ions over time for one of the 
Ciprofloxacin resistant EPEC isolate triplicates 
The top panel shows the MS spectra while the second panel shows the MS2 spectra 
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A good peptide read was noted for the ciprofloxacin susceptible EPEC isolate triplicate. The 
relative abundance of peptides eluting from the column during the run showed a good gradient 
for both the MS and MS2 spectra (Figure 5:7).  
Figure 5:7 Mass spectral files (MS) showing relative abundance of peptides and peptide ions over time for the 
Ciprofloxacin-susceptible EPEC isolate 
The top panel shows the MS spectra while the second panel shows the MS2 spectra 
We identified a total of 1630 proteins across all three strains: 1404 protein groups for the 
ciprofloxacin-resistant EPEC strain; and 1438 proteins groups for the ciprofloxacin susceptible 
EPEC strain; and 1440 proteins groups for the STEC strain. In order to improve proteome 
coverage and increase the number of proteins identified in our discovery analysis we prepared 
three separate stage tip preparations and analysed technical triplicates for each of the 3 clinical E. 
coli strains. Based on the LFQ intensities, the principle component analysis of the proteomics data 
(Figure 5:8) revealed that technical replicates were closely related, to each other, whereas the three 
different EPEC/STEC clinical E. coli strains were well separated.  
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Figure 5:8: Principle component analysis (PCA) component1 versus component 2 from proteome data of 3 
clinical E. coli strains. 
This PCA analysis reveals good reproducibility amongst the technical replicates of these clinical 
isolates clustered separately from each other. 
The overlap in protein groups amongst the three strains is shown in Figure 5:9. A total of 1238 
protein groups, accounting for approximately 85% of proteins, were identified in all three strains 
(common in all the three strains); the remaining protein groups being present in only one or two 
of the isolates.  
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Figure 5:9: Comparison of proteomes of clinical E. coli strains. Demonstrating the unique proteins in each 
strain as well as the overlap of proteins across all three strains.  
5.4.3 Overall comparison of E. coli strains. 
The strains possessed distinct protein profiles, with each producing a set of unique proteins 
that was not identified in the other two. Using strict criteria of unique protein identification, 
(absent in the other two isolates, present in two or more replicates in the single isolate based on 
LFQ intensity values, two ≥ peptides identified per protein group) we identified 28, 56, and 41 
unique protein groups for the ciprofloxacin-resistant EPEC, STEC, and the ciprofloxacin 
susceptible EPEC strain, respectively (The ProteomeXchange accession number is 
PXD005546 and password for access in the interim is <StecEpec2017!>). We then compared 
Label-Free Quantification (LFQ) intensities of 1627 proteins by using ANOVA with a 
permutation-based FDR correction for multiple hypothesis testing (cutoff FDR 1%). In this 
comparison, we identified 943 proteins with statistically significant quantitative differences in 
abundance across the three strains. We also applied a two-tailed t-test with an FDR of 1% when 
comparing each stain to each other.  
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We further analysed the proteome profiles of each strain and identified 41 virulence factors in the 
ciprofloxacin-resistant EPEC strain; 35 virulence proteins in the STEC strain and 46 virulence 
proteins in the ciprofloxacin susceptible EPEC strain (LFQ- intensity values in 2 or more 
replicates) (Table 5.4).  
Table 5.4 Virulence factors identified in each strain 
5.4.4 Comparing the ciprofloxacin-resistant EPEC strain to the STEC strain 
We identified 498 proteins with significant differential abundance between the ciprofloxacin-
resistant EPEC and STEC strains. A total of 220 proteins were significantly abundant in the STEC 
strain while 278 proteins were significantly more abundant in the ciprofloxacin-resistant EPEC 
strain (Figure 5:10a).  
Amongst these, we identified virulence factors and drug resistance associated proteins such as 
YeiP, Fdx, LolA, YaeT, OmpA as well as a number of putative lipoprotein family proteins which 
were significantly more abundant in the ciprofloxacin-resistant EPEC strain. We found the 
virulence factors including serine kinase family protein; OmpC; OmpF and OmpX were 
significantly more abundant in the STEC strain. OmpC, OmpF, and OmpX are outer membrane 
proteins central to the YebF export mechanism which play key roles in antimicrobial 
resistance.31,30 We also identified the virulence factors FepB, YbhA, amidohydrolase family of 
proteins, and Nudix family of proteins which were only in the ciprofloxacin-resistant EPEC 
strain.  
Virulence factor/strain 16_5 29_4 424_2 
Attachment 13 13 13 
Cell Lysis/ Cell invasion  4 4 4 
Invasion/ Iron acquisition 9 8 9 
Motility 1 1 6 
Proteolysis 5 0 0 
Type III secretion system 9 9 9 
Total  41 35 41 
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The silent hemolysin (SheA), which was differentially abundant in the STEC strain has been 
shown to have a cytocidal and apoptotic activity like the Shiga toxin but is prevalent in both 
pathogenic and non-pathogenic E. coli.32 Proteins involved in the formation of attaching and 
effacing lesions, that were significantly more abundant in the STEC strain, and are coded by genes 
located on a chromosomal pathogenicity island called the Locus of Enterocyte Effacement (LEE), 
this is discussed further in the text. The gene ontology (GO) analysis of the comparison of 
ciprofloxacin resistant EPEC to the STEC strain showed an enrichment of GO terms specifically 
for biological processes including iron regulation, transport and homeostasis while no significant 
GO enriched terms were enriched for the ciprofloxacin-resistant EPEC strain.  
5.4.5 Comparison of the STEC strain to the ciprofloxacin susceptible EPEC strain. 
We identified 383 proteins with significant differential abundance between the STEC strain and 
the ciprofloxacin-susceptible EPEC strain. We found that 191 proteins were significantly 
abundant in the STEC strain and 192 proteins significantly more abundant in the ciprofloxacin 
susceptible EPEC (Figure 5:10b). We found the siderophore-interacting protein, enterobactin 
synthetase component F and putative lipoprotein implicated in virulence to be significantly more 
abundant in the ciprofloxacin-susceptible EPEC strain. Virulence factors - LolA, BamD, BamC, 
OmpC, OmpX, putative lipoprotein, serine kinase family protein, OmpA family protein and ion 
protease were significantly more abundant in the STEC strain. Further, we identified virulence 
factors - flagellin, serine protease, EatA, FlgH, YbhA, FepB, CheY and hydrolase, NUDIX family 
protein only present in the ciprofloxacin-susceptible strain. Gene Ontology analysis of the 
ciprofloxacin-susceptible strain was based only on significantly abundant proteins and showed 
that five biological processes were enriched. These included regulation of glycogen metabolic 
processes, generation of precursor metabolites and energy, glucose metabolism, chemotaxis, and 
taxis. No metabolic processes were significantly enriched for the STEC strain when compared to 
the ciprofloxacin susceptible EPEC strain.  
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5.4.6 Comparison of the ciprofloxacin-resistant and the ciprofloxacin susceptible 
EPEC strains 
We identified a total of 543 proteins with significant differential abundance between the 
ciprofloxacin-resistant EPEC and the ciprofloxacin susceptible EPEC strain: 295 proteins were 
significantly more abundant in the ciprofloxacin-resistant EPEC strain, and 248 proteins were 
significantly more abundant in the ciprofloxacin susceptible EPEC strain (Figure 5:10c). We 
identified virulence factors OmpX, OmpC, EntF and a number of putative lipoproteins to be 
significantly more abundant in the ciprofloxacin susceptible EPEC strain. We identified 13 
virulence factors - LolA, YeiP, putative lipoprotein, OmpA family protein, BamC, BamA, DegQ, 
Lon, FepB and Fdx which were significantly more abundant in the ciprofloxacin-resistant strain. 
Furthermore, we identified four virulence factors, flagellin, EatA, FlgH, and SppA, uniquely 
identified in the ciprofloxacin-susceptible EPEC; and one virulence factor, the amidohydrolase 
family of proteins to be uniquely present in the ciprofloxacin-resistant strain.  
We found six biological processes enriched in the ciprofloxacin-resistant EPEC strain. These 
included: cellular response to an antibiotic (including proteins that mediate antibiotic resistance, 
e.g. TolB, PhoU, and DsbA); phosphate starvation; regulation of glucose and glycogen metabolic
processes; generation of precursor metabolites and energy and protein folding. Biological 
processes enriched in the ciprofloxacin-susceptible EPEC strain were chemotaxis and taxis. 
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Figure 5:10: Volcano plots demonstrating significant abundance with P-value of 0.01 and 2-fold change. 
a) Volcano plot of ciprofloxacin resistant EPEC and Shiga toxin producing E. coli strains, b)
Volcano plot of Shiga toxin producing and ciprofloxacin susceptible E. coli strain, c) Volcano
plot of ciprofloxacin resistant and susceptible EPEC strains.
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5.5 Discussion 
Growth on solid media followed by proteomic analysis enable identification of important 
virulence factors and antimicrobial  resistance mechanisms. 
To date, nearly all large-scale bacterial proteomics studies have been done on strains cultured in 
liquid growth media.33-35 However proteomic analysis of bacterial isolates grown on solid media 
are of particular interest; this provides an opportunity to study the proteomes of minimally 
passaged isolates as used in primary culture plates. For instances previous studies that employed 
similar proteomic approach to characterize the global response  of exponential phase E. coli 
O157:H7 Sakai grown under four steady-state conditions revealed a universal response to all 
tested condition that included the activation of the master regulator RpoS and the RcS 
phosphorelay system involved in the biosynthesis of the exopolysaccharide colanic, as well as 
down regulation of elements involved in chemotaxis and motility.36 Consistently, chemotaxis 
genes and proteins were amongst the heaviest down regulated in osmotically adapted cells.37 The 
authors advanced that chemotaxis and motility systems are most dispensable functions during 
steady-state growth at high osmolarity.37 Unlike liquid media, bacterial cells grown on solid 
media experience particular environmental conditions including high osmotic strength and 
dessication that ultimately results in a physiological and morphological transformation of the 
bacteria.38 We have detected a number of proteins implicated in cell motility and virulence more 
abundantly expressed in the ciprofloxacin susceptible EPEC.  
Of those, it is worthy to highlight proteins such as flagellar L-ring protein (FlgH), flagellin, 
flagellar motor switch protein (FliN), sensor histidine kinase (RcsC) that are all proteins 
associated with bacterial lateral flagella and inducible surfaces flagellar systems.39  Additionally, 
within the proteins unique to ciprofloxacin susceptible EPEC strain we have identified CheA, 
CheY and methyl-accepting chemotaxis protein III - chemotactic regulators involved in the 
transmission of sensory signals from chemoreceptors to flagellar motor components. Of interest, 
we did not observe the expected enrichment of osmoprotective proteins and reduced chemotaxis-
associated proteins as expected from solid medium growth.24 The ciprofloxacin-susceptible strain 
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displayed a distinguishable motility swarming/chemotactic profile which may be useful for 
identifying pathogenic E. coli.40  
Among the proteins exclusively identified in STEC is ZapE, a protein associated with cell division 
that seems not be essential in vitro but is required for growth under low-oxygen conditions and 
during an infectious process.41 The detection of proteins such as ZapE suggests that proteomic 
examination of bacteria could be a convenient means to characterise survival determinants with 
important roles during host invasion. In sum, the data presented here clearly indicates that 
limited laboratory passage on solid media followed by mass spectrometry-based proteomic 
analysis presents a valuable avenue to assess proteomic insight into clinical isolates in a 
quantitative manner, enabling identification of important virulence factors that might otherwise 
be missed/lost. 
CHROMagarTMSTEC allows the formation of mauve colonies of strains that are tellurite 
resistant42. Resistance to tellurite is encoded by the terZABCDEF gene cluster present on the 
pathogenicity islands of STEC43,44 and select for strains carrying virulence proteins45. Tellurium 
susceptibility is related to the lack of ter genes.44 We could detect TerA, TerE, TerC, TerB, TerD, 
TerW, and TerZ from CHROMagarSTEC isolates although it has been suggested that 
Enterohaemorrhagic E. coli (EHEC) O157:H7 clinical isolates lose the ter gene cluster during 
laboratory passage.43 
The three clinical E. coli strains in this study carried key virulence and antimicrobial resistance 
proteins. This is in agreement with an earlier study which showed the likely co-occurrence of 
virulence and antimicrobial resistance in individual isolates.16 Recovery of E. coli from tellurite 
containing solid media may select for strains carrying tellurite resistance determinants on 
plasmids (IncHI1,IncHI2, IncP) that are known to harbour multiple antibiotic resistance 
determinants46,47. Also, full or partial deletions of the TelR island (s) diminish the virulence and/or 
fitness of the EHEC O157:H7.43 Additionally, the ter cluster is significantly less widespread in the 
eae-negative STEC strains as compared to the eae-positive ones.48  
Comparative proteomic analysis reveals differential antimicrobial resistance mechanisms. 
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Fluoroquinolones are potent antimicrobial agents used clinically for the management of 
community-acquired and nosocomial infections.49 It is a critically important antimicrobial for 
human medicine.50 Our data showed that the ciprofloxacin-resistant EPEC isolate possesses 
reduced levels of key virulence proteins (e.g. motility, toxins, outer membrane proteins) 
compared to the ciprofloxacin susceptible EPEC strain and STEC strain. In particular, apparent 
losses of OmpF have been associated with increased resistance to multiple antibiotics including 
quinolones.51 Specifically, one study reported that the decreased expression of OmpF in a gyrA 
mutant strain did not affect the survival of the bacteria and could be responsible for the spread 
of high-level quinolone-resistant strains.51 Additionally, coupled with a lower abundance of 
OmpC and OmpF, the ciprofloxacin-resistant EPEC strain showed a significantly higher 
abundance of metallo-beta-lactamase family protein compared to the other two isolates. 
However, the detected MICs to cephalosporins and carbapenems reflect susceptibility to these 
antibiotics. Since in this study we used a quantitative approach, the levels of transcription and 
translation of genes coding for the metallo beta-lactamase may be insufficient for the resistance 
phenotype to be manifest. Furthermore, this strain showed higher levels of multidrug resistance 
proteins and of the ABC superfamily of efflux pump proteins that are chromosomally encoded 
and can cause resistance to multiple drugs when overexpressed.52 The detection of the 
dihydropteroate synthase protein could explain the high level of resistance to trimethoprim-
sulfamethoxazole in all the three strains; this agrees with previous studies investigating resistance 
to sulphonamides.53,54 SXT resistance has been associated with resistance determinants such as sul 
(sul1 and sul2 which encodes the dihydropteroate synthase) and dfrA (encodes the dihydrofolate 
reductase protein), class 1 integrons and mobile genetic elements.55 Overall, the ciprofloxacin 
resistant (multidrug resistant) strain carried more heavy metal and antibiotic efflux pump 
proteins than the susceptible strains, consistent with previous findings.56  
Correlation between levels of key cell envelope proteins , ompF, ompC and ompA with the 
observed cell envelope thicknesses 
The ciprofloxacin resistant isolate which is also multidrug resistant showed a thicker cell wall 
envelope as compared to the ciprofloxacin susceptible isolates.  This strain also had higher levels 
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of OmpA and lower levels of OmpF and OmpC as compared to the ciprofloxacin susceptible 
isolates. Interestingly, previous research has shown an association between high levels of OmpF 
and resistance to fluoroquinolones.51 OmpF and OmpC have also been shown to play a role in 
acidic resistance.57 Further research is needed to determine levels of other key components such 
as lipids and how changes in their levels affect cell thickness. 
The virulence profiles of STEC and EPEC strains 
For the STEC strain, we could detect key LEE virulence proteins such as intimin gamma, serine 
proteases, superoxide dismutase, toxin B and translocated intimin receptor (Tir) proteins. These 
were either totally absent or present at lower levels in the EPEC strains. ToxB is a nontoxic 
homopentameric protein responsible for which toxin binding and internalisation into target cells 
by interacting with the glycolipid, globotriaosylceramide (Gb3).9 The ToxB protein is located on 
a large plasmid found only in STEC strains associated with the most severe form of the disease.58  
Intimin type γ and FeoB are implicated in attachment and iron transport respectively, responsible 
for the colonisation of enterohaemorrhagic E. coli O157:H7.59 
Unlike the EPEC strains, the STEC strain had significantly higher levels of the silent haemolysin 
A responsible for cytolysis and for inducing apoptosis. This haemolysin can play the same role 
as haemolysin A (hlyA) in the pathogenesis of STEC disease.32 We detected higher LFQ values for 
outer membrane proteins such as OmpC, OmpX and the outer membrane assembly factor protein 
in the STEC strain associated with attachment and immune evasion.60,61 
Overall the STEC strain yielded more virulence factors compared to the EPEC strains. However, 
EatA, an immunogenic serine protease, was identified exclusively in the ciprofloxacin-susceptible 
EPEC strain and contributes to virulence by degrading MUC2, the major protein present in the 
small intestinal mucous layer, to accelerate access of the enterotoxin to the enterocyte surface. 
EatA appears to modulate both adherence to epithelial cells and intestinal colonisation in part by 
digesting EtpA, a novel exoprotein adhesin molecule that is secreted by ETEC.62 Another 
example, OmpA a well-described virulence factor among pathogenic E. coli63 was significantly 
more abundant in the ciprofloxacin-resistant EPEC strain. Our findings indicate that the three 
isolates display distinct patterns of virulence factor protein abundance.  
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5.6 Conclusions  
This study demonstrates the utility of tellurite containing screening agar for the detection of EPEC 
and STEC, and the application of tandem MS coupled with UHPLC to characterise the proteome 
of E. coli from solid media.  
This study demonstrates that solid medium aids detection of virulence and antimicrobial 
resistance proteins and that mauve colonies on CHROMagarTMSTEC all secreted tellurite 
resistance proteins, with the selected strains all carrying different arsenals of virulence and 
antimicrobial resistance proteins. The significant abundance of proteins in antimicrobial 
resistance such as the Metallo-beta-lactamase and multidrug efflux pumps and heavy metal efflux 
pumps sheds light on the molecular mechanisms of antimicrobial resistance in this setting.  The 
workflow described here may facilitate further research into bacterial pathogenicity from low 
passage clinically isolated strains.  
Further research is needed to characterise the link between cell envelope thickness and levels of 
key cell envelope proteins. Levels of other key cell envelope components like lipids and sugars 
should be assessed in relation to differences in cell thickness.  
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Chapter Six 
6 Prevalence and characterization of food and waterborne 
bacterial pathogens in Lotus River surface water, meat from 
informal abattoirs, and stool from children in Nyanga 
Township, Cape Town, South Africa. 
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6.1 Summary 
Introduction: Approximately 19% of child deaths globally are due to diarrhoea. Food and 
waterborne bacterial pathogens such as STEC cause diarrhoea or dysentery especially among 
children under the age of five, resulting in malnutrition, dehydration, and/or death. The Nyanga 
Township has one of the highest infant mortality rates in Cape Town and yet little is known about 
the non-human reservoirs and characteristics of food and waterborne pathogens in this area. This 
study aimed to achieve the following objectives: 
i. Determine the epidemiologic characteristics and clinical features of children presenting with
diarrhoea at the Nyanga Community Health Center (NCHC).
ii. Determine the prevalence of STEC, and other food and waterborne bacterial pathogens in the
stool of children with diarrhoea, Lotus River surface water, and meat from informal abattoirs
in Nyanga.
iii. Determine the mean colony forming units of coliforms per millilitre of Lotus River surface
water in the Nyanga Township.
iv. Determine the antimicrobial resistance patterns of food and waterborne bacterial diarrhoeal
pathogens isolated from the stool of children with diarrhoea, Lotus River surface water and
meat from the informal abattoirs in Nyanga.
Methods: Stool from children with diarrhoea, raw and processed meat, and Lotus River surface 
water were collected from the Nyanga Township between June 2015 and March 2016. Real – time 
PCR was done to detect stx in TSB enrichment of the samples and in the E. coli isolates that formed 
mauve colonies on CHROMagarTMSTEC while endpoint PCR was used to detect eaeA, ipa, LT, ST, 
daaC, and aat in TSB enrichment and from E. coli isolates that formed mauve colonies on 
CHROMagarTMSTEC. The antimicrobial susceptibility patterns of the pathogens were determined 
using the VITEK® 2 automated system and the broth microdilution method. 
Results: The commonest form of diarrhoea in children presenting to the health centre in Nyanga 
over the study period was acute diarrhoea affecting children less than 2 years (mean age =14.9 
months) of age, with an average duration of 2.5 days.  
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STEC was isolated from 2% of the stool and water samples but not from meat. We detected one 
or more diarrhoeal pathogens (including detection of diarrheic E. coli virulence marker genes) in 
73% (48/66) of the diarrhoea cases. The most prevalent diarrhoeal pathogens among children were 
diffusely adherent E. coli (DAEC), and Shigella (18% and 17% respectively) and these were much 
more prevalent in stool as compared to meat (no Shigella and 2% for DAEC) and water (5% for 
Shigella and 3% for DAEC). STEC isolated in this study showed resistance to ampicillin (AMP) 
and trimethoprim – sulfamethoxazole (SXT) only. SXT resistance was most commonly observed 
amongst all pathogens, irrespective of their source.  
Conclusions: There was a high prevalence of bacterial pathogens in the stool of children with 
diarrhoea. The Lotus River and meat from the informal abattoirs are potential environmental 
reservoirs for food and waterborne bacterial pathogens. Further public and environmental health 
interventions are needed to ensure food safety in the Nyanga Township. 
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6.2 Background 
Twenty-five percent of deaths among children aged 1-59 months of age in Africa are attributable 
to diarrhoea.1 Even though large-scale studies like the Global Enteric Multicenter Study (GEMS)2, 
provided relevant information on the common causes of paediatric infectious diarrhoea in sub-
Saharan Africa, they did not consider the distribution of such pathogens in the non-human 
environment of the patients. Studying the non-human environment of patients with diarrhoea is 
important because most of the bacterial causes of infectious diarrhoea can be transmitted from 
non-human reservoirs such as food of animal origin, animals, and surface water. According to 
Karen et al, 2016, the GEMS demonstrated that the poorest of the poor might succumb to different 
pathogens at different rates in different parts of the world, and thus potentially altering public 
health intervention strategy.3 For instance, while most attributable cases of moderate-to-severe 
diarrhoea in the GEMS (considering all study sites in sub-Saharan Africa and South Asia) were 
due to four pathogens (Cryptosporidium, heat stable toxin producing Escherichia coli, Rotavirus 
and Shigella), other pathogens (Aeromonas, Vibrio cholerae O1, and Campylobacter jejuni) were 
important in selected sites.2 Essentially, this infers that public health interventions targeting 
diarrhoeal pathogens should be based on locally generated data. 
Food and waterborne bacterial pathogens cause infectious diarrhoea especially among children 
less than five years of age, the elderly, and the immunocompromised.4 Transmission of these 
pathogens is favoured by factors such as inadequate environmental and personal hygiene, as well 
as a lack of access to clean water. Such factors have been reported to be associated with increased 
health vulnerability especially among inhabitants of low-cost housing settlements.5 Food and 
waterborne bacterial pathogens include diarrhoeagenic E. coli6, Salmonella, Shigella, Campylobacter, 
Yersinia, Aeromonas, Vibrio, and Plesiomonas shigelloides.7,8 Among the diarrhoeagenic E. coli, Shiga-
toxin producing E. coli (STEC), has been associated with the most severe clinical sequelae in the 
form of haemolytic uraemic syndrome (HUS), especially among children.9 Outbreaks of STEC 
often occur as a result of consumption of contaminated foods of animal origin such as fermented 
sausages10 and hamburgers11, contact with animals12, and consumption of contaminated water.13 
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The environmental reservoirs of STEC that have been investigated in Africa include water, animal 
faeces, animal carcases, and processed meat products.14-18  
Among food and waterborne bacterial pathogens, some, such as Campylobacter and Salmonella are 
primarily pathogens of domestic animals like poultry, and only accidentally infect the human 
host as a result of meat contamination at slaughter.19 The major food animal reservoirs for Yersinia 
enterocolitica20 and Vibrio21-23 are swine and the molluscan shellfish respectively. Aeromonas and 
Plesiomonas have been shown to cause choleraic diarrhoea24 and can be transmitted to humans 
from cattle25 or surface water26 respectively. 
Studying the environmental antibiotic resistome (the density of antibiotic resistance determinants 
in the environment) is important because there is evidence to suggest a link between antibiotic 
resistance among bacterial pathogens in the environment and resistance to antibiotics, such as 
aminoglycosides, extended-spectrum beta-lactams and quinolones in a clinical setting.27,28 The use 
of treated human and animal waste (slurry) from wastewater treatment plants, for agricultural 
purposes (as manure), leads to contamination of the environment with antibiotic resistance genes. 
Also, the exposure of animals to levels of antibiotics that are less than the minimum inhibitory 
concentration as a result of anthropogenic contamination (the disposal into the environment of 
antibiotics due to human activities such as agriculture) selects for antibiotic-resistant bacteria in 
the animal.29 According to the Advisory Group on the Integrated Surveillance of Antimicrobial 
Resistance (AGISAR) of the World Health Organisation (WHO), a monitoring system should be 
set up only if there is a recognised public health burden of enteric illness due to a specific 
foodborne etiological agent.30 To this end, WHO has recommended country level development of 
antimicrobial surveillance programs that integrate data from bacterial isolates originating from 
humans, food-producing animals, and retail meats.30 There are three categories of such bacteria 
namely; (1) indicator bacteria, for example, E. coli, (2) zoonotic bacterial pathogens such as 
Salmonella31 and (3) strictly animal pathogens like Salmonella gallinarum.32 The three categories of 
bacteria are common in the gastro-intestinal tract of man and animals.  
Diarrhoea and foodborne antimicrobial resistance in Nyanga township 
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The Nyanga township (GPS coordinates: 33.9931S, 18.5822E) was established in 1946 and is in the 
City of Cape Town Municipality, in the Western Cape. It has a population density of 18,775 
persons / km2 and a total population of 57,996 people with 27.3% of these younger than 14 years. 
A burden of disease workgroup under the Child Health Services section of the Provincial 
Government of the Western Cape reports that the infant mortality rate per 1000 live births (60 in 
2001 and 42 in 2004) in Cape Town was highest in Nyanga in the study period 2001-2004.33 Since 
then, this work group has not reported the most recent infant mortality rate in the region. 
The Nyanga Community Health Center (NCHC) is a primary health care facility managed by the 
City of Cape Town, which serves the Nyanga area. Here, diarrhoea is syndromically managed, 
and stool samples are seldom collected for laboratory testing. According to a caregiver survey 
conducted in the Nyanga health district, 80% of the caregivers that attended primary health care 
centres had been advised by health workers to manage diarrhoea from home using Oral 
Rehydration Salts (packets) and home-made sugar-salt solutions. In this survey, only children 
that presented with severe dehydration and or fever were referred to the Red Cross Children’s 
War Memorial Hospital.34 This is in line with the Integrated Management of Childhood Infections 
(IMCI) guidelines. Therefore, there is no routine or systematic laboratory-based surveillance for 
foodborne diarrhoeal bacterial pathogens and foodborne antimicrobial resistance in this area. The 
antimicrobial resistance national policy framework (2014-2024) for South Africa focuses on the 
optimisation of monitoring and early detection of antimicrobial resistance, strengthening, 
coordinating and institutionalising interdisciplinary efforts. The strategy involves enhancing 
infection prevention and control and ensuring appropriate use of antibiotics in human and animal 
health.35 Whilst the formal food production industry is addressed in this framework, there is no 
component to tackle foodborne antimicrobial resistance in the informal abattoir setting. 
The Lotus River 
The Lotus River flows from the Zeekoevlei catchment area and has large and small tributaries. It 
flows through three townships namely; Nyanga, Khayelitsha, and Crossroads. The Lotus River 
is made up of storm-water, and its level fluctuates depending on rainfall amounts and waste 
disposed into it. Domestic animals are often seen grazing along the Lotus River banks and are 
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occasionally slaughtered here (see Figure 6:1A and Figure 6:2B). The extent of use of water from 
the Lotus River is not clear. However, there is an extensive human settlement on its banks (Figure 
6:3). Generally, in South Africa, water collected from rivers is used for irrigation and domestic 
purposes.36 Also, water in this river ends up in the municipal waste water, and sewerage 
treatment system, and therefore the level of contamination of this river affects the cost of 
treatment and recycling of the waste water. 
Figure 6:1A-Photo showing cattle grazing along the Lotus River. 
Figure 6:2B-Chicken feathers on the Lotus River bank indicating possible use of the Lotus River water for carcas 
cleaning or discarding of the slaughter waste into the river. 
Figure 6:3 Informal settlements ("Shacks") located on the banks of the Lotus River in Nyanga, Cape Town. 
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The Water and Sanitation Services Department of the City of Cape Town monitors coliform 
counts in the Lotus River monthly to determine water safety. It follows the South African 
National Standard 241:2011 on drinking water quality. However, the incubation of 
thermotolerant E. coli at 44.5 ̊C in the water microbiology laboratory at this centre, does not favour 
growth and detection of STEC O157:H7.37 Coliform counts are made and water is passed as safe 
for use if it has a low count, but coliforms such as E. coli are never tested for the possession of 
virulence genes. Furthermore, at this laboratory, there is no culture for bacterial pathogens. 
Therefore, a water sample with low coliform count but with pathogenic E. coli of public health 
importance such as E. coli O157:H7 may be passed as safe for distribution, use for irrigation or 
recreational purposes. For example, per the annual report published by the City of Cape Town 
Water and Sanitation Services for the period 2012/13, two samples in the Cape Metropole area 
had an E. coli count of greater than one cell per 100ml and were therefore deemed unfit for 
consumption. In this same report, microbiological monitoring in the informal settlements was 
often hindered by the fact that the communal water standpipes were near the communal toilets 
and were often dirty and leaking.38 
6.2.1 Aims and objectives 
We aimed to use a One - Health approach to study the prevalence and characteristics of STEC 
and other bacterial diarrhoea pathogens isolated from the stool of children with diarrhoea, meat 
from informal abattoirs and surface water from the Lotus River in the Nyanga Township. We also 
noted the epidemiologic and clinical data relating to patients with diarrhoea attending the 
Nyanga Community Health Center (NCHC). The aims of this study were: 
i. Determine the epidemiologic characteristics and clinical features of children presenting with
diarrhoea at the Nyanga Community Health Center (NCHC).
ii. Determine the prevalence of STEC, and other food and waterborne bacterial pathogens in the
stool of children with diarrhoea, Lotus River surface water, and meat from informal abattoirs
in Nyanga.
iii. Determine the mean colony forming units of coliforms per millilitre of Lotus River surface
water in the Nyanga Township.
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iv. Determine the antimicrobial resistance patterns of food and waterborne bacterial diarrhoeal
pathogens isolated from the stool of children with diarrhoea, Lotus River surface water and
meat from the informal abattoirs in Nyanga.
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6.3 Methods 
6.3.1 Selection and enrollment of children with diarrhoea 
Procedures for enrollment and administration of questionnaires: The target population was 
children under twelve years of age with diarrhoea who attended the NCHC on Monday, 
Wednesday, and Friday of every week during the study period from October 2015 to April 2016. 
At enrolment, in the general waiting area, guardians of patients under 12 years of age, were 
approached by the study clinical research worker and presented with an informed consent form 
in isiXhosa (see 9.3), or English (see 9.2) for those for whom isiXhosa was not their first language 
(Ethical Clearance number: HREC 2015/140). Only those that consented were recruited in this 
study. A questionnaire designed using Epi Info 7TM (CDC, USA) (see 9.1) was piloted before it 
was administered to the consenting guardians by the study clinical research worker, to collect 
demographic and clinical data, as well as data on exposure to environmental factors associated 
with diarrhoea.39 Medical staff in the unit managed the diarrhoea cases as is done routinely. 
Collection of clinical data: A trained nurse examined these children for clinical signs associated 
with diarrhoea and collected the relevant clinical data. Diarrhoea was defined as three or more 
loose stools within the past 24 hr period.  
Collection of stool samples from patients older than three years of age: The toilet seat was lifted 
and sample collection tissue paper placed across the toilet bowl (A triple layer of sample 
collection tissue paper was used). The toilet seat was then lowered. The patient was advised to 
urinate first before the sample was collected. Alternatively, three layers of tissue paper roll were 
placed on a clean floor surface, and the patient positioned to pass stool in the middle of the triple 
tier. The scoop on the lid of the screw capped stool collection container was then used to collect 
a pea-sized amount of stool which was then placed into the container. The triple layer tissue was 
then discarded into the toilet.  
Collection of stool from children younger than three years: A freshly passed stool sample was 
collected by scooping from the diaper but with care to avoid contact or scrapping from the diaper 
surface as it has bactericidal chemical compounds. Using a plastic scoop, we transferred at least 
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a pea-sized amount of stool into a screw-capped container. Samples were then transported to the 
laboratory within 12h after collection using a temperature-monitored cool-box. 
6.3.2 Meat sample collection 
Retail meat samples were collected in accordance with the recommendations by the World Health 
Organisation (WHO) on Integrated Surveillance of Foodborne Antimicrobial Resistance.30 
Sampling was active and population based. This was done on the first two Fridays of every month 
for eight months between October 2015 and May 2016. 
Forty-nine raw and 36 ready–to-eat meat samples were collected from 53 local meat retail stalls 
(stalls were selected based on convenience) along main access roads in the Nyanga Township (see 
Figure 6:4). Both prepared (see Figure 6:5), and fresh specimens were received in the original 
packaging and delivered to the laboratory within 12h after collection using a temperature-
monitored cool-box. Reserve samples were held at -80°C for purposes of retesting. Meat 
categorization was done in line with the food categorization scheme recommended by the United 
States’ Interagency Food Safety Analytics Collaboration, with modifications to suit the informal 
meat trade. On this basis, we categorised meat as raw or processed, including chicken, pork, beef 
and mutton as categories.40 
Figure 6:4 The local retail meat stall in the informal slaughter setting in Nyanga. 
Sheep are slaughtered on the dirty floor, slaughter waste scattered on the stallside, and meat sold 
close to the slaughter area. 
190 
Figure 6:5 Ready -to – eat sheep head that has been processed by scalding in hot water and roasting. 
6.3.3 Surface water sample collection from the Lotus River 
Sixty-four water samples were collected over a period of ten months between 7 a.m and 12 noon 
from July 2015 to March 2016 using the depth integrated grab sampling method with samples 
being collected at a depth of approximately 30cm below the surface of the river towards the centre 
of the stream.41 Samples were collected using clean, sterile containers tied to a long pendant rope 
with the first collection released back into the river and then a volume of 100ml poured into a 
100ml sterile collection bottle (see Figure 6:6 A. ). The sample was then immediately transported 
at 4 ̊C to the City of Cape Town Water and Sanitation microbiology laboratory where it was 
processed within 24hr of collection. 
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Figure 6:6 A. The Depth Integrated Grab sampling of Lotus River water using a rope tied to a bucket with water 
collected from the centre of the stream. B. Water collection point showing the nature of surface water at one of the 
collection points along the Lotus River (LR16). 
Water was collected from four points (LR13, LR14, LR15, and LR16) located along the section of 
the Lotus River traversing the Nyanga area. These points were previously used by the City of 
Cape Town Water and Sanitation Division as surveillance points (see Figure 6:7). 
Figure 6:7 The water collection points along the Lotus River in Nyanga. 
LR13, LR14, LR15, and LR16 are water collection points along the Lotus River section that drains the 
Nyanga informal settlement. 
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6.3.4 Microbiological analysis of stool, meat and water samples for STEC and other 
bacterial pathogens. 
6.3.4.1 Enrichment for STEC and other foodborne bacterial pathogens 
 Stool: A pea-sized amount of stool sample was inoculated in 90ml of TSB (Oxoid, Basingstoke, 
UK) and incubated at 35-37 ̊C for 24 hours as described in 3.3.3. 
Meat: Twenty-five grammes of tissue in a sterile stomacher bag was thoroughly pummeled using 
a sterile mortar and pestle, and inoculated into 225ml of Tryptic Soy Broth (TSB; Oxoid, 
Basingstoke, UK) and incubated at 35°C for 24 hours as previously described but with slight 
modifications42 (see Table 6:1).  
Table 6:1 The food sample processing and enrichment protocol. 
Sample type Portion size Volume of TSB Incubation conditions 
Ready-to-Eat Foods 25 ± 0.5 g 225 ± 0.5 ml TSB 35 ± 2°C for 18-24 h 
Raw Poultry Products 25 ± 0.5 g 225 ± 0.5ml TSB 35 ± 2°C for 18-24 h 
Raw Meat  25 ± 0.5 g 225± 0.5 ml TSB 35 ± 2°C for 18-24 h 
Whole bird rinsate 25 ± 0.5 ml sample 
rinsate 
225± 0.5 ml TSB 35 ± 2°C for 18-24 h 
Sheep heads 25 ± 0.5 ml sample 
rinsate 
225± 0.5 ml TSB 35 ± 2°C for18-24 h 
Water: One hundred millilitres of surface water (without dilution) was filtered through a 0.45µM 
membrane filter (Pall Corporation, Port Washington, USA). The membrane filter was then placed 
in 90ml of TSB and incubated for 18h at 35̊C. This was in accordance with the International 
Organization for Standardisation guidelines on microbiology of water (ISO 9308-3: 1998).43 
Enumeration of faecal coliforms in water samples: The mTEC agar enumeration method which 
provides a direct count of coliforms growing on the surface of the filter membrane was used.44 
This approach is routinely used by the City of Cape Town, Water and Sanitation Division, 
Athlone. Briefly, six ten-fold serial dilutions of 10ml of surface water sample in 90ml of distilled 
water were made. A 0.45 µM nitrocellulose membrane (Pall Corporation, Port Washington, USA) 
was placed in a filter funnel (Pall Corporation, Port Washington, USA) and fixed on a filter funnel 
manifold (Pall Corporation, Port Washington, USA) (see Figure 6:8). The water (100ml at each of 
193 
the six dilutions) was poured over the membrane, and the vacuum pump turned on until the 
water was completely drained. Using sterile forceps, the layer was placed on modified mTEC 
agar (Difco, Detroit, USA) and incubated at 35°C for two hours to revitalise stressed cells. This 
was followed by incubation at 44°C for 22 hours as per the routinely used protocol in the 
environmental water microbiology laboratory at the City of Cape Town microbiology laboratory 
in Athlone, Cape Town, and according to the ISO guidelines on water processing with slight 
modifications.43 Pink coloured colonies were counted and the number of coliforms per 100ml of 
water sample calculated. 
Figure 6:8 Water filtration unit used for the filtration of the water samples, the City of Cape Town Water and 
Sanitation Division. 
The five funnels with blue sterile paper covers are connected to a vacuum pump 
6.3.4.2 Isolation and characterization of STEC from TSB 
To isolate STEC from TSB enrichments of stool, food and surface water, we streaked a 3mm 
loopful of TSB on CHROMagarTMSTEC following overnight incubation and incubated overnight 
at 37 ̊C (Figure 6:9, Figure 6:10, Figure 6:11). Subsequently, up to five mauve colonies were sub-
cultured separately on MacConkey agar with crystal violet and sorbitol MacConkey agar plates. 
Lactose and sorbitol fermentation properties were determined for each colony after incubation at 
37 ̊C for 24h. Isolate characterization was then done as described in 3.3.5. 
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Figure 6:9 Workflow scheme for stool processing 
Figure 6:10 Workflow scheme for meat sample processing 
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Figure 6:11 Workflow scheme for processing Lotus River surface water. 
6.3.4.3 Detection of serotype-specific O-antigen genes and other DEC virulence genes in TSB 
We screened the TSB for serotype-specific O-antigen genes (rfbE for E. coli O157 and wbdl for E. 
coli O111) and other diarrheic E. coli (DEC) virulence genes. The detection of the DEC virulence 
genes was performed as described earlier in 3.3.5. 
DNA extracted from ATCC strains, E. coli ATCC43887 (Positive for the wbdl, a marker gene for E. 
coli O111) and E. coli C4193-1 (Positive for the rfbE, a marker gene for E. coli O157) using the boiling 
lysis method were used as positive controls in the PCR reactions. The following primers were 
used as previously described (see Table 6:2).45 
Table 6:2 The primers used for the amplification of serotype-specific O-antigen genes in TSB enrichments of stool, 
water, and meat samples. 
Target Gene PCR primer Primer sequence PCR product size 
rfbE O157-F CGGACATCCATGTGATATGG 259bp 
O157-R TTGCCTATGTACAGCTAATCC 
wbdl O111-F TAGAGAAATTATCAAGTTAGTTCC 406bp 
O111-R ATAGTTATGAACATCTTGTTTAGC 
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6.3.4.4 Isolation and characterization of Salmonella, Shigella, Vibrio, Plesiomonas, Aeromonas, 
Yersinia, and Campylobacter 
Salmonella enterica and Shigella spp: Following overnight incubation, a 3mm loopful of TSB was 
used to inoculate an XLD (Xylose Lysine Deoxycholate) agar plate. Red colonies with a black 
centre (for Salmonella enterica) or red colonies (for Shigella spp. or Salmonella Typhi) were sub-
cultured on MacConkey agar with crystal violet and 2% blood agar. The Triple Sugar Iron (TSI), 
oxidase, indole, urease, and citrate tests (Greenpoint Media Laboratory, NHLS, Albertynshof) 
were done to determine the biochemical properties of the suspect colonies. The VITEK® 2 system 
was used to confirm the identification. Speciation of Shigella was done using the Wellcolex* colour 
Shigella Rapid latex agglutination test (Oxoid, Basingstoke, UK) which consists of two reagents 
comprised of coloured latex particles coated with antibodies that are specific for each of the 
Shigella species. 
Salmonella enterica were sent to the NICD and serotyped (for the common serotypes) using 
antiserum specific to the 46 different O antigens and the 119 H antigens (including the Phase 1 
and Phase II). 
Vibrio spp: For Vibrio spp., 10ml of surface water sample was inoculated in 90ml of Alkaline 
Peptone Water and incubated at 42 ̊C for eight hours. Subsequently, a 3mm loopful of the surface 
pellicle of Alkaline Peptone Water (APW) (Greenpoint Media Laboratory, NHLS, Albertynshof) 
was sub-cultured onto a dried Thiosulfate – Citrate – Bile salts – Sucrose (TCBS) agar plate 
(Greenpoint Media Laboratory, NHLS, Albertynshof). The plate was incubated for 24h at 35 ̊C 
with yellow or green colonies sub-cultured on MacConkey agar with crystal violet and incubated 
for 18h at 35 ̊C before identification using the VITEK® 2 system.46  
Plesiomonas spp: A 3mm loopful of TSB was used to inoculate MacConkey agar with crystal 
violet and Cefsulodin – Irgasan - Novobiocin (CIN) agar (Greenpoint Media Laboratory, NHLS, 
Albertynshof) and incubated at 35°C for 24 hours. Non- lactose fermenting colonies on 
MacConkey agar with crystal violet and opaque colonies with a pink centre on CIN agar were 
tested for oxidase activity. Further, biochemical testing was possessed out on the oxidase positive 
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colonies using the spot indole, urea slants, citrate agar slants and TSI slants with confirmatory 
identification done using the VITEK® 2 system. 
Aeromonas spp: A 3mm loopful of TSB was inoculated on Aeromonas-Yersinia agar (Greenpoint 
Media Laboratory, NHLS, Albertynshof) and incubated at 37°C for 24 hours. Pale colonies with 
a rose to red centre were tested for oxidase activity. Oxidase positive colonies were then streaked 
on MacConkey agar with crystal violet and incubated overnight at 35 ̊C before confirmatory 
identification using the VITEK® 2 system.  
Yersinia enterocolitica: Following overnight incubation in TSB, a 3mm loop was used to inoculate 
a Cefsulodin – Irgasan - Novobiocin (CIN) agar plate. The CIN plate was then incubated 
overnight at room temperature. Characteristic “bull’s eye” colonies (colourless colonies with a 
red centre) were subjected to further biochemical testing. Catalase positive, non-lactose 
fermenting, urease positive colonies were identified using the VITEK® 2 system. 
Campylobacter spp: Twenty-five millilitres of carcas rinsate was centrifuged at 3000 r.p.m, and 
the resultant pellet streaked on a Charcoal Cefoperazone Deoxycholate modified Agar (CCDA) 
plate and incubated under microaerophilic conditions for 72 hours at 35 ̊C. Suspect colonies were
Gram stained for characteristic “birds-in-flight” appearance. Oxidase positive colonies with the 
characteristic Gram appearance were then identified using the VITEK® 2 system. 
6.3.4.5 Quality control strains used during isolation of STEC and other foodborne bacterial pathogens 
ATCC controls strains for Yersinia spp., E. coli, S. enterica and Campylobacter, were used (see Table 
6:3). In-house control clinical isolates of Vibrio spp., Plesiomonas spp., and Aeromonas spp., whose 
identification was initially confirmed using the VITEK® 2 automated system were used. For each 
run of samples, a known negative sample was spiked with a positive control and run in the same 
batch and the same way as the test food and water samples, depending on the pathogen being 
screened for. 
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Table 6:3 Quality control strains used in the processing of stool, meat, and water samples. 
Organism ATCC strain 
STEC E. coli O157 ATCC 35150
Yersinia enterocolitica Yersinia enterocolitica subs. enterocolitica
Campylobacter spp. Campylobacter jejuni ATCC 33292D-5
Salmonella enterica S. enterica subsp. enterica serovar Pomona strain B (ATCC® BAA-2653™)
Aeromonas hydrophila In – house, positive control isolates used. Identified using VITEK 2® automated
system
Plesiomonas shigelloides In – house, positive control isolates used. Identified using VITEK 2® automated
system
Vibrio vulnificus In – house, positive control isolates used. Identified using VITEK 2® automated
system
Vibrio metchnikovii In – house, positive control isolates used. Identified using VITEK 2® automated
system
6.3.4.6 Antimicrobial Susceptibility Testing of STEC and other bacterial pathogens 
Gram-negative bacterial pathogens were subcultured on MacConkey agar with crystal violet and 
sent for identification and antimicrobial susceptibility testing using the GNI card on the VITEK® 
2 automated system as described in 3.3.3. For all the bacterial pathogens, species-specific break 
points, as per the CLSI 2015 guidelines (U.S.A), were used. The WHONET software has these 
breakpoints built-in.  
6.3.5 Data Analysis 
Questionnaire information was filled into Epi Info 7TM (CDC, USA) for analysis. Data analysis was 
done using Epi Info 7TM (Centre for Disease Control, Atlanta, USA) and STATA (STATA Corp 
LLC, College Station, Texas, USA). Comparison of proportions and statistical significance were 
calculated using a two-tailed Chi-square test or Fischer’s exact test, with p<0.05 considered 
significant.  
Antimicrobial susceptibility MIC data were analysed using the WHONET version 5.6 software. 
Within the software, the CLSI interpretation guidelines were used to categorise isolates as 
resistant, intermediate or susceptible to selected antimicrobials. The types of analysis undertaken 
with this software included determination of the percentage of isolates that were Resistant or 
Susceptible and generation of resistance profiles. 
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6.4 Results 
6.4.1 Epidemiological and clinical and data of children with diarrhoea attending 
Nyanga Community Health Center. 
6.4.1.1 Area of origin of diarrhoea cases 
Of the 66 patients recruited in this study, 56 (84.8%) were residents of the Nyanga township (Area 
B), 6 (9.1%) were from the Khayelitsha township (Area A) while 4 (6.1%) were from the 
Crossroads township (Area C) (see Figure 6:12).  
Figure 6:12 Map showing the areas of origin of patients that attended the Nyanga Community Health Center. 
Area A=Crossroads, Area B= Nyanga, Area C= Khayelitsha 
Red dots represent diarrhoea cases -the larger dots correspond to a higher number of cases. 
6.4.1.2 Temporal distribution of diarrhoea cases over the study period 
Every patient that presented with diarrhoea during the enrollment days was recruited into the 
study. Most cases were recruited in February 2016 and the lowest number in October 2015 (see 
Figure 6:13). There was a bimodal peak (November 2015 and February 2016) in the number of 
patients recruited over the study period. 
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Figure 6:13 The number of cases recruited per month for the study period. 
6.4.1.3 Clinical data collected at enrollment 
The mean duration of diarrhoea was 2.5 days. The most common symptom was weakness and 
dehydration (30/66, 46%), and was noted among patients infected with DECs, Plesiomonas 
shigelloides, and Shigella. Of all the cases, 5%, 20%, and 17% presented with bloody stool, vomiting, 
and fever respectively. Fever was noted among patients with Salmonella, Plesiomonas shigelloides, 
and Shigella. Blood in stool was observed only in a single patient for each of STEC and Aeromonas 
infections. Blood in stool was not noted among any of the patients from whom Shigella was 
cultured. Only 2% (1/66) of the recruited children had a history of immediate prior antibiotic use 
before recruitment into this study (see Table 6:4). The proportion of children that were using 
antibiotics immediately prior to visiting the health centre was significantly higher (p=0.024) 
among those that presented with fever 9% (1/11) compared to those that didn’t 0% (0/55). 
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Table 6:4 Clinical characteristics of enrolled participants, stratified by bacterial pathogen. 












Plesiomonas(n=6) Shigella (n=11) 





2.4 (1.5) 1.7 (0.98) 1.67 (1.52) 3 (1.4) 2.5 (1.7) 2.5 (1.37) 1.2 (0.82) 
Number presenting with symptom 
Blood in stool 3 1 1 - 1 
Vomiting 13 - 5 - 1 - 1 2 
Fever (>38 ̊C) 11 - 4 - 2 1 2 
Weakness and 
dehydration 
30 - 3 - - - 2 1 
Cough 6 1 - 1 2 
Belly pain 3 - - - - - 1 2 
Antibiotic use 
Antibiotic use 1 - - - - - - 1 
*N/A= Not applicable; A bacterial pathogen was not isolated from some of the patients that presented with the symptoms.
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6.4.1.4 Epidemiological data acquired using questionnaires from patients attending Nyanga 
Community Health Center 
Of the 66 outpatients with acute diarrhoea that were recruited in the study, 36 were female while 
30 were male. The mean age in months of the cases was 14.9 months (±10.9). The mean number 
of children under 5 years of age per household was two while the mean household size was 4 
persons.  
Thirty percent of the patients had domestic animals in their households. The commonest animal 
kept was the dog (kept by 17% of the households).  
Most of the children were brought to the clinic by their mothers as the primary caregivers (85%), 
and only 24% of the mothers were still breastfeeding their children. Of the primary caregivers, 
11%, 74%, and 6% had a primary, secondary and tertiary level of education respectively. 
Seventeen percent of the study recruits were brought to the clinic for immunisation and routine 
health checks and not for purposes of illness (see Table 6:5).  
Of the study recruits, 39% reported having received rotavirus vaccination and 85% of the 
households disposed of the child’s faecal waste into the domestic refuse bin. 
Seventy-nine percent of the households (of the enrolled patients) used the communal standpipes 
as the primary source of water for daily use while 21% used in-house piped water.  
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Table 6:5 Epidemiologic data from patients attending the Nyanga Community Health Center. 
95% Confidence Interval (CI) 
Number (%) Lower CI Upper CI 
Sex 
Male 30 (45%) 34 57 
Female 36 (55%) 43 66 
Animals kept at home 
Dog 11 (17) 7.4 25.9 
Cat 5 (8) 1.0 14.1 
No animal 46 (70) 58.3 81.1 
Other 4 (6) 2.4 14.6 
Primary caregiver 
Mother 56 (85) 74.3 91.6 
Grand Mother 2 (3) 1.2 7.3 
No relation 1(2) 0.3 8.0 
Aunt 1 (2) 0.3 8.0 
Sister 2 (3) 1.2 7.3 
Other 2 (3) 1.2 7.3 
Level of education of primary caregiver 
Primary 7 (11) 5.2 20.3 
Secondary 49 (74) 62.6 83.3 
Tertiary 6 (9) 4.2 18.5 
Religious Education 4 (6) 2.4 14.6 
Purpose of visit to the clinic 
Immunization 5 (8) 3.3 16.5 
Sickness 55 (83) 72.6 90.4 
Routine Health check 6 (9) 4.2 18.45 
Breastfeeding status 
Breast feeding 16 (24) 13.6 34.9 
Rotavirus immunization 
Rotavirus immunized 26 (39) 27.3 51.49 
Disposal of soiled nappies 
Bin 56 (85) 76 93.73 
Source of water for domestic use 
House piped water 14 (21) 9.1 33.4 
Communal stand pipe 52 (79) 66.6 90.86 
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6.4.2 Microbiological analysis results 
6.4.2.1 Foodborne bacterial pathogens and DEC virulence genes identified from stool of children with 
diarrhoea and from environmental samples  
A summary of the foodborne bacterial pathogens and diarrheic E. coli virulence genes detected 
in the stool of children with diarrhoea, Lotus River surface water, and meat from the informal 
abattoirs in Nyanga, Cape Town is given in Table 6:6. 
Table 6:6 Prevalence of foodborne bacterial pathogens and diarrheic E. coli virulence genes in the stool, Lotus River 
surface water, and meat from the informal abattoirs in Nyanga. 
Pathogens isolated per sample type n (%) 
Pathogen Human (n=66) Meat (n=85) Water (n=64) 
Salmonella enterica 4 (6) 4 (5) - 
Shigella flexneri. 11 (17) - 3 (5) 
Plesiomonas shigelloides 6 (9) 1 (1) 11 (17) 
Aeromonas sorbria. 2 (3) 3 (3) 4 (6) 
Campylobacter jejuni. 3 (5) 6 (7) - 
DAEC 8 (12) 2 (2) 2 (3) 
EaggEC 2 (3) - 1 (2) 
STEC 1 (2) - 1 (2) 
EPEC 1 (2) 1 (1) - 
EIEC 1 (2) - - 
Vibrio vulnificus - - 6 (9) 
Yersinia enterocolitica - - - 
Genes 
aat 9 (14) - - 
daaC 23 (35) 6 (7) 24 (38) 
stx1 4 (6) 17 (20) 19 (30) 
stx2 2 (3) 4 (5) - 
Ipa 4 (6) - 5 (8) 
LT 5 (8) 1 (1) 21 (33) 
rfbE 1 (2) 5 (6) 9 (14) 
wbdl 1 (2) - 5 (8) 
aat 9 (14) - - 
daaC 23 (35) 6 (7) 24 (38) 
eaeA - 6 (7) - 
6.4.2.1.1 Bacterial pathogens and DEC virulence genes detected in stool 
A bacterial pathogen was isolated from 36 (55%) of the 66 patients with diarrhoea. From 6 (6/36, 
17%) of these, more than one bacterial pathogen was isolated (Shigella flexneri and STEC-one 
patient, Shigella flexneri and Campylobacter jejuni jejuni-one patient, Aeromonas sorbria and DAEC-
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one patient, Shigella flexneri and DAEC-one patient, DAEC and EAEC-one patient, DAEC and 
EaggEC-one patient). Of the 66 stool samples that were cultured on CHROMagarTMSTEC, the 
formation of mauve colonies was observed for thirteen of the samples (20%). All the mauve 
colonies were confirmed to be E. coli. Of these 13, eight were DAEC, two were EAggEC, one was 
STEC, one was EPEC, and one was EIEC. The single STEC isolate from stool belonged to serotype 
O106. Of the eight DAEC isolates, six were non-typeable while two belonged to serotype O153. 
Of the two EAggEC, one was non-typeable while one belonged to serotype O143. The single EPEC 
belonged to serotype O49, while the single EIEC was non-typeable. 
Of the 66 stool samples, 23 samples (35%) tested positive for the daaC gene, a virulence marker 
for DAEC (compared to the 8 samples (12%) from which tellurite resistant DAEC were isolated-
these 8 stool samples also tested positive for the daaC). Four stool samples (6%) possessed the ipa, 
a virulence marker for EIEC- but which can also be detected in Shigella (compared to only one 
sample from which tellurite resistant EIEC were isolated- this one sample also tested positive for 
the ipa). Five stool samples (8%) possessed the LT (see Figure 6:14), a virulence marker for ETEC 
(no tellurite resistant ETEC were isolated from any of the stool samples).  
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Figure 6:14 Electrophoresis gel image obtained after running a PCR to detect the LT gene (size 440bp). 
Lane 1 and 20 contains the 1kb ladder (GeneRuler™ DNA molecular weight ladder -ThermoFisher 
Scientific Inc., MA, USA). Lanes 2-38 contained samples except for lane 20 (contained the 1kb ladder), 
lane 32 which was the negative control and lane 34 which was the positive control. Samples in lanes 
21-28 were positive while the rest of the samples were negative.
Nine stool samples (14%) possessed aat (seeFigure 6:15), a virulence marker for EAggEC 
(compared to 2 samples from which tellurite resistant EAggEC were isolated- these two samples 
also tested positive for the aat). 
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Figure 6:15 Electrophoresis gel image for PCR product following multiplex PCR amplification for aat, ipa, and daaC. 
Lanes 1 and 17 contained the 1kb ladder (GeneRuler™ DNA molecular weight ladder -ThermoFisher 
Scientific Inc., MA, USA). Lanes 2-32 contained samples except for lanes 14 (positive control for aat),18 
(positive control for ipa), 19 (negative control), 32 (positive control for daaC). Samples in lanes 9, 10, 13, 
21, 22, 23, 24, 25, 26, and 29 were positive for daaC. The sample in lane 30 was positive for ipa. The rest 
of the samples were negative for aat, ipa, and daaC. 
The wbdl gene (for E. coli serotype O111) and the rfbE gene (for E. coli serotype O157: H7) were 
detected in a single specimen each (none of the tellurite resistant diarrheic E. coli isolated from 
stool belonged to serotype O111 or serotype O157).  
Upon screening TSB from clinical samples for stx genes, stx1 and stx2 were detected in 4 (6%) and 
2 (3%) specimens respectively (compared to one sample from which a tellurite resistant STEC 
carrying stx1 was isolated – no stx2 carrying tellurite resistant STEC was isolated; the one sample 
from which STEC was isolated also tested positive for stx1).  
Overall, a bacterial pathogen was isolated, or a DEC virulence marker gene detected in 48 (73%, 
48/66) stool samples. For all the pathotypes, more of the virulence marker genes were detected in 
TSB enrichment of stool as compared to the actual number of diarrheic E. coli pathotypes isolated 
on CHROMagarTMSTEC. This could be explained by the fact that not all diarrheic E. coli are 
tellurite resistant and so would not form colonies on CHROMagarTMSTEC. 
208 
6.4.2.1.2 Bacterial pathogens and diarrheic E. coli virulence genes in meat  
Of the 85 meat samples, mauve colony formation on CHROMagarTMSTEC was noted for 32 (38%). 
From the 32 samples, 32 mauve colonies were picked all of which were identified to be E. coli. 
Only three of the 32 E. coli possessed virulence genes. Of these three, two possessed the daaC 
genes (DAEC) while one possessed the eae gene (EPEC). None of the mauve colonies had stx 
genes. The two DAEC and one EPEC were non-typeable. 
Following screening of the 85 TSB enrichments of meat samples using real-time and gel-based 
PCR, stx1 (20%, 17/85), stx2 (5%, 4/85), eae (7%, 6/85), aat (1%, 1/85), daaC (7%, 6/85), rfbE (6%, 5/85), 
and lt (1%, 1/85) were detected. Comparatively, no tellurite resistant STEC was isolated from any 
of the meat samples while one tellurite resistant EPEC (the meat sample from which the EPEC 
strain was isolated also tested positive for eae), and two tellurite - resistant DAEC (the two meat 
samples from which the DAEC were isolated also tested positive for the daaC) were isolated from 
the meat samples. The most commonly detected virulence gene in all the meat samples was the 
stx1 genes. These were detected in 17 (20%) of the meat samples (see Table 6:7). 
For all sample types, more of the virulence marker genes were detected in TSB enrichments as 
compared to the actual number of diarrheic E. coli pathotypes isolated. 
In addition, the following bacterial pathogens were isolated: Salmonella enterica Idikan (5%, 4/85), 
Plesiomonas shigelloides (1%, 1/85), Aeromonas sorbria (3%, 3/85), Campylobacter jejuni jejuni (7%, 
6/85), EPEC (1%, 1/85) and DAEC (2%, 2/85).  
6.4.2.1.2.1 Foodborne bacterial pathogens and DEC virulence gene detection rates per meat type 
Raw meats: Mainly the raw beef cuts possessed the stx1 genes (53% of the beef cuts, n=17) while 
14% (3/22) of the raw pork samples possessed the stx1 genes (see Table 6:7). The rfbE gene, which 
signifies the presence of E. coli O157, was detected only in the raw meats including beef cuts, 
mutton, pork, and chicken. Only one of the raw pork samples possessed the aat genes. 
Ready-to-eat meats: Among the ready to eat meats, 12% (3/26) of the roast beef possessed stx1 
while 13% (1/8) and 13% (1/8) of the roast pork samples possessed the stx1 and stx2 genes 
respectively. The daaC genes were detected only in the roast beef. Of all the ready-to-eat meats, 
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the LT gene was detected in only one pork sample while the ipa gene was not detected in any 
meat sample.  
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Table 6:7 Distribution of DEC virulence genes and bacterial pathogens in the different meat types from the informal trade in Nyanga. 
Number of samples with virulence gene/ bacterial pathogen (%) 
Food type (n) Category stx1 stx2 eaeA aat daaC RfbE LT Salmonella Campylobacter Plesiomonas Aeromonas DEC 
Beef cuts (17) Raw 9 (53) 1 (6) 2 (12) - 3 (18) 1 (6) - 1 (6) - 1 (6) 2 (12) 2 (12) 
Mutton (9) Raw 1 (11) - - - - 1 (11) - 1 (11) - 1 (11) - 
Pork (22) Raw 3 (14) 2 (9) 3 (14) 1 (5) - 1 (5) 1 (5) - - - 1 (5) 
Chicken (11) Raw - - - - - 2 (18) - 3 (27) 5 (45) - - - 
Roast beef (26) Processed 3 (12) - 1 (4) - 3 (12) - - - - - - 
Roast pork (8) Processed 1 (13) 1 (13) - - - - - - - - - 
Roast chicken 
(3) 
Processed - - - - - - - - - - - 
Total 17 4 6 1 6 5 1 4 6 1 3 3 
DEC= Diarrheic E. coli, rfbE=putative perosamine synthetase gene, daaC= fimbrial adhesion gene, LT=gene for the heat-labile toxin of ETEC, aat= an anti-
aggregation protein transporter gene, stx=Shiga toxin gene, eae= intimin encoding gene.” – “means that the gene was not detected or the pathogen was not 
isolated. 
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6.4.2.1.3 Bacterial pathogens and DEC virulence genes detected in TSB enrichments of Lotus 
River surface water 
From the 64 water samples, 16 formed mauve colonies (all the 16 were identified as E. coli) on 
CHROMagarTMSTEC. Of the 16 E. coli, only four isolates had virulence genes. Overall, from the 
64 surface water samples, the following bacterial pathogens were isolated: STEC (2%), DAEC 
(3%), EPEC (2%), EaggEC (2%), Shigella flexneri (5%), Plesiomonas shigelloides (17%), Aeromonas 
sorbria (6%), and Vibrio vulnificus (9%). The proportion of all bacterial pathogens from the Lotus 
River was highest at collection point LR13 (p<0.001), and lowest at collection point LR16. 
Aeromonas sorbria was isolated from point LR15 and LR16 only while Vibrio vulnificus and Shigella 
flexneri were isolated from all points except LR16. Plesiomonas shigelloides was isolated from all the 
water collection points (Table 6:8).  
Table 6:8 Diarrhoeal Pathogens isolated from the water collection points along the Lotus River. 
Site Diarrhoeal pathogens detected 
STEC Salmonella EPEC EAggEC Aeromonas DAEC Vibrio 
spp. 
Shigella Plesiomonas Total 
LR13 1 ND ND 1 ND 1 4 1 2 10 
LR14 ND ND ND ND ND ND 1 1 4 6 
LR15 ND ND ND ND 3 ND 1 1 4 9 
LR16 ND ND ND ND 1 1 ND ND 1 3 
Total 1 - - 1 4 2 6 3 11 28 
ND= not detected, LR13, LR14, LR15, and LR16 are surface water collection points along the Lotus River. 
Stx1 genes were detected in 30% (19/64) of the water samples (compared to only one STEC isolated 
from the water samples- the one sample from which the single STEC was isolated also tested 
positive for stx1) (Figure 6:16).  
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Figure 6:16 Amplification curves following Real-time PCR for stx1. 
Curves 1-9 represent test samples. The curve labelled + represents the positive control while the curve 
labelled – represents the negative control. Water samples represented by curves 1-6 were considered 
positive while samples represented by curves 7-9 were considered negative. 
The rfbE gene for STEC O157 and the wbdl gene for STEC O111 were detected in 14% (9/64) and 
8% (5/64) of the water samples respectively (none of the diarrheic E. coli isolated from the Lotus 
River surface water was E. coli serotype O157 or E. coli serotype O111). 
The eaeA gene was detected in 14% (9/64) of the surface water samples (No EPEC was isolated 
from any of the Lotus River surface water samples). The most commonly detected gene in the 
surface water samples was the daaC which was detected in 38% (24/64) of the surface water 
samples (compared to the two tellurite-resistant DAEC that were isolated from the Lotus River 
surface water. These two DAEC were positive for the daaC). The LT and ipa were detected in 33% 
(21/64) and 8% (5/64) of the surface water samples respectively (no ETEC or EIEC were isolated 
from any of the surface water samples). The prevalence of stx1 genes was highest at site LR13 
compared to other sites along the Lotus River (p =0.020) (Table 6:9). For all the pathotypes, more 
of the virulence marker genes were directly detected from TSB-enriched surface water as 
compared to the actual number of diarrheic E. coli pathotypes isolated on CHROMagarTMSTEC. 
This could be explained, in part, by the fact that not all diarrheic E. coli are tellurite resistant and 
so will not grow on CHROMagarTMSTEC or the presence of non-viable bacteria in the water. 
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Table 6:9 Number of E. coli virulence genes at water collection points along the Lotus River. 
Site Number of E. coli virulence genes (n=64) 
IpaH eaeA stx1 rfbE wbdl daaC LT 
LR13 0 6 8 3 2 5 6 
LR14 2 3 3 3 1 7 5 
LR15 2 0 1 1 1 4 3 
LR16 1 0 7 2 1 8 9 
Total 5 9 19 9 5 24 21 
rfbE=putative perosamine synthetase gene, daaC= fimbrial adhesion gene, LT=gene for the heat-labile 
toxin of ETEC, aat= an anti-aggregation protein transporter gene, stx=Shiga toxin gene, eae= intimin 
encoding gene, wbdl = O111 antigen gene. 
6.4.2.2 Lotus River surface water faecal coliform counts per millilitre of surface water 
Overall, the water collection point LR16 had the highest mean coliform CFU/ml of surface water 
while LR13 had the lowest (see Table 6:10). There was no significant difference in the mean 
CFU/ml for the different collection points (p=0.5908). The month of February 2016 had the highest 
CFU/ml as compared to the other months (p= < 0.001) while March 2016 had the lowest mean 
CFU/ml. 
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Table 6:10 Faecal coliform counts (CFU/ml) for water collection points LR13, LR14, LR15, and LR16. 











































































































































































Std.Dev.= Standard deviation 
6.4.3 Antimicrobial susceptibility of STEC, and other bacterial foodborne pathogens 
from stool, water, and meat from the informal abattoirs in Nyanga 
6.4.3.1 Antimicrobial susceptibility patterns of STEC and other diarrheic E. coli from the stool, water, 
and meat. 
Diarrheic E. coli from the environment (Lotus River surface water and meat from informal 
abattoirs) and children with diarrhoea may be considered both as major foodborne pathogens 
and sentinel organisms (an indicator organism used for monitoring antimicrobial resistance in 
faecal bacteria because they are ubiquitous in a wide range of hosts, acquire resistance easily, and 
are reliable indicators of resistance in other foodborne pathogens).47 We isolated 3, 13 and 4 DECs 
from meat, stool, and water respectively. Overall, amongst these 20 isolates, there was resistance 
to the following antibiotics: ampicillin (8/20, 40%), amoxicillin-clavulanate (3/20, 15%), cefoxitin 
(2/20, 10%), cefuroxime (2/20, 10%), cefotaxime (2/20, 10%), cefepime (1/20, 5%), ciprofloxacin 
(1/20, 5%), trimethoprim-sulfamethoxazole (20/20, 100%), and nitrofurantoin (1/20, 5%). 
Two isolates were ESBL-producing (resistant to cefotaxime and confirmed using the ESB1F 
sensititre plate). 
Only three isolates were multi-drug resistant and were isolated from meat (one isolate) and stool 
(two isolates). 
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Of the two STEC isolated, the isolate from water was susceptible to all the antimicrobials tested 
except SXT while the other, from a child, was resistant to AMP and SXT. 
There was no significant difference between resistance rates of diarrheic E. coli from children with 
diarrhoea and those isolated from the environment (seeTable 6:11). 
Table 6:11 Differences in the rates of resistance to selected antibiotics for isolates from human (stool from children), 
and non-human sources (water and meat) sources in Nyanga. 
Percentage resistant to antibiotic per source (Child, N=13, Environment, N=7) 
Antibiotic Children n (%) Environment n (%) p-value
AMP 5, (38) 3 (43) 0.84 
AMC 2, (15) 2 (29) 0.45 
FOX 2 (15) - (0) 0.28 
CXM 2 (15) 1 (14) 0.95 
CXA 2 (15) 1 (14) 0.95 
CTX 2 (15) -(0) 0.28 
FEP 1 (8) - (0) 0.44 
NIT 1 (8) - (0) 0.44 
CIP - (0) 1 (14) 0.17 
Notably, resistance to ciprofloxacin was only noted for one environmental isolate. AMP=ampicillin, 
AMC=amoxicillin-clavulanate, FOX=cefoxitin, CXM=cefuroxime, CXA=cefuroxime-axetil, 
CTX=cefotaxime, FEP=cefepime, NIT=nitrofurantoin, CIP=ciprofloxacin. 
6.4.3.2 Antimicrobial susceptibility patterns of the Shigella, Salmonella, Aeromonas, Plesiomonas 
shigelloides, Campylobacter, and Vibrio from the stool, meat and Lotus River surface water in 
Nyanga. 
Shigella: Shigella showed resistance to ampicillin (67%, 10/15), amoxicillin-clavulanate (67%, 
10/15), cefuroxime (47%, 7/15), cefuroxime axetil (47%, 7/15), cefoxitin (53%, 8/15), amikacin (47%, 
7/15), and gentamicin (47%, 7/15). (see Table 6:12). 
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Table 6:12 Resistance profiles of Shigella spp. from meat, water, and stool in Nyanga (N=15). 
Resistance profile Number of isolates Percentage of Isolates 
FOX 1 7 
AMP AMC 3 21 
CXM CXA FOX 2 14 
AMP AMC FOX 1 7 
AMP AMC CXA 2 14 
AMP AMC CXM FOX 1 7 
AMP AMC CXM CXA FOX 3 21 
FOX-cefoxitin, AMP-ampicillin, AMC-amoxicillin clavulanate, CXM-cefuroxime, CXA-cefuroxime-
axetil. 
The antibiotic susceptibility patterns for Salmonella enterica, Aeromonas sorbria, Plesiomonas 
shigelloides, Vibrio vulnificus, and Campylobacter jejuni from the different sources are as shown in 
the table below (Table 6:13).  
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Table 6:13 Percentage Resistant per specimen type for Salmonella, Shigella, Plesiomonas, Vibrio, and Aeromonas. 1 
Salmonella n (%R) Shigella n (%R) Plesiomonas n (%R) Aeromonas n (%R) Vibrio n 
(%R) 
Antibiotic Meat (n=4) Stool (n=4) Water (n=4) Stool (n=11) Water (n=11) Stool (n=6) Meat (n=2) Stool (n=1) Water (n=6) 
AMP - - 3 (75) 7 (64) 11 (100) 6 (100) 2 (100) 1 (100) - 
AMC - - 3 (75) 7 (64) - - - - - 
CXM NT NT - 6 (55) - - - - - 
CXA NT - 1 (25) 6 (55) - - - - - 
FOX 4 (100) 1 (25) - 8 (73) 2 (18) - - - 6 (100) 
CAZ - - - - - 1 (17) - - - 
ETP - - - - - - 1 (50) 1 (100) 6 (100) 
AMK NT - - 7 (64) - - - - 1 (17) 
GEN NT NT - 7 (64) 2 (18) - - - - 
CIP 4 (100) 4 (100) - - - - - - - 
TGC - - - - - - -- 1 (100) - 
SXT 3 (75) 4 (100) 4 (100) 11 (100) 11 (100) 6 (100) 2 (100) 1 (100) 6 (100) 
*NT= Not Tested for.  Campylobacter from water, stool, and the meat were all susceptible to ciprofloxacin and thus not included in this table.
Salmonella not tested against amikacin, gentamicin, cefuroxime and cefuroxime axetil as they are inactive against the agent in-vivo. Expert
interpretation rules embedded in the WHONET software were used to classify as resistant or susceptible. The CLSI clinical guidelines and
breakpoints were used to analyse the data sets. AMP=ampicillin, AMC=amoxicillin-clavulanate, CXM=cefuroxime, CXA=cefuroxime axetil,




The key findings of this study were; (1) the patients that presented with diarrhoea at the Nyanga 
Community Health Centre were less than two years old and presented with an acute form of 
diarrhoea, (2) for a high number of patients (73% - 48/66), we detected at least one bacterial 
pathogen in stool- the most prevalent bacterial pathogen being Shigella, (3) the number of 
diarrheic E. coli virulence genes detected in the TSB enrichments was higher than the actual 
number of diarrheic E. coli isolated from human stool, Lotus River surface water, and meat from 
the informal abattoirs, (4) meat from the informal abattoirs and surface water from the Lotus 
River carried bacterial pathogens that could cause diarrhoea, (5) surface water from the Lotus 
River surface water possessed a high number of faecal coliforms indicating faecal contamination., 
(6) there was no significant difference in the prevalence of resistance to selected antibiotics among
human and environmental diarrheic E. coli isolated in Nyanga. 
Globally, in 2010, 22 foodborne diseases resulted in two billion diarrhoea cases and 25.2 million 
DALYs (Disability Adjusted Life Years) in children. Of the 22 foodborne diseases, sixteen were 
bacterial and included the following; heat-stable toxin producing enterotoxigenic E. coli (ST-
ETEC), STEC, Campylobacter, Shigella, Salmonella, and typical enteropathogenic E. coli among 
others.48 In the Global Enteric Multi-centre Study (GEMS), a longitudinal study, EPEC and ST-
ETEC were significantly associated with an increased risk of death in children less than one year 
of age with moderate-severe-diarrhoea as compared to age-matched controls, in sub-Saharan 
Africa.2 These pathogens occur at different rates in different regions, and therefore public health 
interventions should be based on locally generated data.49 Therefore, this study focused on 
determining the prevalence of STEC and other selected food and waterborne bacterial pathogens 
in human and non-human sources in an informal settlement setting- Nyanga Township, Cape 
Town.  Furthermore, this study aimed to determine the clinical and epidemiological 
characteristics of children under the age of 12 years with diarrhoea that attended the Nyanga 
Community Health Centre (NCHC) The faecal coliform counts per millilitre of Lotus River 
surface water were determined as indicators of faecal contamination. 
Food and Waterborne bacterial pathogens in stool of children with diarrhoea 
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In this study, we detected one or more diarrhoeal pathogens in 73% (48/66) of the diarrhoea cases. 
This is lower than the 83% reported by the GEMS study.2 This can be explained by the fact that 
we focused on only the bacterial pathogens while the GEMS study considered the bacterial, viral 
and parasitic causes of diarrhoea. Importantly, carriage of the pathogens or their virulence genes 
does not necessarily infer their role in causation50,51. Normal carriage of most bacterial diarrhoea 
pathogens has been well documented in the previous research.2 
Among the four key pathogens highlighted in the GEMS study as being significantly abundant 
in children with moderate-to-severe diarrhoea as compared to age-matched controls (the highest 
number of attributable cases of moderate-to-severe diarrhoea were due to these four pathogens) 
at all the study sites in sub-Saharan Africa and Asia (Shigella, Cryptosporidium, Rotavirus, and 
heat stable toxin producing enterotoxigenic Escherichia coli), we investigated only for Shigella and 
tellurite-resistant ETEC. Tellurite-susceptible ETEC was not investigated because they could not 
be isolated on CHROMagarTMSTEC-given that the main focus of this study was tellurite resistant 
STEC. Other pathogens like Aeromonas and Campylobacter jejuni were significant (had more 
attributable cases of moderate-to-severe diarrhoea) at some sites (for example in Bangladesh) but 
not in the other sites. Aeromonas and Campylobacter were also investigated in this study. 
Temporal distribution of the diarrhoea cases 
The peak of the summer (dry) season is February or March each year.52 At around this time, the 
City of Cape Town reports the highest diarrhoea related mortalities every year.52 In this study, a 
bimodal distribution of cases was noticed with high numbers reported in November 2015 and 
February 2016 (In the same months, we noted the highest concentration of faecal coliforms in the 
Lotus River surface water). Several other studies have already reported the association between 
summer months and a high number of diarrhoea cases. For instance, in the Western Cape, 
research has shown that the peak in diarrhoea cases admitted to the Red Cross War Memorial 
Children’s Hospital’s Rehydration Unit, has shifted (in tandem with the peak of the dry season) 
from January (1976) to March (2015) over a period of four (1976-2015) decades.52  
Clinical characteristics of cases 
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The average duration of diarrhoea in all patients was 2.5 days. Per the World Health Organization 
(WHO) scheme on the classification of diarrhoea53, the commonly reported form of diarrhoea in 
the Nyanga community was acute diarrhoea, which was observed to affect children under the 
age of five mainly.  
The most common symptom among children with diarrhoea was weakness and dehydration 
(moderate) (30/66, 46%), and was noted among patients infected with DECs, Plesiomonas 
shigelloides, and Shigella flexneri. Some of the patients that possessed Shigella flexneri and 
Plesiomonas shigelloides in the stool, also presented with a fever (>38 ̊C). Where as infections with 
Shigella flexneri and EIEC have commonly been associated with fever, Plesiomonas shigelloides 
infections have rarely been associated with development of fever.53 
Of all the cases, 5% (3/66), 20% (13/66), and 17% (11/33) presented with bloody stool, vomiting, 
and fever respectively. Blood in stool was noted among the patients that had STEC, DECs, and 
Aeromonas infections. In the absence of screening for other possible causes of blood in stool such 
as Entamoeba histolytica, it cannot be assumed that dysentery was related to the pathogens 
detected in the stool sample. It would be expected that blood in stool be observed for stool 
samples from which Shigella flexneri was isolated, which was not the case in this study. However, 
recent research has shown that Shigella infection is increasingly associated with watery diarrhoea 
as opposed to dysentery and that many cases of Shigella would be untreated if only stool samples 
with blood are screened.2,3 
On the other hand, all the patients that possessed Salmonella enterica (non-typeable) in stool 
presented with a fever. Invasive non-typhoidal salmonellosis has previously been shown to be 
on the increase in sub-Saharan Africa.54  
Antibiotic use was significantly higher among patients with fever compared to those without 
(p=0.024). Therefore, antibiotic prescription appears to have been appropriate in this study 
population.  
Epidemiological characteristics of diarrhoea cases that attended the Nyanga Community Health 
Centre 
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Unlike the GEMS study, we did not have controls and thus could not conduct a risk factor 
analysis. The inclusion of a control group would have enabled us to conduct a risk factor analysis 
comparing the cases and the controls.  
The average age of the children recruited in this study was 14.9±10.9 months. In agreement with 
earlier studies, children under five years of age are more vulnerable to diarrhoeal disease. 55,56 The 
mean age in this study is similar to that described in the GEMS study (16.9 months in the 11-23-
month old age strata). 39 
The male: female ratio was 1:0.83. There was no significant difference in the occurrence of the 
different bacterial pathogens between the sexes. 
Only 83% (55/66) of the children recruited in the study visited the clinic due to diarrhoeal sickness, 
8% (5/66) had visited for immunisation, while 9% (6/66) had visited for a routine health check. 
This means that in approximately 17% (11/66) of the diarrhoeal patient's diarrhoea was 
incidentally identified. This may be an indicator of the health care-seeking behaviour of patients 
with diarrhoea in Nyanga. In the Gambian site of GEMS, it was reported that only 49% of the 
diarrhoea patients visited a health care setting.57  
Of the recruited patients, none kept domestic ruminants at home such as goats, sheep or cattle. 
The ruminants are the common reservoirs of STEC infection58. Instead, dogs were the most 
common household animals (17%-11/66).  
Of the recruited patients, mothers were the primary caregivers in 85% (56/66) of the patients, and 
24% (16/66) of the children were still breastfeeding. Breastfeeding confers protection against 
diarrhoeal disease as protective antibodies are passed on to the child via breast milk.59  
Only 39% (26/66) stated they had received rotavirus vaccination (likely to have been under-
reported-medical records were not available for some of the patients). Rotavirus has been 
reported as an important cause of acute gastro-enteritis in children.60 In the GEMS, it was 
confirmed that rotavirus was the most common cause of moderate to severe diarrhoea during the 
first year of life and therefore that immunisation against rotavirus would substantially reduce the 
burden of moderate-to-severe diarrhoea. It will be important to determine the ongoing 
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contribution of rotavirus to the burden of acute diarrhoea in this setting, post implementation of 
routine rotavirus immunisation.  
Most the diarrhoea patients in this study (79% - 52/66) used the communal standpipe as the 
primary source of water for daily use. In Nyanga, 93% of the population uses the regional water 
scheme where water is provided via community water standpipes and in-house piped water, 
while 2% use the services of a water vendor.61 In informal settlements, like Nyanga, there have 
been reports of illegal connections to the municipal water supply network. Such connections are 
possible avenues for contamination of communal standpipe water. Lack of access to clean water 
is linked to high incidences of diarrhoeal disease.62 According to the City of Cape Town Water 
and Sanitation Department, the communal standpipe nozzles in the informal settlements like 
Nyanga often are contaminated.38 The GEMS study reports a lack of access to clean water as a key 
risk factor for diarrhoea in such settings.2  
Prevalence of STEC, DECs, and DEC virulence genes in stool, water and meat 
We found a 2% (1/66, 1/64) prevalence of tellurite resistant STEC isolates in both stool and water; 
no STEC was isolated from meat. Compared to the prevalence of stx in the stool (6%-4/66 for stx1 
and 3%-2/66 for stx2), water (30%-19/64 for stx1 and no stx2), and meat (20%-17/85 for stx1 and 5%-
4/85 for stx2), the STEC isolation rate was very low. This could be because not all STEC are tellurite 
resistant and as such did not grow on CHROMagarTMSTEC. Alternatively, the stx genes detected 
could represent non-viable STEC or free floating phages. A similar study conducted in Amathole 
district, South Africa, on meat and meat products found a 3% prevalence of STEC.63 The STEC 
isolate from stool belonged to serotype O106, while that from the Lotus River surface water was 
non-typeable. STEC O106 has not previously been reported in South Africa. 
The 30% (19/64) prevalence of stx1 genes in Lotus River water was higher than the 15% previously 
detected in the Berg River system.36 There was a significant difference in the levels of detection of 
the stx1 genes between the different collection points located along this river (p =0.02) with LR13 
(13%) and LR16 (11%) having the highest stx1 detection rates. Surprisingly, LR13 had the lowest 
mean CFU/ml of coliforms and yet had a high stx1 detection rate. This is in agreement with 
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previous research which showed the absence of correlation between levels of microbial indicators 
(coliform counts per millilitre of surface water) and the carriage of stx genes.64 This could also 
point towards possible different water use trends at the different points along the Lotus River, 
differences in the rate of flow of the river at the various points, and the level and type of 
contamination of the water runoff joining the river at these points.  
The high number of stx1 genes compared to stx2 genes in the environmental samples could mean 
that there is a lesser risk of severe STEC disease associated with the non-human samples. This is 
because strains carrying stx2 alone or with stx1, have been more commonly associated with the 
development of HUS in human patients.65 Therefore, the detection of stx2 genes in meat (beef and 
pork) from the informal slaughter setting could mean that meat is a possible source of STEC 
capable of causing the more severe form of STEC infection.  
Serotype-specific marker genes (rfbE for E. coli O157 and wbdl for E. coli O111) were detected more 
in Lotus River surface water as compared to meat from the informal abattoirs and stool from 
children with diarrhoea. There was an 8% (5/64) and 14% (9/64) prevalence of STEC O111 wbdl 
genes and STEC O157:H7 rfbE genes in the Lotus River surface water (none of the diarrheic E. coli 
from water belonged to serotype O157 or O111). The failure to isolate these serotypes could be 
explained by the fact that not all E. coli O157 or O111 are tellurite resistant and as such, they did 
not grow on CHROMagarTMSTEC. This highlights the Lotus River surface water as a potential 
reservoir of STEC O157:H7 and STEC O111 for human and animal transmission in Nyanga. This 
is of clinical and epidemiological significance because STEC O157 and STEC O111 are key 
serotypes associated with STEC infection.66  
The prevalence of DAEC isolated from stool, meat, and water was 12% (8/66), 2% (2/85), and 3% 
(2/64) respectively (compared to a prevalence of 35% (23/64), 7% (6/85), and 38% (24/64) of daaC 
genes in stool, meat, and surface water respectively). This difference can be explained by the fact 
that not all DAEC are tellurite resistant while others may be unviable. There was a higher 
prevalence of DAEC isolated from stool as compared to the environmental samples.  
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EAggEC was only isolated from stool (3%-2/66) and water (2%-1/64) respectively (compared to a 
14% -9/66 prevalence of aat genes in the stool, and none in water). No EAggEC was isolated from 
meat. There was generally a low prevalence of EAggEC in this setting.  
The prevalence of EPEC isolated from stool and meat was 2% (1/66) and 1% (1/85) respectively 
(compared to 0% and 7%- 6/85 of eae in stool and meat). No EPEC was isolated from the Lotus 
River surface water. EIEC was only isolated from a single stool sample (2% of all stool samples) 
and was not isolated from meat and water.  
We noted higher levels of the LT genes in the water (21/64 – 33%) as compared to stool (5/66 – 
8%). Water also possessed several other DEC virulence genes. This could be explained by the fact 
that the Lotus River is used as a drinking water source for various ruminants. Ruminant excreta 
get washed into the Lotus River surface water. The water would then act as a common source of 
contamination for human (if used for domestic chores and for recreational activity- slaughter of 
chicken was observed along the banks of this river), cattle (drink water from the Lotus River) and 
other domestic animals such as stray dogs (drink water from the Lotus River). Even though 
humans may not directly consume water from this river, contamination of hands of food handlers 
and carcases is a potential route of transmission. On this basis, the Lotus River can be considered 
a potential “environmental common” for both human and animal STEC infection. An 
environmental common is defined as an ecosystem from which humans and animals derive 
livelihood. 
Aeromonas, Shigella, Salmonella, Plesiomonas, and Campylobacter, in stool, water, and meat 
The most prevalent diarrhoeal pathogen among the children with diarrhoea was Shigella (17%, 
11/66), which was more common in stool as compared to meat (no Shigella) and water (5%, 3/64 
for Shigella). Since Shigella was significantly more abundant in human stool, it’s possible that stool 
is the likely source of contamination of the environment with Shigella. Invasive shigellosis has 
been reported to be more prevalent in children less than one year of age in South Africa, especially 
those that are HIV-positive.67 High prevalence of Shigella in stool can also be explained by 
secondary Shigella infections in households, nurseries and daycare centres.68,69 
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Salmonella enterica causes 93.8 million cases of gastro-enteritis and 155,000 deaths globally each 
year- of which 80.3 million cases are foodborne.70 Salmonella enterica (non-typeable) was detected 
in only 6% (4/66) of the stool samples and all the children that possessed Salmonella presented 
with a fever. The fevers in the patients that had Salmonella could be due to Salmonella undetected 
invasive infection.  
Salmonella enterica Idikan was not isolated from the Lotus River surface water but was isolated 
from 5% (4/85) of the meat samples. Salmonella enterica Idikan is less commonly associated with 
infectious disease but has previously been isolated from food producing animals, animal feeds, 
meat from abattoirs, water, and associated environments in South Africa at a prevalence of 6% 
(between 2012 and 2014).71 An earlier study in South Africa showed broiler chickens to be the 
environmental reservoirs of multi-drug resistant Salmonella.72 
Plesiomonas shigelloides was detected in 9% (6/66) of the stool samples, 17% (11/64) of the water 
samples, and was not detected in meat. Some of the patients that possessed Plesiomonas shigelloides 
presented with bloody diarrhoea. Previous research has associated bloody diarrhoea with 
Plesiomonas shigelloides infection.73 Several other reports have indicated its role in causing 
diarrhoea with varying severity.74-76 However, this pathogen is not routinely screened for in South 
Africa. 
Campylobacter jejuni was isolated from 5% (3/66) of the stool samples, and 7% (6/85) of the meat 
samples. Related studies in South Africa have reported a prevalence of 10% for Campylobacter in 
the stool of diarrhoea patients in the Venda region, Limpopo, South Africa.77 Campylobacter jejuni 
in South Africa is commonly isolated from poultry and is increasingly becoming resistant to 
antibiotics.78-80 In this study, it was not isolated from Lotus River surface water. 
Aeromonas sorbria was isolated from only 3% (2/66) of the stool samples and 4% (3/85) of the meat 
samples and was not isolated from the Lotus River surface water. Aeromonas has been reported 
to cause fatal invasive disease in West Africa.81 It was reported among diarrhoea patients in the 
Venda region of South Africa82 and has been isolated from treated wastewater effluents in 
Durban.83 
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Non-cholera Vibrio (Vibrio vulnificus) was only isolated from the Lotus River surface water and 
was not isolated from meat and stool. Non-cholera Vibrio has rarely been associated with 
diarrhoea in South Africa. 
Yersinia was not detected in any sample. There have only been a few reports of Yersinia in Cape 
Town, mostly before 1990.84,85 Yersinia enterocolitica has previously been reported in a food handler 
and a child with diarrhoea.86,87 
Faecal coliform contamination of the Lotus River 
In February 2016, the colony forming units of faecal coliforms per millilitre of Lotus River surface 
water peaked at all water collection points, and the water levels were visibly low. Coincidentally, 
in the same month, the number of diarrhoea cases reported at the Nyanga Community Health 
Center was highest. The mean CFU/ml over the study period was 1.11E+06 -2.74E+05. As per the 
Department of Water and Forestry of South Africa regulations for microbial quality of 
recreational surface water (it should not have more than 1000 CFU/ml), the water in the Lotus 
River is not fit for drinking or recreational use. The highest mean CFU/ml for the Lotus River was 
observed for collection point LR16, and the lowest was noted for LR13. However, most of the 
bacterial pathogens were isolated from sampling point LR13. It is not clear as to the use habits of 
the Lotus River surface water at these two points. However, LR13 is located upstream of LR16, 
and it appears that LR13 is situated close to a dense concentration of semi-permanent shelters. 
Since point LR16 is located downstream of LR13, there could be a higher concentration (due to a 
reduced flow rate of surface water) of faecal coliforms downstream. 
Eventually, storm water in this channel ends in the urban sewerage treatment system. 
Contamination of storm water, therefore, leads to highly contaminated sewage and waste water 
which becomes difficult to treat and recycle by the urban sewage treatment systems and thus 
affecting the water quality of the urban aquatic system. 
Bacterial pathogens per meat type 
Among the raw meats, Salmonella was isolated from beef, chicken, and mutton, while 
Campylobacter was isolated from chicken and mutton. DAEC was isolated from beef and mutton. 
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As per the Food Safety Inspection Services of USDA, 25g of raw meat should not possess 
detectable levels of foodborne pathogens such as Salmonella and Campylobacter. This means that 
raw meat from the informal slaughter setting is unsafe for human consumption. A similar study 
conducted in the Eastern Cape found only Aeromonas and not Salmonella or E. coli.88 
Raw beef and pork samples mainly possessed the stx1 gene (53% - 9/17 of the beef cuts and 14% - 
2/22 of the raw pork samples). The rfbE gene which signifies the presence of E. coli O157 was 
detected only in the raw meats including beef cuts, mutton, pork, and chicken. Stx1 was more 
prevalent among the different meat types as compared to stx2. Notably, stx2 has been associated 
with the more severe disease. Thus, there may be less risk of severe STEC disease linked to meat 
from the informal abattoirs. 
Among the ready to eat foods, 12% (3/26) of the roast beef possessed stx1 while 13% (1/8) and 13% 
(1/8) of the roast pork samples possessed the stx1 and stx2 genes respectively. The genes detected 
could represent dead bacteria, free floating phages, or viable organisms. If they represent viable 
organisms, this could mean that there is a risk of STEC infection associated with consumption of 
ready to eat foods vended in the informal abattoirs.  
As per the South Africa Bureau of Standards (SABS) and the regulations governing the 
microbiological standards for foodstuffs in South Africa, section 15 (1) of the Foodstuffs, 
Cosmetics and Disinfectants Act, 1972 (Act No. 54 of 1972), 25g of ready to eat meat should not 
contain organisms of the genera Salmonella, Shigella, and E. coli. 
Antimicrobial resistance patterns of STEC and other diarrheic E. coli isolated from clinical and 
environmental samples. 
STEC isolated in this study showed resistance to only ampicillin. Antibiotics are generally 
contraindicated incase of STEC infections because of the elevated risk of fatal complications such 
as Haemolytic Uraemic Syndrome.89 Antibiotic resistance, however, is easily transferred among 
the gram-negative bacteria in the intestinal tract. 
The multidrug resistant diarrheic E. coli from the chicken was resistant to ampicillin, 
ciprofloxacin, amoxicillin-clavulanate, cefotaxime, cefuroxime-axetil, and trimethoprim-
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sulphamethoxazole. Antimicrobial resistance among zoonotic pathogens is of clinical 
significance. Importantly, ciprofloxacin is an important antibiotic used in the treatment of 
invasive E.coli infection.  
There was no significant difference in the levels of resistance for isolates from human and non-
human sources. The single isolate that was ciprofloxacin resistant was isolated from chicken. 
However, further investigations would help ascertain the use of quinolone antibiotics in poultry 
traded in the informal abattoirs. 
The two ESBL-producing E. coli isolates reported in this study were both isolated from the stool 
of children. No ESBL producing strain was isolated from water or meat. In this study, we did not 
evaluate the antibiotic use history of the cases. The ESBL-producing strain could have been 
acquired from another source. Alternatively, previously non-ESBL-producing E. coli strains 
acquiring the ESBL phenotype due to horizontal gene transfer or due to antibiotic selection 
pressure. 
Since some of diarrhoeagenic E. coli might have been missed (tellurite-susceptible diarrhoeagenic 
E. coli), the actual incidence of antimicrobial resistance for human and non-human sources might
have been underreported. An adjunct approach including screening for the presence of 
antimicrobial resistance genes (for instance, the ESBL genes) in human and non-human sources 
would provide a better understanding of antimicrobial resistance in this setting. 
Antimicrobial susceptibility patterns of Aeromonas, Shigella, Salmonella, Plesiomonas, 
Campylobacter, and Vibrio from human and non-human sources.  
Given the high prevalence of Shigellosis among the children with diarrhoea in Nyanga, we noted 
with concern the resistance to multiple antibiotics. Shigella showed resistance to ampicillin (67%, 
10/15), amoxicillin-clavulanate (67%,10/15), and trimethoprim-sulfamethoxazole (100%, 15/15). 
Notably, ampicillin and trimethoprim-sulfamethoxazole are the first line antibiotics used for the 
treatment of shigellosis.90 On this basis; there is a need for an alternative treatment strategy for 
Shigellosis in Nyanga. Also, 13 of the 15 Shigella isolates from all sources were resistant to at least 
one antibiotic. Specifically, resistance to cefoxitin, amikacin, and gentamicin for Shigella was only 
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seen among the human isolates and not the water isolates. A related study showed ESBL 
production by Shigella isolates screened between 2003 and 2009. 91All isolates from water and stool 
were resistant to SXT. The most common resistance profile ( in 21% -14/66 of the isolates) was 
AMP, AMC, CXM, CXA and FOX.  
Worryingly, we noted that all the Salmonella isolates from meat and stool were resistant to 
ciprofloxacin, a choice antibiotic for the treatment of invasive salmonellosis.  
Even though Aeromonas has not frequently been reported as a serious cause of diarrhoea in South 
Africa, with a few exceptions, we noted resistance to tigecycline in the one isolate obtained. 
Tigecycline resistance has rarely been reported in Aeromonas but was reported in a single isolate 
from a clinical sample in Taiwan.92  
6.5.1 Limitations of this study 
For us to be able to attribute bacterial pathogens to diarrhoea among the children presenting with 
diarrhoea at the NCHC, we would ideally have matched cases with controls (case-control study 
design). However, this was not done due to logistical and administrative reasons.  
We used TSB enrichment media mainly targeting STEC which is the primary focus of the study. 
However, this medium is not the most suited for other bacterial pathogens such as S. enterica.  
In this study, we only report on the tellurite resistant STEC but not the tellurite susceptible STEC 
which fail to grow on CHROMagarTMSTEC. 
6.6 Conclusions 
This study provides information on the epidemiology and characteristics of food and waterborne 
bacterial pathogens in children from Nyanga, Cape Town, who presented to primary care with 
diarrhoea, as well as from potential sources of infection in their physical environment.  
There were high detection rates for bacterial pathogens or DEC virulence genes in stool from 
patients attending the Nyanga Community Health Centre. There was a higher prevalence of stx1 
in both human and environmental samples as compared to stx2. 
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The Lotus River surface water was pathogen-rich (high prevalence of stx1 and ETEC) and highly 
contaminated with faecal coliforms (mean CFU/ml =1.11E+06 -2.74E+05). Therefore further 
research needs to be done to establish water use habits and activity along this river to prevent 
transmission of bacterial pathogens like STEC to users. 
The raw and ready-to-eat beef and pork meat types possessed high prevalence of stx1, and stx2 as 
compared to the other food types and therefore are a more likely source of STEC infection in 
Nyanga. The Codex Alimentarius public health guidelines for the hygiene of street vended meats 
in Africa (CAC/GL 22R-2013), for the control of Campylobacter and Salmonella in chicken (CAC/GL 
78-2011), for the control of non-typhoidal Salmonella in beef and pork (CAC/GL/87-2016), and for
the general control of food hygiene to control foodborne parasites (CAC/GL89-2016) need to be 
enforced to ensure consumer safety. The South African National Standards (SANS 885:200X) on 
processed meat should also be enforced in the informal abattoir setting in the Nyanga Township. 
This means that further measures need to be put in place to ensure the safety of meat from the 
informal slaughter in Nyanga, Cape Town, South Africa.  
These results suggest the need for a larger scale (over at least 12 months) age-matched case-
control study to better understand the role of these bacterial pathogens in the causation of 
diarrhoea in children in this (and similar) settings. Given the high rates of bacterial contamination 
of meat and water, a detailed study of risk factors for bacterial diarrhoea would be useful to 
determine the role of these potential sources of infection.  
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Chapter Seven 
7 Multi-Locus Variable Number of Tandem Repeats Analysis 
(MLVA) to determine genetic relatedness of STEC and other 
diarrheic E. coli from stool, meat from the informal abattoirs, 




Introduction: Multi Locus Variable number of Tandem repeats Analysis (MLVA) of STEC and 
other diarrheic E. coli is important for source tracing and outbreak identification. 
Objectives: To determine the MLVA profiles of diarrheic E. coli from Lotus River surface water, 
meat from the informal abattoirs, and stool of children with diarrhoea in Nyanga Township. 
Methods: MLVA typing of tellurite-resistant diarrheic E. coli from the stool of children with 
diarrhoea, meat from the informal abattoirs, and the Lotus River surface water was done. 
Conventional PCR using dye-labelled primers was done to amplify seven Variable Number 
Tandem Repeats Loci (VNTR). Capillary electrophoresis was done to determine the amplicon 
sizes per locus which were then used to determine the allele (number of tandem repeats per 
locus). A dendrogram was generated using the allelic string in BioNumérics version 7.6 software; 
isolates that showed 100% similarity of MLVA profiles were considered a clone. 
Results: The diarrheic E. coli from human and non-human sources in Nyanga were genotypically 
diverse and showed 19 distinct MLVA genotypes. The two DAEC isolates (NY60 and NY28) that 
were isolated from children with diarrhoea had identical MLVA genotypes and were assumed to 
be clonal. Overall, the dendrogram showed that tellurite resistant diarrheic E. coli from human 
and non-human sources were intermingled (genotypically close to strains from different sources). 
The two STEC (NY29 and 710) showed a 71.4% level of genotypic homology and belonged to 
different serotypes. The two extended-spectrum beta-lactamase (ESBL)-producing DAEC from 
stool belonged to the same serotype (O153) but had different MLVA genotypes.  
Conclusions: Diarrheic E. coli from human and non-human sources in Nyanga Township were 
genotypically diverse. Two DAEC isolates formed a clone and could have been transmitted 
between the children or acquired from the same source. Further larger scale studies are needed 
to fully understand the epidemiology of STEC and other diarrheic E. coli in the Nyanga Township. 
7.2 Introduction 
STEC is an environment-induced zoonosis which is emerging due to changes in livestock farming 
habits, food processing, and consumer food habits.1 It can be transmitted through different routes 
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including person to person, contaminated food, animal contact, and through contact with 
recreational water.2 To determine the likely sources (human and non-human) of STEC, isolates 
from the different sources must be genotyped to determine their genetic relatedness. In cases of 
an outbreak, this would assist with source tracing. In the absence of an outbreak, subtyping 
would help establish an epidemiological linkage between STEC isolates from different sources, 
identify previously unidentified outbreaks, and determine the dominant subtypes in the different 
human and non-human sources. Bacterial subtyping is also useful for monitoring the impact of 
product recalls in response to outbreaks.3 In many cases, MLVA is used in addition to other 
subtyping tools such as Pulse Field Gel Electrophoresis (PFGE) to increase discriminatory power 
between closely-related strains. MLVA is based on detection of varying numbers of tandem 
repeats at distinct variable-number tandem repeat loci along the bacterial genome.4 It has 
previously shown to be highly discriminatory and gives concordant results to Whole Genome 
Sequencing (WGS).5,6  
Conventional MLVA protocols require gel electrophoresis to determine the band sizes. Improved 
MLVA assay approaches involved the use of multiple dye colours (analysed by multi-coloured 
capillary electrophoresis) and enhanced PCR multiplexing targeting the various loci with the 
MLVA patterns based on allele sizes, thus eliminating the need to analyse band patterns on gel 
images.5-7 Several MLVA protocols have already been developed for all STEC serotypes including 
both O157 and non-O157 STEC strains,8,9 while others are only discriminatory and applicable 
among the O157 STEC.10 However, in non-outbreak scenarios (no single STEC strain is targeted), 
and due to the emerging trend of hybrid STEC strains, a more generic MLVA protocol targeting 
both the O157 and non-O157 STEC serotypes (plus other pathotypes in the case of hybrid strains) 
would be suited for public health investigations to establish epidemiological linkage between 
strains from different sources. It has been argued that the discriminatory power at serotype level 
is likely to be diminished if multiple serotypes are targeted.3 However, there are over 450 
serotypes of STEC with new serotypes continually being reported as STEC serotypes.11 The 
generic MLVA protocol that facilitates discrimination of both O157 and non-O157 STEC (plus 
other diarrheic E. coli pathotypes) was developed using the ECOR (Escherichia coli reference 
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collection) strains to target seven genomic Variable Number of Tandem Repeats (VNTR) loci and 
proved to be highly discriminatory for O157 and non-O157 STEC.5-7 As an improvement to this 
protocol, additional three loci were included to improve its discriminatory power.9 The extra 
three loci would particularly be useful when dealing with closely similar strains as would be the 
case in an outbreak situation. 
Despite the high burden of diarrhoea that is characteristic of informal settlements such as the 
Nyanga Township, the poor hygiene and sanitation standards in the informal settlements, and 
unhygienic slaughter practice in the informal abattoirs, there is no information on the 
epidemiological linkage (or MLVA genotypes) between STEC and other diarrheic E. coli from 
human and non-human sources.  
7.2.1 Aims and objectives 
 In this study, we aimed to determine the MLVA genotypes of tellurite-resistant STEC and other 




Meat, stool, and water were collected from informal abattoirs, children with diarrhoea, and the 
Lotus River in Nyanga (Figure 7:1). 
7.3.1 Meat ,stool, and water collection, processing, and microbiological analysis. 
The samples were processed and diarrheic E. coli isolated on CHROMagarTMSTEC. Confirmed E. 
coli were screened for eae, aggr, daaC, ipa, stx1, stx2, ST, and LT genes as described in 3.3.5. 
Serotyping was done to determine the O-antigens using specific antisera as described in 3.3.5. 
Antimicrobial susceptibility testing was done using the VITEK® 2 automated system with the 
minimum inhibitory concentrations (MIC) confirmed using the broth microdilution method as 
described in 4.3.3. 
Figure 7:1 Street map showing the location of Groote Schuur Hospital and the Nyanga community. 
In Nyanga, it shows the Location of the Lotus River, the Nyanga Community Health Centre and the 
Informal Settlements. The informal slaughter places are located within the informal settlement 
7.3.2 Selection of isolates for MLVA typing 
All the diarrheic E. coli isolated from the different sources were genotyped using the generic 
MLVA protocol. 
7.3.3 MLVA typing 
7.3.3.1 DNA template preparation for PCR 
DNA was extracted from the E. coli isolates using the MagNApure bacterial/fungal DNA 
extraction kit on a MagNApure LC machine. 
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7.3.3.2 Gel-based PCR amplification of VNTR gene targets 
The following dye labelled primers were used as previously described with a minor modification 
(Table 7.1). The NED dye was used instead of TET for suitability with the available 16-capillary 
fluorescence-based capillary electrophoresis system 3130xl Genetic Analyser (Applied 
Biosystems, Forster City, California, U.S.A).8 
Table 7.1 Primers and dye colours used to detect the seven loci. 
Primer /Probe Name Dye-Sequence (5'-3') Primer Tm 
CVN001-F HEX-AACCGGCTGGGGCGAATCC 57.6 ̊C 
CVN001-R GGCGGCGGTGTCAGCAAATC 57.9 ̊C 
CVN002-F NED-AACCGTTATGAARGRAAGTCCT 49.2 ̊C 
CVN002-R TCGCCCAGTAAGTATGAAATC 50.5 ̊C 
CVN003-F 6FAM-AAAAATCCGGATGAGWTGGTC 50.5 ̊C 
CVN003-R TTGCGTTGTCAGTAATTTGTTCAG 52.3 ̊C 
CVN004-F HEX-MGCTGCGGCRCTGAAGAAGA 53.8 ̊C 
CVN004-R CCGGCAGGCGAAGCATTGT 57.9 ̊C 
CVN007-F 6FAM-ACCGTGGCTCCAGYTGATTTC 54.4 ̊C 
CVN007-R ACCAGTGTTGCGCCCAGTGTC 58.3 ̊C 
CVN014-F 6FAM-TCCCCGCAATCAGCAAMACAAAGA 55.7 ̊C 
CVN014-R GCAGCRGGGACAACGGAAGC 57.9 ̊C 
CVN015-F NED-TAGGCATAGCGCACAGACAGATAA 55.7 ̊C 
CVN015-R GTACCGCCGAACTTCAACACTC 56.7 ̊C 
Subsequently, three gel-based PCR reactions targeting seven VNTR loci were done involving two 
multiplex PCR reactions and one singleplex PCR reaction.8 The multiplex PCR reactions were run 
with the QIAGEN PCR-multiplex kit (QIAGEN GmbH, Hilden, Germany). 10pmol each of 
CVN003 and CVN014 primers were included in one multiplex PCR reaction, while 10pmol each 
of CVN001, CVN004, CVN007 and CVN015 primers were included in the second multiplex PCR. 
CVN002 was run separately with 10pmol of each primer, 1 unit of Amplitaq polymerase (Applied 
Biosystems, Forster City, California, U.S.A), 200µM dNTP and 1x polymerase buffer (Applied 
Biosystems, Forster City, California, U.S.A). The multiplexes were run under the following 
conditions: 95 ̊C for 15 min, 94 ̊ C for 30 s, 63 ̊C for 90 s, 72 ̊C for 90 s, and 72 ̊ C for 10 min. The 
singleplex PCR reaction for CVN002 was run at 94 ̊ C for 5 min, 30 cycles of 94 ̊ C for 30 s, 50 ̊ C 
for 30 s and 72 ̊C for 50 s, and 72 ̊C for 7 min.  
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As a positive control, we considered an in-house strain (NY50) that possessed all the seven VNTR 
loci. PCR grade water was used as the negative control for the PCR. 
To confirm PCR amplification for each of the seven VNTR loci, and to estimate the amount of 
PCR product prior to pooling, gel electrophoresis was run at 80 volts for 45 minutes on a 1.5% 
agarose gel. A Bioline hyperladder IV was run as a DNA ladder marker.  
7.3.3.3 Dilution of PCR fragments by pooling PCR amplicons from the three PCR runs 
After the PCR amplifications, 20µl of the multiplex which had CVN003 and CVN014 amplicons, 
3.5µl of the multiplex which had CVN001, CVN004, CVN007, and CVN015 amplicons, and 10µl 
of the reaction which had CVN002 amplicon were pooled together to make a total volume of 
33.5µl. Water (66.5µl) was then added to make 100µl.  
7.3.3.4 Fragment Analysis using capillary electrophoresis 
Subsequently, 1µl of the mixture was added to 1µl of the ILS600 internal size standard (Promega, 
Madison, Wisconsin, USA) and 12µl of formamide (Promega, Madison, Wisconsin, USA) and 
loaded onto the 16-capillary fluorescence-based capillary electrophoresis system 3130xl Genetic 
Analyser (Applied Biosystems, Forster City, California, U.S.A). The electrophoresis was run at 60 
̊C for 35 min using POP4 polymer (Applied Biosystems) with an injection voltage of 15kV. 
7.3.3.5 Data analysis  
Analysis of isolate characteristics data 
Serotype, virulence genes, and Minimum Inhibitory concentration related data was analysed as 
described in 6.3.5. 
Raw data files from the Genetic Analyser were first analysed using GeneMapper® software 
Version 4.0 (Applied Biosystems, Forster City, U.S.A) to generate data on the peak sizes for each 
of the seven VNTR loci and to confirm amplification. Information on the dye used, sample name, 
and the size of the fragments was exported from the GeneMapper® software in tab-delimited 
format.  
The electropherogram files from the Genetic Analyser were directly imported as curves into 
BioNumerics version 7.6 software (Applied Maths, bioMérieux, N.V, U.S.A). Data on the 
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fingerprint dyes used for the different VNTR loci was acquired along with the importation of the 
ABI sequencer trace files to create a new fingerprint type. The raw chromatograms were 
normalised as per the reference system which was based on the marker peaks defined in the 
reference dye (ILS 600 internal size standard). All the VNTR peaks of interest were identified 
based on colour and size and each new multiple of repeats assigned to a distinct allele number 
using the MLVA plug-in in for BioNumerics v 7.6. The Internal Lane Standard 600 (Promega®, 
Madison, Wisconsin, USA) was used as a reference to assign sizes to DNA fragments separated 
by capillary electrophoresis. Using the sizes of the DNA fragments, the VNTR copy numbers or 
allele numbers were determined using an amplicon size - allele number conversion table 
previously described by Linstedt et al. 2007. A dendrogram was then constructed based on the 




7.4.1 Diarrheic E. coli from human and non-human sources and their characteristics 
Of the 20 diarrheic E. coli isolates, 13 were from the stool of children with diarrhoea who attended 
the Nyanga Community Health Centre while seven were from the non-human sources (3 from 
meat and 4 from surface water). The pathotypes detected included; EPEC (2/20, 10%), STEC (2/10, 
10%), DAEC (12/20, 60%), EIEC (1/20, 5%), and EAggEC (3/20, 15%). Fourteen isolates could not 
be serotyped using the antisera available (were non-typeable). The serotypes detected varied 
widely (Table 7.2). Of the 20 isolates, eight were resistant to at least one antibiotic while two 
isolates from stool were resistant to multiple antibiotics. 
Table 7.2 STEC and other diarrheic E. coli from human and non-human sources in Nyanga that were included in the 
MLVA analysis. 
Isolate Number Source Pathotype Serotype Resistance profile 
777 Mutton DAEC Non-Typeable AMP AMC CXM CXA 
LR16 Lotus River water DAEC O101 AMP 
NY29 Child STEC O106 AMP 
789 Beef EPEC Non-Typeable - 
NY3.2 Child DAEC Non-Typeable - 
NY1.2 Child DAEC O153 AMP AMC CXM CXA FOX 
CTX 
NY50 Child EPEC O49 - 
767 Lotus River water DAEC Non-Typeable AMP AMC TZP 
NY1.1 Child DAEC O153 AMP AMC CXM CXA FOX 
CTX 
NY13.1 Child EAggEC Non-Typeable - 
NY43 Child EAggEC O143 - 
NY58 Child DAEC Non-Typeable - 
710 Lotus River water STEC Non-Typeable - 
NY4 Child EIEC Non-Typeable - 
E101.1 Lotus River water EAggEC Non-Typeable - 
NY60 Child DAEC Non-Typeable AMP 
NY28 Child DAEC Non-Typeable AMP 
E33.1 Child DAEC Non-Typeable - 
E34.1 Child DAEC Non-Typeable - 
PK-STEC Pork DAEC Non-Typeable - 
The pathotypes included: diffusely adherent E. coli (DAEC), Enteroinvasive E. coli (EIEC), Shiga-toxin producing 
E. coli (STEC), and Enteroaggregative E. coli (EAggEC). Resistance profiles include the following antibiotics:
ampicillin (AMP), amoxicillin-clavulanate (AMC), cefuroxime (CXM), cefuroxime-axetil (CXA), cefoxitin (FOX), and
cefotaxime (CTX).
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7.4.2 Amplification of the different genomic VNTR loci genes. 
For each of the VNTR loci, the amount of amplicon was roughly assessed by gel-based PCR and 
gel electrophoresis on a randomly selected isolate (Figure 7:2). 
Figure 7:2 Electrophoresis Gel image for pooled PCR product for the two multiplex and one singleplex PCR for two 
randomly selected diarrheic E. coli isolates 
Lanes 1 and 2= reaction 1 showing amplification of the VNTR loci CVN002 (450bp) for isolate 1 and 2 
respectively, lanes 3 and 4=both showing amplification of VNTR loci CVN001 (484bp), and CVN004 
(322bp) for isolate 1 and 2 respectively and lanes 5 and 6= both showing the amplification of the CVN014 
locus (140bp) for isolate 1 and 2 respectively. Lane L= 1 kb DNA ladder. 
7.4.3 Fragment data analysis using capillary electrophoresis 
Capillary electrophoresis was done on the pool of the amplicon product from the three PCRs that 
were run per isolate (two multiplexes and one singleplex). The resultant electropherograms 
(viewed using the GeneMapper® software) showed distinct peaks (different sizes and dye 
colours) for each VNTR locus. PCR amplification of the seven VNTR loci showed different 
amplicon sizes (in base pairs) (Table 7.3). Considering the 20 diarrheic E. coli isolates from human 
and non-human sources, some of the genomic VNTR loci were amplified, while others were not 
(Figure 7:3). For example, the VNTR locus CVN003 was not amplified (It was a null allele) in 70% 
(14/20) of the isolates.  
1 2 3 4 5 6 L 
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Table 7.3 Examples of amplicon sizes observed for each of the VNTR loci 
VNTR loci CVN014 CVN015 CVN002 CVN007 CVN001 CVN004 CVN003 
Amplicon size (base 
pairs) 
104-159 210-300 362-470 342-359 433-499 300-392 413-488
Figure 7:3 Electrophoregram showing the difference in the VNTR loci detected for two isolates (Isolate 1 and Isolate 
2). 
The red (size standard), blue (FAM), black (NED), and green (HEX) peaks of different sizes represent 
the different VNTR loci. VNTR loci represented by the NED dye= CVN002 and CVN015, FAM dye= 
CVN003, CVN014, and CVN007, HEX dye= CVN001 and CVN004. The vertical axis shows relative 
fluorescence while the horizontal axis (at the top of each electropherogram) is the size in base pairs.  
7.4.4 Alleles detected per VNTR locus 
The number of repeats that were detected per genomic VNTR locus ranged from none to twelve 
(Table 7.4). 
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Table 7.4 Alleles detected by MLVA: distribution per isolate, serotype and locus. 
Isolate Serotype Allele number per genomic VNTR Locus 
CVN001 CVN002 CVN003 CVN004 CVN007 CVN014 CVN015 
777 NT 6 NA NA 7 2 3 1 
LR16 O101 6 6 NA 7 2 3 1 
NY29 O106 5 8 4 7 2 2 3 
789 NT 1 8 4 7 3 1 3 
NY3.2 NT 6 NA NA 6 1 6 3 
NY1.2 O153 5 NA 5 7 2 2 1 
NY50 O49 5 6 5 7 2 3 1 
767 NT NA NA NA 7 2 3 3 
NY1.1 O153 6 NA NA 7 2 7 3 
NY13.1 NT 6 10 NA 6 2 6 1 
NY43 O143 5 8 NA 7 2 4 1 
NY58 NT 6 NA NA 2 NA NA NA 
710 NT 6 8 NA 7 2 2 3 
NY4 NT 5 NA NA 4 4 7 3 
E101.1 NT 6 6 NA 7 2 4 3 
NY60 NT 6 12 NA 7 2 4 3 
NY28 NT 6 12 NA 7 2 4 3 
E33.1 NT 5 8 5 7 4 3 1 
E34.1 NT 5 8 4 6 2 1 3 
PK-1 NT 6 NA NA 8 2 4 1 
NA=Null Allele; NT= Non-Typeable 
7.4.5 MLVA genotypes of tellurite resistant diarrheic E. coli from human and non-
human sources in Nyanga Township. 
The MLVA genotype for each isolate was represented by the allele string for the seven VNTR loci 
(for example 6-NA-NA-8-2-4-1 was the allele string for the isolate PK-1). Overall, analysis of the 
twenty tellurite-resistant diarrheic E. coli from human and non-human sources showed nineteen 
distinct MLVA genotypes. Indeed, it was expected that the different diarrheic E. coli pathotypes 
belonged to different MLVA genotypes. Two diffusely adherent E. coli (DAEC) isolates from the 
stool of children with diarrhoea, NY28 and NY60 had identical MLVA profiles and had the same 
antibiotic resistance profiles. These two DAEC isolates were therefore assumed to be a clone. 
The dendrogram showed that the MLVA genotypes of tellurite resistant diarrheic E. coli from 
Lotus River surface water, meat from the informal abattoirs, and stool of children with diarrhoea 
were intermingled. Isolates from the different sources did not form a clone (Figure 7:4). 
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The two STEC isolates (710 and NY29) were relatively closely related (71.4% level of genotypic 
homology), had different antibiotic resistance profiles and belonged to different serotypes. 
The two ESBL producing DAEC isolates (NY1.1 and NY1.2) from the stool of children with 
diarrhoea belonged to the same serotype (O153) but had different MLVA genotypes. 
Figure 7:4 Dendrogram of the MLVA results of diarrheic E. coli from human and non-human sources in the 
Nyanga Township, Cape Town. 
STEC= Shiga toxin producing E. coli, DAEC= Diffusely adherent E. coli, EIEC= Enteroinvasive E. coli, 
EaggEC=Enteroaggregative E. coli, EPEC= Enteropathogenic E. coli. NT=Non-typeable. 
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7.5 Discussion 
In summary, the main findings of this study were; (1) tellurite resistant diarrheic E. coli from 
human and non-human sources were genotypically diverse and showed 19 distinct MLVA 
genotypes, (2) the two DAEC isolates (NY60 and NY28) had the same MLVA genotypes and 
antibiograms and were likely to be clonal, (3) tellurite resistant diarrheic E. coli from human 
sources were intermingled with those from the non-human sources but there were no clear clones, 
(4) the two STEC (NY29 and 710) showed a 71.4% level of genotypic homology and belonged to
different serotypes, (5) the two ESBL producing DAEC from stool belonged to the same serotype 
(O153) but had different MLVA genotypes. 
According to the joint Food and Agricultural Organisation (FAO)/ World Health Organisation 
(WHO) Core Expert Group Meeting on STEC, Geneva Switzerland, 19-22 July, 2016, the following 
was decided as regards source attribution (which was defined as the partitioning of the human 
disease burden of foodborne STEC illnesses to reservoirs and vehicles): (1) the subtyping 
approach is useful to determine the non-human reservoirs, (2) two approaches should be used to 
attribute regional and global burden of STEC infections to specific foods, namely; analysis of 
outbreak data and systematic review of case-control studies of sporadic laboratory-confirmed 
infections.12 In this study, for source attribution, we used the MLVA subtyping approach to 
characterise tellurite resistant diarrheic E. coli from human and non-human sources in the Nyanga 
Township, Cape Town. The MLVA subtyping method that was used in this study is generic for 
all pathogenic E. coli and has been previously used to type both O157 and non- O157 STEC with 
high accuracy.13,14  
The diversity of genotypes in this study could be affected by the sample size and sampling 
strategy, for example the study was conducted during a non-outbreak scenario and in summer 
months only. It was, however, expected that the different diarrheic E. coli pathotypes belonged to 
different MLVA genotypes. 
The two DAEC isolates (NY60 and NY28) had the same MLVA genotypes, serotype and antibiotic 
resistance profile and were suspected to be a clone. The two children from whom these DAEC 
were isolated attended the same health care centre (Nyanga Community Health Centre) and were 
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both residents of the informal settlement in the Nyanga Township. Therefore, there is a possibility 
of transmission between these two children or a common source. Whole genome sequencing of 
the two isolates would help to confirm similarity. 
MLVA genotypes of the other tellurite-resistant diarrheic E. coli from human sources were 
intermingled with those from the non-human sources but none belonged to matching clones (did 
not have 100% similar MLVA genotypes). The two STEC (NY29 and 710) showed a 71.4% level of 
genotypic homology and belonged to different serotypes. As per the  Codex Committee on Food 
Hygiene (CCFH) recommendations for the attribution of STEC infection to reservoirs and 
vehicles15, these two isolates are not from the same source.  
The two ESBL-producing DAEC from stool belonged to the same serotype (O153) but had 
different MLVA genotypes and were therefore unlikely to result from a common source or 
transmission event. 
Limitations of the study 
The genotypic diversity is likely to have been affected by the small sample size and the short 
study period. Also, tellurite susceptible STEC and other diarrheic E. coli were not detected in this 
study. MLVA typing is not as discriminatory as Whole Genome Sequencing (WGS). The two 
DAEC isolates that had 100% similar MLVA genotypes might have differences at whole genome 
sequence level. 
7.6 Conclusions 
Diarrheic E. coli from Lotus River surface water, meat from the informal abattoirs, and stool of 
children with diarrhoea in the Nyanga Township were genotypically diverse. Two DAEC isolates 
from children with diarrhoea formed a clone. STEC detected in this study were genotypically 
diverse as were the ESBL-producing DAEC. 
These results suggest that diarrheic E. coli from human and non-human sources in Nyanga are 
genotypically diverse. Further larger scale studies are needed to fully understand the 
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 Chapter Eight 
8 General discussion and conclusion 
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Over sixty percent of human infectious diseases and newly emerging infectious diseases are 
transmitted from animals through direct or indirect means globally.1,2 Mitigation of zoonotic 
disease threats requires an understanding of the dynamics of infectious diseases in complex 
multi-host communities.2 Many foodborne diseases are zoonotic and exemplify the importance 
of the emerging ‘One Health’ approach to studying human and non-human infectious disease.3  
Globally, foodborne infections are increasing because of the globalisation of food trade, 
modernization and intensification of food production systems, and international travel. In South 
Africa, as is the case in many other countries, foodborne outbreaks are common but are rarely 
reported.4 Since STEC is a persistent global pathogen, efforts to control foodborne disease should 
consider the contribution of STEC in the target population.5  
This study aimed to use the One-Health approach to determine the prevalence of Shiga-toxin 
producing Escherichia coli in Cape Town and to characterise the epidemiology of STEC and other 
foodborne bacterial pathogens isolated from stool, meat and Lotus River surface water in 
Nyanga, Cape Town. 
In summary, the main findings of this study were as follows: 
The performance of CHROMagarTMSTEC 
For all sample types, the performance of CHROMagarTMSTEC was poor compared to that of the 
duplex real-time PCR. This limitation of CHROMagarTMSTEC is in agreement with previous 
research which concluded that the use of tellurite-containing media in screening for STEC would 
allow the detection of STEC O26, O157, O111 and O145 but most strains from other serotypes 
would be missed.6  However, the duplex real-time PCR may have detected the stx genes from 
non-viable bacteria (in the absence of live pathogens) or that are carried by free floating phages. 
Prevalence of stx genes in stool, meat and surface water 
There was generally a low prevalence of STEC in the different sources with a dominance of stx1 
as compared to stx2. This could mean that STEC is a major public health threat in this setting. 
However, the tellurite susceptible STEC where missed.  
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Characteristics of diarrheic E. coli isolates from stool submitted to Groote Schuur Hospital 
This study demonstrated that diarrheic E. coli in this clinical setting are resistant to some 
antibiotics and that solid medium allows proteomic detection of virulence and antimicrobial 
resistance proteins and that tellurite resistance proteins were detected in mauve colonies from 
CHROMagarTMSTEC. Additionally, we showed possible links between ciprofloxacin resistance 
and cell envelope thickness among pathogenic strains. Therefore these strains could be of clinical 
relevance and might be considered for routine screening at the  tertiary health center level. 
Prevalence and characteristics of diarrheic bacterial pathogens in Nyanga 
This study was conducted in the absence of an outbreak and investigated the human and non-
human sources in an informal settlement setting. Since the environment is highly contaminated 
with food and waterborne pathogens, it could be an important reservoir of these pathogens for 
human infection. The MLVA tool used in this study was not so informative especially given that 
there was no outbreak. 
Foodborne antimicrobial resistance  
There was no significant difference in resistance to antibiotics between diarrheic E. coli from stool 
(human), and the environment (meat and Lotus River surface water). Alterations of patient 
treatment regimes may be necessary especially for pathogens like Shigella flexneri which were 
prevalent in this setting. 
8.1 Conclusions and future work 
These studies demonstrate the importance of a One – Health surveillance approach for foodborne 
disease, and the need for broader adoption of similar surveillance approaches in South Africa. 
Specific gaps in this work, which should be addressed by further studies include the following: 
(a) Since we were unable to determine whether tellurite-susceptible STEC are circulating,
further research is needed using alternative culture media that allow growth of tellurite
susceptible STEC. Use of a more sensitive test such as real-time PCR in parallel to
enrichment and solid medium culture might be helpful.
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More improved techniques such as whole genome sequencing might aid better 
characterisation of the STEC isolated in this study. 
(b) To determine the STEC strains associated with severe disease, comprehensive
microbiological testing and strain characterization should be done on patients presenting
with HUS.
(c) To determine contribution of diarrheic pathogens (bacterial, viral, and parasitic) to
diarrhoea in children in similar settings in South Africa, a larger scale case-control study
over at least 12 months needs to be carried out in both primary health care and the
community. Larger scale studies of food from informal abattoirs and surface water are
needed to determine the generalizability of our findings.
(d) To understand the extent of foodborne antimicrobial resistance in this setting, there is
need to screen for antimicrobial resistance genes in the human and non-human samples
in addition to determining the antibiograms of specific foodborne pathogens isolated.
(e) To understand the linkage between ciprofloxacin resistance in STEC/EPEC strains and cell
envelope thickness (as determined by transmission electron micrography), a larger
sample size and carefully controlled experimental design is needed.
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Section 1: Demographic and Epidemiological information 
1) Case interviewed by:
















e. No formal education
f. Home address:




6) Date of birth of patient:
7) Sex of patient:
a. Male
b. Female
8) What is the purpose of your visit to the health Centre?
a. Immunisation of child
b. Child is sick
c. Routine health check





e. More than 4
















c. Protected water spring
d. River
e. Open well
f. House piped water
g. Communal standpipe
13) Do you store water before drinking it?
a. Yes
b. No








g. More than 6







g. More than 6
16) What kind of toilet facility does your household use?
a. Flush toilet
b. Traditional pit latrine
c. Ventilated Improved Pit Latrine
d. Bucket system
17) When you wash your hands, what do you usually use?
a. Water
b. Water and soap
c. Other; specify










Section 2: Clinical Information 
19) Did the child have any of the following signs since the illness began?
a. Blood in stool
b. Fever
c. Cough d. Drank much less
than usual
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e. Vomiting f. Decreased activity
or weakness
g. Belly pain
h. Unable to drink
20) Is the child currently breast fed?
a. Yes
b. No
21) Was the patient on antibiotics prior to the visit?
a. Yes
b. No





Section 3: Diagnostic CRF 



























9.2 Informed consent form in English 
1. For ill participants – You/Your child’s illness/symptoms
Your child is presenting with diarrhea which could be caused by Salmonella and E. coli – two 
germs that are spread by contaminated food and water. 
2. What is the University of Cape Town and what is this study about?
The University of Cape Town (UCT) works in collaboration with the National Institute for 
Communicable Diseases (NICD). The NICD is a public health laboratory organization that carries 
out surveillance and medical research to better understand the spread of germs. This study 
focuses on germs that cause diarrhea in children under the age of 12 years and their environment 
to better understand where these diseases come from. 
3. What will it involve for me/my child?
Your child may have picked up a germ from food or water, or someone else in your community. 
To find out where this germ was picked up we are asking your permission for your child to 
participate in a surveillance study by providing a stool sample. If we find the germ in your child’s 
stool, we will also ask for a sample of food or water from your home that may have been 
contaminated. 
4. Compensation for study participants
 If we remove some food from your home for testing, you will immediately be compensated with 
replacement cost. We will offer a one-off inconvenience compensation worth R50 for each study 
participant. 
5. Are there any risks or disadvantages to me/my child of taking part?
There is no associated risk to collection of a stool sample from your child. 
6. Are there any benefits to me/my child of taking part?
By taking part you/your child may help us find the sources of food and waterborne germs and 
improve the health of many other children and adults. 
7. What happens if I refuse to participate?
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All participation in research is voluntary. You are free to decide if you want your child to take 
part.    
8. What happens to the samples?
Individual names are removed from all samples and replaced by codes, to ensure that samples 
can only be linked to the participants by people closely concerned with the study. 
Most of the tests that will be done on the sample will be done at UCT.  However, for some tests 
that cannot be done in South Africa, part of the samples will be sent to laboratories overseas. 
After the research, a small portion of the stool samples will be stored. In the future, new research 
about food and waterborne germs may be done on these samples. Future research must first be 
approved by the University of Cape Town Research Ethics Committee to ensure participants’ 
safety and rights are respected. 
9. Who will have access to information about me/my child in this study?
All our study documents are stored securely in locked cabinets and password protected 
computers. Only a few people, pathologists and scientists closely concerned with the research, 
will be able to view information from participants.  
10. Who has allowed this research to take place?
The University of Cape Town Research Ethics Committee have looked carefully at this work and 
agreed that the study is important, that it will be conducted properly and participants’ safety and 
rights have been respected. 
11. What if I have any questions?
You may ask any of our staff questions at any time:  
Dr. Lourens Robberts 
University of Cape Town, Division of Medical Microbiology 
Telephone:  021 406 6727  
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I, (being a guardian/next of kin of) ________________________________ (name of child/next of 
kin), have had the study explained to me. I have understood all that has been read and had my 
questions answered satisfactorily.  
(Please insert the boxes below or add others where relevant) 
  Yes, please tick I agree to allow my child/next of kin to take part in this research. 
  Yes, please tick I agree to samples being stored. 
  Yes, please tick I agree to samples being exported. 
I understand that I can change my mind at any stage and it will not affect care in any way. 
Parent/Next of Kin/Guardian’s: Name: ________________________________ 
          (Please print name) 
Signature: _______________________________Date ___________ Time ___________ 
I certify that I have followed the study SOP to obtain consent from the participant/guardian.  S/he 
apparently understood the nature and the purpose of the study and consents to the participation 
[of the child] in the study. S/he has been given opportunity to ask questions which have been 
answered satisfactorily. 
Designee/investigator’s signature: ________________________ Date ___________ 
Designee/investigator’s name:   _________________________Time __________ 
  (Please print name) 
Only necessary if the parent/next of kin/guardian cannot read: 
I attest that the information concerning this research was accurately explained to and apparently 
understood by the subject/parent/guardian and that informed consent was freely given by the 
subject/parent/guardian. 
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Witness’ signature:  _____________________________________ Date _____________ 
Witness’ name:       _____________________________________ Time ______________ 
*A witness is a person who is independent from the trial or a member of staff who was not
involved in gaining the consent. 
Thumbprint of the parent/guardian/next of kin as named above if they cannot write: 
THE SUBJECT/PARENT/GUARDIAN SHOULD NOW BE GIVEN A SIGNED COPY TO 
KEEP. 
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9.3 Informed Consent Form in IsiXhosa 
1. Kubathathi nxaxheba abagulayo-impawu zokugula kwakho nomntwana wakho
Umntwana wakho ubonakalisa urhudo olwenziwa zintsholongwane ezimbini ekuthiwa  yi 
salmonella ne e. Coli ezisasazwa lungcoliseko lwamanzi nokutya 
2. Ingantoni idyunivesiti yasekapa kwakunye noluphando?
Idyunivesity yasekapa isebenzisana ne national institute for communicable diseases ( nicd)  incd
ngumbutho we laboratory yezempilo kawonke-wonke eyenza ngcono uphando lwezempilo 
kulwazi ngosasazo lwentsholongwane. Oluphando lugxila kwintsholongwane ezibanga urhudo 
ebantwaneni abangaphantsi kweminyaka eyi-12 nakwi ndawo abahlala kuzo ukuze bazingcono 
ukuba ezi zifo zivelaphi. 
3. Ndibandakanyeka ngantoni mna nomntwana wam?
Umntwana wakho angayifumana intsholongwane ekutyeni okanye emanzini endlwini yakho
okanye komnye umntu ekuhlaleni. Ukwazi ukuba intsholongwane uyifumene phi siyakucela
imvume yakho ukuba umntwana wakho athathe inxaxheba kolu phando ngokuthi anikezele
ngelindle lakhe,ukuba sithe safumana intsholongwane kwilindle lomntwana wakho,siyakucela
ukuba sithathe intwana yokutya okanye amanzi endlwini yakho ekunokuthi kanti
anongcoliseko.
4.imbuyekezo kumthathi nxaxheba wophando.
Uyakuhlawulwa imali engange r50.00 voucher  ngenxa yexesha lakho olichithileyo 
Ukuba ngaba sithe sasusa intwana yokutya endlwini yakho ukuze kuvavanyelwe 
intsholongwane ,uyakufumana kwangoko imbuyekezo engange r50.00 ye voucher. 
5.ingaba bukhona ubungozi okanye ukuhleleleka kum nomntwana wam ekuthatheni
inxaxheba?
Akho bungozi obayanyaniswa nokuthathwa kwelindle kumntwana wakho.
6.ingaba ikhona imbuyekezo eza kum nomntwana wam ngokuthatha inxaxheba?
Ngokuthatha inxaxheba kwakho nomntwana wakho kunganceda ekufumaneni unobangela




7.kwenzeka ntoni ukuba andivumi ukuthatha inxaxheba?
Wonke umntu uthatha inxaxheba ngokuzi thandela,ukhululekile ukuba uthathe isigqibo
sokuvuma ukuba umntwana wakho athathe inxaxheba. 
8.kwenzeka ntoni kwi sampuli ezithathiweyo?
Igama lomntu ngamnye liyakususwa kwilindle elithatyathiweyo kusetyenziswe i
codes,ukuqinisekisa ukuba ilindle elithatyathiweyo lidityaniswa nomthathi nxaxheba ngabantu
abasebenza sondeleyo nophando.
Phantse lonke uvavanyo oluyakwenziwa kweli lindle luya kwenziwa e uct.nangona olunye 
uvavanyo lungenakwenziwa e south africa inxenye yelindle iyakuthunyelwa kwi laboratories 
zaphesheya. 
Emveni kokuba luphelile uphando intwana yelindle iyakugcinwa.kwixa elizayo kusenziwa 
uphando olutsha lwentsholongwane yokutya namanzi lungenziwa kweli lindle 
liselugcinweni.uphando lwexesha elizayo kufuneka luqale luphunyezwe yi university of 
capetown research ethics committee ukuqinisekisa ukhuseleko nama lungelo omthathi nxaxheba 
ayahlonitshwa. 
9.ngubani onelungelo kwi nkcukacha  zam  nomntwana wam?
Zonke inkcukacha zophando zivalelwa kwi khabhathi ezitshixwayo kwakunye ne computers
ezikhuseleke nge nombolo eziyimfihlo.bambalwa abantu abanjenge ngcaphephe no so science 
kwakunye nabasebenza ngokusondeleyo koluphando abayakukwazi ukujonga ezi nkcukacha. 
10.ngubani ovumele oluphando luqhutywe?
I university of capetown research ethics committee iye yajonga ngononophelo lomsebenzi
yavumelana ukuba oluphando lubalulekile kwaye luyakwenziwa ngendlela eyiyo kwaye 
ukhuseleko namalungelo omthathi nxaxheba ahloniphekile. 
11.ndingenza ntoni xa ndinemibuzo?
Ungabuza nawuphi na umsebenzi wophando imibuzo nangaliphi na ixesha.
Dr.lourens robberts 
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University of cape town, division of medical microbiology 
Umnxeba: 021 406 6727 
Mna( mzali okanye isizalwane sika) ________________________________ ( igama lomntwana/ 
isizalwana ), ndivile ngengcaciso yophando.ndiyakuqonda konke okufundiweyo nemibuzo yam 
iphendulekile ngokwaneleyo.   
(phendula ngokufanelekileyo) 
  ewe         ndiyavuma umntwana wam/isizalwane sam sithathe inxaxheba koluphando 
  ewe         ndiyavuma ilindle libeselugcinweni. 
  ewe         ndiyavuma ilindle lithunyelwe  
Ndiyaqonda ukuba ndingatshintsha isigqibo nangaliphi ixesha kwaye akukho nto 
izakuchaphazela unyango lwam. 
Umzali /isizalwane : igama:________________________________ 
  (onobumba abakhulu) 
Utyikityo:_______________________________umhla ___________ ixesha __________ 
Ndiya qinisekisa ukuba ndiyilandele imigaqo yophando ukuthatha isivumelwano kumthathi 
nxaxheba/kumzali. Uye wakuqonda ubume nenjongo yophando wavuma ukuthatha 
inxaxheba(komntana)koluphando.ulifumene ithuba lokubuza imibuzo yaphenduleka 
ngokwanelisayo. 
Igama elipheleleyo lomntu othatha imvume: __________________ixesha___________ 
  (onobumba abakhulu) 
Utyikityo lomntu othatha imvume       _________________________umhla __________ 
Xa umzali /isizalwane singakwazi ukufufunda: 
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Ndiya ngqinisisa ukuba inkcukacha malunga noluphando zicaciswe ngqo kwaye luyaqondwa 
ngumthathi nxaxheba/umzali kwaye isivumelwano sinikezelwe ngumthathi nxaxheba 
ngokuzithandela. 
Utyikityo lwengqina  __________________________________umhla _____________ 
Igama lengqina:       __________________________________ixesha ______________ 
*ingqina ngumntu oxhomekeke kuvavanyo okanye kwilungu lomsebenzi elingazanga
lizibandakanye ngokuzuza kwisivumelwano: 
Ubhontsi womzali/ummeli/isizalwane esikhankanyiweyo ngentla ukuba asikwazi kubhala. 
Umthathi nxaxheba kufuneke enikwe i kopi etyikityiweyo ibekuye. 
Amagama okuqala omthathinxaxheba: ______________ 
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9.4 Ethics approval 
signature removed
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